Document:

exv10w26

Exhibit 10.26

	 	 	 
	
	 	CONFIDENTIAL

DO NOT COPY

 

SEPARATION PAY AGREEMENT

 

By and Between

WRIGHT MEDICAL TECHNOLOGY, INC.

and

EDWARD A. STEIGER

 

April 1, 2009

 

 

	 	 	 

	Wright Medical Technology, Inc.
	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	 

	 	DO NOT COPY

SEPARATION PAY AGREEMENT

TABLE OF CONTENTS

	 	 	 	 	 

	1. Definitions.
	 	 	1	 
	2. Sarbanes-Oxley Act of 2002.
	 	 	5	 
	3. Notice and Date of Termination
	 	 	6	 
	4. Termination from the Board and any Offices Held.
	 	 	6	 
	5. Severance Benefits upon Involuntary Termination Prior to Change in Control
	 	 	6	 
	6. Severance Benefits upon Involuntary Termination in Connection with and after a
Change in Control.
	 	 	8	 
	7. Severance Benefits upon Termination by the Company for Cause or by the Executive
Other than for Good Reason.
	 	 	9	 
	8. Severance Benefits upon Termination due to Death.
	 	 	10	 
	9. Adjustments to Maximize After-Tax Benefits
	 	 	10	 
	10. Nonexclusivity of Rights.
	 	 	10	 
	11. Full Settlement; Mitigation.
	 	 	11	 
	12. Representations.
	 	 	11	 
	13. Executive’s Covenants.
	 	 	11	 
	14. Specific Remedies for Executive Breach of the Covenants as outlined in Section 13.
	 	 	13	 
	15. Potential Impact of Accounting Restatements on Certain Bonuses and Profits.
	 	 	14	 
	16. Successors.
	 	 	14	 
	17. Administration Prior to Change in Control.
	 	 	15	 
	18. Delayed Commencement of Certain Payments.
	 	 	15	 
	19. Miscellaneous.
	 	 	15	 
	EXHIBIT A
	 	 	18	 
	EXHIBIT B
	 	 	21	 
	 
	 	 	 	 

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	 

	 	DO NOT COPY

SEPARATION PAY AGREEMENT

     THIS SEPARATION PAY AGREEMENT (“Agreement”), dated as of April 1, 2009 (the
“Effective Date”) is made by and between WRIGHT MEDICAL TECHNOLOGY, INC., a corporation
organized and existing under the laws of the State of Delaware with its principal place of business
at 5677 Airline Road, Arlington, Tennessee 38002 (the “Company”), and EDWARD A. STEIGER
(the “Executive”).

     WHEREAS, the Company or its Affiliate (collectively referred to as the “Company”)
employs the Executive as Vice President, Human Resources and recognizes the Executive as performing
key functions for the success of the Company; and

     WHEREAS, the Company has determined that it is in the best interests of the Company to
institute formalized separation arrangements for certain executives of the Company, including
Executive, in the event of a separation of employment; and

     WHEREAS, the Executive desires to enter into this Agreement with Company;

     NOW, THEREFORE, based on the foregoing, and for and in consideration of the mutual covenants
contained in this Agreement, the Company and the Executive hereby agree as follows:

     1. Definitions. For the purposes of this Agreement, the following capitalized terms
have the meanings set forth below:

          1.1.
“Accounting Firm” has the meaning assigned thereto in Section 9.4 hereof.

          1.2. “Act” has the meaning assigned in Section 2 hereof.

          1.3. “Affiliate” has the meaning set forth in Rule 12b-2 promulgated under the
Exchange Act.

          1.4. “Buyer” has the meaning assigned thereto in Section 19.11 hereof.

          1.5. “Cause” means:

               1.5.1. Prior to a Change in Control, (i) the willful failure by the Executive to substantially
perform the Executive’s duties with the Company (other than any such failure resulting from the
Executive’s incapacity due to physical or mental illness) as determined by the Board, which failure
amounts to an intentional and extended neglect of the Executive’s duties, (ii) continued,
documented poor performance on the part of the Executive following a reasonably sufficient time for
the Executive to improve, (iii) the determination by the Board, in its sole discretion, that the
Executive has engaged or is about to engage in conduct materially injurious to the Company, (iv)
the Executive’s conviction of or entering of a guilty or no contest plea to a felony charge (or
equivalent thereof) in any jurisdiction; and/or (v) the Executive’s participation in activities
proscribed in Sections 13.1, 13.3, and 13.4 or the material breach of any other covenants contained
herein. For the purposes of clause (i) of this definition, no act, or failure to act, on the
Executive’s part shall be deemed to be “willful” unless done, or omitted to be done,
by the Executive not in good faith and without reasonable belief that the Executive’s act, or
failure to act, was in the best interests of the Company.

               1.5.2. From and after a Change in Control, (i) the willful failure by the Executive to
substantially perform the Executive’s duties with the Company (other than any such failure
resulting from the Executive’s incapacity due to physical or mental illness) as determined by the
Board, which failure amounts to an intentional and extended neglect of the Executive’s duties, (ii)
the determination by the

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 2

	 	DO NOT COPY

Board, in its sole discretion, that the Executive has engaged or is about
to engage in conduct materially injurious to the Company, (iii) the Executive’s conviction of or
entering of a guilty or no contest plea to a felony charge (or equivalent thereof) in any
jurisdiction; and/or (iv) the Executive’s participation in activities proscribed in Sections 13.1,
13.3, and 13.4 or the material breach of any other covenants contained herein. For the purposes of
clause (i) of this definition, no act, or failure to act, on the Executive’s part shall be deemed
to “willful” unless done, or omitted to be done, by the Executive not in good faith and without
reasonable belief that the Executive’s act, or failure to act, was in the best interests of the
Company. Notwithstanding the foregoing, the Executive shall not be deemed terminated for Cause
pursuant to clause (i) of this definition unless and until the Executive shall have been provided
with reasonable notice of and, if possible, a reasonable opportunity to cure the facts and
circumstances claimed to provide a basis for termination of the Executive’s employment for Cause.

          1.6. “Change in Control” shall be deemed to have occurred on or after the Effective
Date of any of the following:

               1.6.1. the acquisition by any Person or Persons acting as a group of capital stock of Wright
Medical Group, Inc. (“WMG”), a Delaware corporation and the sole stockholder of the
Company, which when added to any capital stock of WMG already owned by the Person, constitutes more
than fifty percent (50%) of either (i) the total fair market value of the outstanding capital stock
of WMG, or (ii) the total voting power of the outstanding capital stock of WMG; provided, however,
that a Change in Control will not be deemed to have occurred when any Person who owns more than
fifty percent (50%) of the total fair market value or the total voting power of the outstanding
capital stock of WMG as of the date of this Agreement acquires any additional capital stock of WMG;
and provided further, that an increase in the percentage of the outstanding capital stock of WMG
owned by a Person as a result of a transaction in which WMG acquires its capital stock in exchange
for property will be treated as an acquisition of such capital stock by such Person; or

               1.6.2. the acquisition by a Person, in a single transaction or a series of transactions within
a twelve (12) month period, of capital stock of WMG representing not less than thirty-five percent
(35%) of the total voting power of the outstanding capital stock of WMG; or

               1.6.3. the acquisition by a Person, in a single transaction or a series of transactions within
a twelve (12) month period, of consolidated assets of WMG which have a total gross fair market
value of not less than forty percent (40%) of the total gross fair market value of all the
consolidated assets of WMG immediately prior to such acquisition(s), in each case without regard to
any liabilities associated with such assets; provided, however, that a Change in Control will not
be deemed to have occurred when such assets are acquired by:

                    1.6.3.1. an entity of which WMG owns, directly or indirectly, fifty percent (50%) or more of
the total fair market value or the total voting power of the outstanding capital stock;

                    1.6.3.2. a Person which owns, directly or indirectly, fifty percent (50%) or more of the total
fair market value or the total voting power of the outstanding capital stock of WMG;

                    1.6.3.3. an entity of which a Person described in clause ii above owns, directly or
indirectly, fifty percent (50%) or more of the total fair market value or the total voting power of
the outstanding capital stock;

                    1.6.3.4. an entity which is controlled by the stockholders of WMG immediately after the
transfer; or

                    1.6.3.5. a stockholder of WMG in exchange for or with respect to capital stock of WMG.

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 3

	 	DO NOT COPY

          1.6.4 a majority of the members of the WMG Board of Directors (the “Board”) is
replaced in any twelve (12) month period by directors whose appointment or election is not endorsed
by a majority of the members of the Board prior to the date of the appointment or election; or

          1.6.5 there is consummated a merger or consolidation of the Company or any direct or indirect
subsidiary of the Company with any other corporation or partnership which results in a forty
percent (40%) or more of the Company’s assets to be transferred under the control of a different
legal entity.

          1.7. “Change in Control Date” means the date on which a Change in Control occurs.

          1.8. “Code” means the Internal Revenue Code of 1986, as amended and the Treasury
Regulations promulgated thereunder, as in effect from time to time.

          1.9. “Compensation Committee” means the compensation committee of the Board.

          1.10. “Competitive Business” means the manufacturing, supplying, producing, selling,
distributing, marketing or providing for sale of any product, device or instrument manufactured or
sold by the Company or any of its Affiliates or subsidiaries, in each case as of the Executive’s
Date of Termination.

          1.11. “Confidential Information” means non-public privileged or confidential
information and trade secrets concerning the operations, future plans and methods of doing
business.

          1.12. “Date of Termination” has the meaning assigned thereto in Section 3.2 hereof.

          1.13. “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the
applicable rulings and regulations thereunder.

          1.14. “Excise Tax” has the meaning assigned thereto under Section 9 hereof.

          1.15.“Good Reason” means:

               1.15.1. Prior to a Change in Control, the occurrence of any of the following without the prior
written consent of the Executive, unless such act or failure to act is corrected prior to the Date
of Termination specified in the Notice of Termination (as discussed in Section 3 hereof):

                    1.15.1.1. the assignment to the Executive of any duties materially inconsistent with the range
of duties and responsibilities appropriate to a senior executive within the Company, such range
determined by reference to past, current and reasonable practices within the Company;

                    1.15.1.2. a material reduction in the Executive’s overall standing and responsibilities within
the Company, but not including a mere title change or a transfer within the Company which does not
singly or together adversely affect the Executive’s overall status within the Company, provided
however, that no change in reporting relationship resulting from organizational realignment due to
the addition of a Chief Operating Officer or Chief Commercial Officer shall be included in this
definition of Good Reason;

                    1.15.1.3. a material reduction by the Company in the Executive’s aggregate annualized
compensation and benefits opportunities, except for across-the-board reductions or modifications of
benefit plans similarly affecting all similarly situated executives of comparable rank with the
Executive;

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 4

	 	DO NOT COPY

                    1.15.1.4. the failure by the Company to pay to the Executive any portion of the Executive’s
current compensation and benefits under any program with the Company within thirty (30) days of the
date such compensation and/or benefits are due;

                    1.15.1.5. any purported termination of the Executive’s employment that is not effected
pursuant to a Notice of Termination satisfying the requirements of Section 3 hereof; for the
purposes of this Agreement, no such purported termination shall be effective;

                    1.15.1.6. the failure by the Company to obtain a satisfactory agreement from any successor of
the Company requiring such successor to assume and agree to perform the Company’s obligations under
this Agreement, as contemplated in Section 16.3 hereof;

                    1.15.1.7. the failure of the Company to provide indemnification and D&O insurance protection
as required in Section 10 of this Agreement; or

                    1.15.1.8. the failure by the Company to comply with any material provision of this Agreement.

               1.15.2. From and after a Change in Control, the occurrence of any of the following without the
prior written consent from the Executive, unless such act or failure to act is corrected prior to
the Date of Termination specified in the Notice of Termination (as discussed in Section 3 hereof):

                    1.15.2.1. a material and adverse change in the Executive’s title, authority as an executive
officer, duties, responsibilities or reporting lines as in effect immediately prior to the Change
in Control;

                    1.15.2.2. a material reduction in the Executive’s aggregate annualized compensation
opportunities or the failure to continue in effect any material benefit plan in which the Executive
participates immediately prior to the Change in Control, unless an equitable arrangement, agreeable
to the Executive, has been made with respect to such plan as replacement or the reduction in
participation levels of such replacement plans of the Executive;

                    1.15.2.3. the relocation of the Executive’s principal place of employment immediately prior to
the Change in Control Date (the “Principal Location”) to a location which is more than
forty (40) miles from the Principal Location.

               1.15.3. Notwithstanding any of the foregoing, placing the Executive on a paid leave for up to
ninety (90) days pending a determination of whether there is a basis to terminate the Executive for
Cause shall not constitute a Good Reason.

               1.15.4. Following a Change in Control, the Executive’s determination that an act or failure to
act constitutes Good Reason shall be presumed to be valid unless the Company can provide
incontrovertible evidence to the contrary. The Executive’s right to terminate the Executive’s
employment for Good Reason shall not be affected by the Executive’s incapacity due to physical or
mental illness. The Executive’s continued employment shall not constitute consent to, or a waiver
of rights with respect to, any act or failure to act constituting Good Reason hereunder.

          1.16. “Incentive Compensation Awards” means awards granted under Incentive
Compensation Plans providing the Executive with the opportunity to earn, on a year-by-year or a
multi-year basis, annual and long-term incentive compensation.

          1.17. “Incentive Compensation Plans” means annual incentive compensation plans and
long-term incentive compensation plans of the Company, which long-term incentive compensation plans
may include plans offering stock options, restricted stock and other forms of long-tern incentive
compensation.

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 5

	 	DO NOT COPY

          1.18. “Involuntary Termination” means (a) a termination of employment by the Company
for other than for Cause or death, or (b) the Executive’s resignation of employment for Good
Reason; provided, however, that except as provided in the last paragraph of Section 6 hereof, a
termination of the Executive’s employment by reason of the Executive’s retirement on or after age
[65] prior to a Change in Control shall not constitute an Involuntary Termination hereunder. In
addition, an Involuntary Termination that would cause an amount to be paid to an Executive which is
non-qualified deferred compensation subject to Code Section 409A, shall also mean an Executive’s
“separation from service” within the meaning of Section 409A of the Code.

          1.19. “Notice of Termination” has the meaning assigned thereto under Section 3.1
hereof.

          1.20. “Payment” has the meaning assigned thereto in Section 9 hereof.

          1.21. “Person” has the meaning set forth in Section 3(a)(9) of the Exchange Act, as
modified and used in sections 13(d) and 14(d) thereof, except that the term shall not include (i)
the Company or any of its Affiliates, (ii) a trustee or other fiduciary holding securities under an
employee benefit plan of the Company or any of its Affiliates, (iii) an underwriter temporarily
holding securities pursuant to an offering of such securities, (iv) a corporation owned, directly
or indirectly, by the shareholders of the Company in substantially the same proportions as their
ownership of the stock in the Company, or (v) a person or group as used in Rule 13d-1(b)
promulgated under the Exchange Act.

          1.22. “Post-Change In Control Accrued Obligations” has the meaning assigned thereto in
Section 6.3.1 hereof.

          1.23. “Post-Change In Control Severance Payment” has the meaning assigned thereto in
Section 6 hereof.

          1.24. “Pre-Change In Control Accrued Obligations” has the meaning assigned thereto in
Section 5.3.1 hereof.

          1.25. “Pre-Change In Control Severance Payment” has the meaning assigned thereto in
Section 5 hereof.

          1.26. “Principal Location” has the meaning assigned thereto in Section 1.15.2.3 above.

          1.27. “Release” has the meaning assigned thereto in Section 13.5 hereof.

          1.28. “Total Number of Months” has the meaning assigned thereto in Sections 5 and 6
hereof.

          1.29. “Underpayment” has the meaning assigned thereto in Section 9.2 hereof.

     2. Sarbanes-Oxley Act of 2002. Notwithstanding anything herein to the contrary, if
the Company determines, in its good faith judgment, that any provision of this Agreement is likely
to be interpreted as a personal loan prohibited by the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder (the
“Act”), then such provision shall be modified as necessary or appropriate so as to not
violate the Act; and if this cannot be accomplished, then the Company shall use its best efforts to
provide the Executive with similar, but lawful, substitute benefit(s) at a cost to the Company not
to significantly exceed the amount the Company would have otherwise paid to provide such benefit(s)
to the Executive. In addition, if the Executive is required to forfeit or to make any repayment of
any compensation or benefit(s) to the Company under the Act or any other law, such forfeiture or
repayment shall not constitute Good Reason.

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 6

	 	DO NOT COPY

     3. Notice and Date of Termination

          3.1. Any termination of the Executive’s employment by the Company or by the Executive shall be
communicated by a written notice of termination to the other party (the “Notice of
Termination”). Where applicable, the Notice of Termination shall indicate the specific
termination provision in this Agreement relied upon and shall set forth in reasonable detail the
facts and circumstances claimed to provide a basis for termination of the Executive’s employment
under the provision so indicated. Unless the Board determines otherwise, a Notice of Termination
by the Executive alleging a termination for Good Reason must be made within 90 days of the initial
instance, or the initial instance which should reasonably have been known to the Executive, of an
act or failure to act that the Executive alleges to constitute Good Reason.

          3.2. The date of the Executive’s termination of employment with the Company (the “Date of
Termination”) shall be determined as follows:

               3.2.1. If due to Company terminating the Executive’s employment, either with or without Cause,
the Date of Termination shall be the date specified in the Notice of Termination; if for other than
Cause, the Date of Termination shall not be less than two (2) weeks from the date such Notice of
Termination is given, unless the Company elects to pay the Executive for that period in lieu of
notice.

               3.2.2. If due to death, the Date of Termination is the date of death.

               3.2.3. If the basis of the Executive’s Involuntary Termination is the Executive’s resignation
for Good Reason, the Date of Termination shall be determined by the Company, but shall not be less
than two (2) weeks nor more than eight (8) weeks form the date such Notice of Termination is given.

     4. Termination from the Board and any Offices Held. Upon termination of the
Executive’s employment for any reason, the Executive agrees the Executive’s membership on the Board
of the Company, the board of directors of any of the Company’s Affiliates, any committees of the
Board, any committees of the board of directors of any of the Company’s Affiliates and any and all
offices held, if applicable, shall be automatically terminated. Executive hereby agrees to
cooperate with the Company and execute any documents reasonably required by the Company or
competent authorities to effect this provision.

     5. Severance Benefits upon Involuntary Termination Prior to Change in Control. Except
as provided in Sections 6 and 17 hereof, in the event of the Involuntary Termination of the
Executive prior to a Change in Control, the Company shall pay to the Executive the following
Pre-Change in Control Severance Payment in the following amounts and manner:

          5.1. The total payment will be equal to the product of twelve (12) months (the “Total
Number of Months”) multiplied by 1.45 times monthly base pay. Provided, however, if the
termination occurs within the first two (2) years of the Executive’s initial employment, the
Total Number of Months shall not be less than eighteen (18) months.

          5.2. The payment will be made as follows: (i) half in a lump sum payable at or within a
reasonable period of time after the Date of Termination and (ii) subject to receipt of an executed
Release that has not been revoked, the remaining half in installments starting six (6) months after
the Date of Termination with a final installment of all remaining amounts to be paid on or before
March 15 of the calendar year following the year in which the Date of Termination occurred. The
amount of each installment payment described in clause (ii) of the preceding sentence will be
determined by dividing half of the total payment by 50% of the Total Number of Months. The final
installment will be equal to the total payment reduced by all the amounts previously paid (i.e.,
the lump sum payment and the sum of all the installment payments previously paid). Notwithstanding
the provisions of clause (ii) to the contrary, if the

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 7

	 	DO NOT COPY

six month period would cause the installments to begin to be paid after the March 15 date described in the first sentence of this section 5.2,
then no installments will be paid, and the second payment will be a lump sum equal to half the
total payment and that payment will be paid on or before March 15 of the calendar year following
the year in which the Date of Termination occurred. The installment payments (or the second lump
sum payment, if applicable) are specifically designated as consideration for execution of the
Release required in Section 13 and compliance with Executive’s covenants outlined in Section 13.
All payments will have applicable taxes withheld and any installment payments will be paid at the
same time as the normal Company payroll.

          5.3. In addition to the Pre-Change in Control Severance Payment, the Executive shall be
entitled to receive the following additional benefits:

               5.3.1. Accrued Obligations. The Company shall pay to the Executive a lump sum amount
in cash equal to the sum of (i) the Executive’s annual base salary through the Date of Termination
to the extent not theretofore paid, (ii) an amount equal to any annual cash Incentive Compensation
Awards earned (based on the performance for the most recently completed incentive period, whether
that period is the prior quarter or the prior calendar year), but not yet paid, (iii) an amount
equal to the value of any accrued and/or untaken vacation, if any, and (iv) reimbursement for
unreimbursed business expenses, if any, properly incurred by the Executive in the performance of
the Executive’s duties in accordance with the policies established from time to time by the Board.
(The amounts specified in clauses (i), (ii), (iii) and (iv) shall be hereinafter referred to as the
“Pre-Change in Control Accrued Obligations”.)

               5.3.2. Equity Based Compensation. All equity-based Incentive Compensation Awards
(including, without limitation, stock options, stock appreciation rights, restricted stock awards,
restricted stock units, performance share awards or other related awards) held by the Executive
shall be governed by the terms of the applicable Incentive Compensation Plan and Incentive
Compensation Award agreement, and this Agreement shall have no effect upon them.

               5.3.3. Welfare Benefits. Subject to Section 11 herein, the Executive shall be
eligible for health and dental coverage as provided for under COBRA, using the normal COBRA
administration process of the Company. The Company will pay all costs of these benefits for a
period up to, but not exceeding 18 months. If the Executive accepts employment with another
employer or otherwise is no longer eligible for COBRA coverage, these welfare benefits will cease
to be provided.

               5.3.4. Outplacement Benefits. The Executive shall receive outplacement assistance and
services following the Date of Termination for a period of months equal to the Total Number of
Months. These services will be provided by a national firm whose primary business is outplacement
assistance, selected by the Company. Notwithstanding the above, if the Executive accepts
employment with another employer, these outplacement benefits shall cease on the date of such
acceptance.

               5.3.5. Financial Planning Services. The Executive shall receive financial planning
services for a period of months equal to the Total Number of Months following the Date of
Termination, at a level consistent with the benefits provided under the Company’s financial planning program
for the Executive as in effect immediately prior to the Date of Termination.

               5.3.6. Annual Physical. The Executive may, within the 12 months following the Date of
Termination, receive an annual physical consistent with the physical provided under the Company’s
annual physical program as in effect immediately prior to the Date of Termination.

               5.3.7. General Insurance Benefit. No later than March 15 of the calendar year
following the year in which the Date of Termination occurred, provided Executive has made a request
for the payment described in this section 5.3.7 on such form as the Company may require. Executive shall

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 8

	 	DO NOT COPY

receive a payment for use in continuation of insurance coverage, such payment to be equal to
the annual supplemental executive insurance benefit provided to the Executive prior to the
Executive’s Date of Termination. The Company will use its best efforts to make this payment at the
time requested.

               5.3.8. Attorney’s Fees in Defense of This Agreement. Notwithstanding any provision in
this Agreement, the Company shall pay all reasonable attorneys’ fees and expenses for the Executive
if the Executive must engage an attorney in order to enforce this Agreement following the
Executive’s Date of Termination. The Company will make payments on at least a quarterly basis
based on billings presented by the Executive from his or her legal counsel.

     6. Severance Benefits upon Involuntary Termination in Connection with and after a Change
in Control. Notwithstanding the provisions of Section 5 above, in the event of the Involuntary
Termination of the Executive within twelve (12) months following a Change in Control, the Company
shall pay to the Executive the following Post-Change in Control Severance Payment in the
following amounts and manner:

          6.1. The total payment will be equal to twelve (12) months multiplied by 1.45 times monthly
base pay. This is the Total Number of Months (the “Total Number of Months”). Provided,
however, if the termination occurs within the first two (2) years of the Executive’s initial
employment, the Total Number of Months shall not be less than eighteen (18) months.

          6.2. The payment will be made as follows: (i) half in a lump sum payable at or within a
reasonable period of time after the Date of Termination and (ii) subject to receipt of an executed
Release that has not been revoked, the remaining half in installments starting six (6) months after
the Date of Termination with a final installment of all remaining amounts to be paid on March 15 of
the calendar year following the year in which the Date of Termination occurred. The amount of each
installment payment described in clause (ii) of the preceding sentence will be determined by
dividing half of the total payment by 50% of the total Number of Months. The final installment
will be equal to the total payment reduced by all the amounts previously paid (i.e., the lump sum
payment and the sum of all the installment payments previously paid). Notwithstanding the
provisions of clause (ii) to the contrary, if the six month period would cause the installments to
begin to be paid after the March 15 date described in the first sentence of this section 6.2, then
no installments will be paid, and the second payment will be a lump sum equal to half the total
payment and that payment will be paid on March 15 of the calendar year following the year in which
the Date of Termination occurred. The installment payments (or the second lump sum payment, if
applicable) are specifically designated as consideration for execution of the Release required in
Section 13 and compliance with Executive’s covenants outlined in Section 13. All payments will
have applicable taxes withheld and any installment payments will be paid at the same time as the
normal Company payroll.

          6.3. In addition to the Post-Change in Control Severance Payment, the Executive shall be
entitled to receive the following additional benefits:

               6.3.1. Accrued Obligations. The Company shall pay to the Executive a lump sum amount
in cash equal to the sum of (i) the Executive’s annual base salary through the Date of Termination
to the extent not theretofore paid, (ii) an amount equal to any annual cash Incentive Compensation
Awards earned (based on most recently completed performance period, whether that period is the
prior quarter or the prior year), but not yet paid, (iii) an amount equal to the value of any
accrued and/or untaken vacation, if any, (iv) reimbursement for unreimbursed business expenses, if
any, properly incurred by the Executive in the performance of the Executive’s duties in accordance
with the policies established from time to time by the Board and (v) an annual incentive payment at
target for the year that includes the Date of Termination, prorated. (The amounts specified in
clauses (i), (ii), (iii), (iv) and (v) shall be hereinafter referred to as the “Post-Change in
Control Accrued Obligations”.)

               6.3.2. Equity Based Compensation. All equity-based Incentive Compensation Awards
(including, without limitation, stock options, stock appreciation rights, restricted stock awards,

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 9

	 	DO NOT COPY

restricted stock units, performance share awards or other related awards) held by the Executive
shall be governed by the terms of the applicable Incentive Compensation Plan and Incentive
Compensation Award agreement, and this Agreement shall have no effect upon them.

               6.3.3. Welfare Benefits. Subject to Section 11 herein, the Executive shall be
eligible for health and dental coverage as provided for under COBRA, using the normal COBRA
administration process of the Company. The Company will pay all costs of these benefits for a
period up to, but not exceeding 18 months. If the Executive accepts employment with another
employer or otherwise is no longer eligible for COBRA coverage, these welfare benefits will cease
to be provided.

               6.3.4. Outplacement Benefits. The Executive shall receive outplacement assistance and
services following the Date of Termination for a period of months equal to the Total Number of
Months. These services will be provided by a national firm whose primary business is outplacement
assistance, selected by the Company. Notwithstanding the above, if the Executive accepts
employment with another employer, these outplacement benefits shall cease on the date of such
acceptance.

               6.3.5. Financial Planning Services. The Executive shall receive financial planning
services for a period of months equal to the Total Number of Months following the Date of
Termination, at a level consistent with the benefits provided under the Company’s financial
planning program for the Executive as in effect immediately prior to the Date of Termination.

               6.3.6. Annual Physical. The Executive shall, within the 12 months following the Date
of Termination, receive an annual physical consistent with the physical provided under the
Company’s annual physical program as in effect immediately prior to the Date of Termination.

               6.3.7. General Insurance Benefit. No later than March 15 of the calendar year
following the year in which the Date of Termination occurred, provided Executive has made a request
for the payment described in this section 6.3.7 on such form as the Company may require. Executive
shall receive a payment for use in continuation of insurance coverage, such payment to be equal to
the annual supplemental executive insurance benefit provided to the Executive prior to the
Executive’s Date of Termination. The Company will use its best efforts to make this payment at the
time requested.

               6.3.8. Attorney’s Fees in Defense of This Agreement. Notwithstanding any provision in
this Agreement, the Company shall pay all reasonable attorneys’ fees and expenses for the Executive
if the Executive must engage an attorney in order to enforce this Agreement following the
Executive’s Date of Termination. The Company will make payments on at least a quarterly basis
based on billings presented by the Executive from his or her legal counsel.

          6.4. Notwithstanding anything contained herein, if a Change in Control occurs and the
Executive’s employment with the Company is terminated by reason of Involuntary Termination prior to
the Change in Control Date, and if such termination of employment (i) was at the request of a
third party who has taken steps reasonably calculated to effect the Change in Control or (ii)
otherwise arose in connection with or in anticipation of the Change in Control, then the Executive
shall, in lieu of the payments described in Section 5 hereof, be entitled to the Post-Change in
Control Severance Payment and the additional benefits described in this Section 6 as if such
Involuntary Termination had occurred within twelve (12) months following the Change in Control.

     7. Severance Benefits upon Termination by the Company for Cause or by the Executive Other
than for Good Reason. If the Executive’s employment shall be terminated for Cause, or if the
Executive terminates employment other than for Good Reason, the Company will have no further
obligations to the Executive under this Agreement other than the Pre-Change in Control Accrued
Obligations and any amounts described in Section 10 hereof.

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 10

	 	DO NOT COPY

     8. Severance Benefits upon Termination due to Death. If the Executive’s employment
shall terminate by reason of death, the Company shall pay the Executive’s estate the Post-Change in
Control Accrued Obligations and any amounts or benefits described in Section 10 herein. Such
payments shall be in addition to those rights and benefits to which the Executive’s estate may be
entitled under the relevant Company plans or programs.

     9. Adjustments to Maximize After-Tax Benefits. In the event it shall be determined
that any payment or distribution by the Company or its Affiliates to or for the benefit of the
Executive (whether paid or payable or distributed or distributable pursuant to the terms of this
Agreement or otherwise, but determined without regard to any additional payments required under
this Section 9 ( a “Payment”) would be subject to the excise tax imposed by Section 4999 of
the Code or any interest or penalties are incurred by the Executive with respect to such excise tax
(such excise tax, together with any such interest and penalties, are hereinafter collectively
referred to as the “Excise Tax”) , then the Executive’s Unreduced and Reduced Net Benefit
shall be determined and the Payments shall be adjusted in accordance with Section 9.3.

          9.1. For purposes of Section 9.3 the Unreduced Net Benefit shall equal the Payments, less the
amount of federal, state and local income and other taxes (including the excise tax under Code
Section 4999) payable with respect to such benefits. For these purposes, the federal, state, local
and any other taxes shall be calculated at the maximum marginal income tax rates applicable to such
Executive for each year in which the foregoing amounts shall be paid.

          9.2.For purposes of Section 9.3 the Reduced Net Benefit shall equal the amount determined
under Section 9.1 but with the Payments first reduced by an amount such that the present value of
all payments and benefits that the Executive receives or is entitled to receive from the Company
that would constitute “parachute payments” within the meaning of Code Section 280G does not exceed
2.99 times the Executive’s “base amount,” as defined under Code Section 280G. For purposes of
calculating the aggregate present value of such parachute payments, the requirements of Code
Section 280G shall be followed.

          9.3. If the Executive’s Reduced Net Benefit is greater than the Unreduced Net Benefit, then
the amount of the Payments set forth in Section 9.2 of the Agreement shall be reduced to an
aggregate present value amount that does not subject any of the payments to taxation under Code
Section 4999.

          9.4. A nationally recognized accounting firm as may be agreed upon by the Company and the
Executive (the “Accounting Firm”) shall perform any and all calculations required under Code
Section 280G, and shall determine the Executive’s Reduced and Unreduced Net Benefit. Such
determination shall be made within ten (10) business days of the date of a change in control or ownership as
determined under Code Section 280G and such determinations shall be binding on the Company and the
Executive. In the event a reduction of the Payments is to be made pursuant to Section 9.3, the
Executive shall have discretion to determine which and how much of the Payments shall be eliminated
or reduced consistent with the requirements of Section 9.3 and in accordance with the requirements
of Code Section 409A. The Executive shall make such decision no later than five (5) business days
following the determination by the independent accounting firm of the Executive’s Reduced and
Unreduced Net Benefit.

     10. Nonexclusivity of Rights. Nothing in this Agreement shall prevent or limit the
Executive’s continuing or future participation in any benefit plan, program, policy or practice
provided by the Company and for which the Executive may qualify (except with respect to any benefit
to which the Executive has waived the Executive’s rights in writing), including, without
limitation, any and all indemnification arrangements in favor of the Executive (whether under
agreements or under the Company’s charter documents or otherwise), and insurance policies covering
the Executive, nor shall anything herein limit or otherwise affect such rights as the Executive may
have under any other contract or agreement entered into after the Effective Date with the Company.
Amounts which are vested benefits or which the

 

 

	 	 	 

	Wright Medical Technology, Inc.

	 	 
	Separation Pay Agreement

	 	CONFIDENTIAL
	Page 11

	 	DO NOT COPY

Executive is otherwise entitled to receive under any benefit, plan, policy, practice or program of, or any contract or agreement entered into with, the
Company shall be payable in accordance with such benefit, plan, policy, practice or program or
contract or agreement except as explicitly modified by this Agreement. At all times during the
Executive’s employment with the Company and thereafter, the Company shall provide the Executive
with indemnification and director and officer insurance insuring the Executive against insurable
events which occur or have occurred while the Executive was a director or executive officer of the
Company, on terms and conditions that are at least as generous as that then provided to any other
current or former director or executive officer of the Company or any Affiliate.

     11. Full Settlement; Mitigation. The Company’s obligation to make the payments
provided for in this Agreement and otherwise to perform the obligations hereunder shall not be
affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which
the Company may have against the Executive or others, provided that nothing herein shall preclude
the Company from separately pursuing recovery from the Executive based on any such claim. In no
event shall the Executive be obligated to seek other employment or take any other action by way of
mitigation of the amounts (including amounts for damages for breach) payable to the Executive under
any of the provisions of this Agreement, and such amounts shall not be reduced whether or not the
Executive obtains other employment.

     12. Representations. The Executive hereby represents to the Company that the
Executive is legally entitled to enter into this Agreement and to perform the Executive’s
obligations hereunder, and that the Executive has the full right, power and authority, subject to
no rights of any third parties, to grant to the Company the rights contemplated in Section 13.2.

     13. Executive’s Covenants. The Executive hereby agrees to the following:

          13.1. Confidentiality. The Executive recognizes and acknowledges that the Company’s
and its predecessor’s Confidential Information is a valuable, special and unique asset of the
Company’s businesses, access to and knowledge of which are essential to the performance of the
Executive’s duties. Confidential Information shall include trade secrets and includes information
acquired by the Executive in the course and scope of the Executive’s job with the Company,
including information acquired from third parties, that is (i) not generally known or disseminated
outside the Company (such as nonpublic information), (ii) is designated or marked by the Company as
“confidential” or reasonably should be considered confidential or proprietary, or (iii) the Company indicates through its policies,
procedures or other instructions should not be disclosed to anyone outside the Company. Without
limiting the foregoing definitions, some examples of Confidential Information under this Agreement
include (a) matters of a technical nature, such as scientific, trade or engineering secrets,
“know-how”, formulae, secret processes, inventions, and research and development plans or projects
regarding existing and prospective customers, and products and services, (b) information about
costs, profits, markets, sales, customer lists, customer needs, customer preferences and customer
purchasing histories, supplier lists, internal financial data, personnel evaluations, nonpublic
information about medical devices or products of the Company (including future plans about them),
information and material provided by third parties in confidence and/or with nondisclosure
restrictions, computer access passwords, and internal market studies or surveys and (c) any other
information or matters of a similar nature. The Executive shall not, during or after the
Executive’s employment by the Company, in whole or in part, disclose such Confidential Information
to any person, firm, corporation, association or other entity for any reason or purpose whatsoever,
nor shall the Executive make use of any such property for the Executive’s own purposes or for the
benefit of any person firm, corporation, association or other entity (except the Company) under any
circumstances during or after the Executive’s employment by the Company; provided, however, that
after the Executive’s employment by the Company ceases these restrictions shall not apply to such
Confidential Information, if any, which are then in the public domain, and provided further that
the Executive was not responsible, directly or indirectly, for such Confidential Information
entering the public domain without the Company’s consent.

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 12

	 	

CONFIDENTIAL

DO NOT COPY

          13.2. Inventions. The Executive hereby sells, transfers and assigns to the
Company or to any person or entity designated by the Company all of the right, title and interest
of the Executive in and to all inventions, ideas, disclosures and improvements, whether patented or
unpatented, and copyrightable material, made or conceived by the Executive, solely or jointly,
during the Executive’s employment by the Company or any of its predecessors which relate to
methods, apparatus, designs, products, processes or devices sold, leased, used or under
consideration or development by the Company or any of its predecessors, or which otherwise relate
to or pertain to the business, functions or operations of the Company or any of its predecessors,
or which arise from the efforts of the Executive during the Executive’s employment with the Company
or any of its predecessors. The Executive shall, during and after the Executive’s employment with
the Company, communicate promptly and disclose to the Company, in such form as the Company
requests, all information, details and data pertaining to the aforementioned inventions, ideas,
disclosures and improvements. The Executive shall, during and after the Executive’s employment by
the Company, execute and deliver to the Company such formal transfers and assignments and such
other papers and documents as may be necessary by the Company to file and prosecute the patent
applications and, as to copyrightable material, to obtain copyright thereof. Any invention
relating to the business of the Company and disclosed by the Executive within one (1) year after
the Executive’s employment with the Company ceases shall be deemed to fall within the provisions of
this Section 13.2 unless proved to have been first conceived and made following such termination or
expiration.

          13.3. Non-Solicitation of Employees. The Executive recognizes that the Executive
possesses and will possess confidential information about other employees of the Company and its
Affiliates relating to their education, experience, skills, abilities, compensation and benefits,
and inter-personal relationships with customer of the Company and its Affiliates. The Executive
recognizes that the information the Executive possesses and will possess about these other
employees is not generally known, is of substantial value to the Company and its Affiliates in
developing their business and in securing and retaining customers, and has been and will be
acquired by the Executive because of the Executive’s business position with the Company and its
Affiliates. The Executive agrees that at all times during the Executive’s employment with the
Company and for a period equal to the Executive’s Total Number of Months thereafter, the Executive
will not, directly or indirectly, solicit or recruit any employee of the Company or its Affiliates
for the purpose of being employed by the Executive or by any competitor of the Company or its
Affiliates on whose behalf the Executive is acting as an agent, representative or employee and that
the Executive will not convey such confidential information or trade secrets about other employees
of the Company and its Affiliates to any other Person; provided, however, that it shall not
constitute a solicitation or recruitment of employment in violation of paragraph to discuss
employment opportunities with any employee of the Company or its Affiliates who has either first
contacted the Executive or regarding whose employment the Executive has discussed with and received
the written approval of the Company’s Vice President, Human Resources (or, if such position is
vacant, the Company’s then Chief Executive Officer), prior to making such solicitation or
recruitment. In view of the nature of the Executive’s employment with the Company, the Executive
likewise agrees that the Company and its Affiliates would be irreparably harmed by any such
solicitation or recruitment in violation of the terms of this paragraph and that the Company and
its Affiliates shall therefore be entitled to preliminary and/or permanent injunctive relief
prohibiting the Executive from engaging in any activity or threatened activity in violation of the
terms of this paragraph and to any other relief available to them.

     13.4. Non-Interference and Non-Competition. During the Executive’s employment by
the Company and its Affiliates and for a period of months equal to the Executive’s Total Number of
Months after such employment ceases, the Executive shall not, directly or indirectly (whether as an
officer, director, owner, employee, partner, or other participant), engage in any Competitive
Business. During this period, the Executive shall not solicit or entice any agent, supplier,
consultant, distributor, contractor, lessors or lessees of the Company or its Affiliates to make
any changes whatsoever in their current relationships with the Company or its Affiliates, and will
not assist any other Person or entity to interfere with or dispute such relationship. In view of
the nature of the Executive’s employment with the Company, the Executive likewise agrees that the
Company and its Affiliates would be irreparably harmed by any

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 13

	 	

CONFIDENTIAL

DO NOT COPY

such interference or competitive actions in violation of the terms of this paragraph and that
the Company and its Affiliates shall therefore be entitled to preliminary and/or permanent
injunctive relief prohibiting the Executive from engaging in any activity or threatened activity in
violation of the terms of this paragraph and to any other relief available to them.

          13.5. Release. The Executive and the Company agree that if the Executive’s employment
is terminated for any reason other than Cause or death, the Executive and the Company will execute
a release (the “Release”) of all claims substantially in the form attached hereto as
Exhibit A within forty-five (45) days after the applicable Date of Termination and does not revoke
such Release in accordance to the terms thereof. The Executive recognizes and agrees that
notwithstanding any other section to the contrary, this executed Release is required to be made
prior to any payments of any kind under this Agreement. Furthermore, in the event that the
Executive is covered under the Age Discrimination in Employment Act (“ADEA”), the Executive
agrees to execute the ADEA Release of all ADEA claims substantially in the form attached
hereto as Exhibit B as provided in the ADEA Release.

          13.6. Cooperation with Legal Matters. Executive agrees to cooperate with the Company
and its designated attorneys, representatives and agents in connection with any actual or
threatened judicial, administrative or other legal or equitable proceeding in which the Company is
or may become involved. Upon reasonable notice, Executive agrees to meet with and provide to the
Company or its designated attorneys, representatives or agents all information and knowledge
Executive may have relating to the subject matter of any such proceeding. The Company agrees to
reimburse Executive for any reasonable costs incurred by Executive in providing such cooperation.

     14. Specific Remedies for Executive Breach of the Covenants as outlined in Section 13.
Without limiting the rights and remedies available to the Company, and notwithstanding the rights
of the Executive set forth in Section 11, in the event of any breach by the Executive of the
covenants set forth in Section 13 above, the following actions may be taken by the Company:

          14.1. if the Company believes a breach has occurred, it will deliver to the Executive a
summary of the breach and a demand for explanation or agreement that such breach has occurred; the
Executive shall have twenty (20) business days to respond in writing to this demand, whereupon the
Company will make a decision as to whether the breach has, in fact, occurred; if it is determined
such a breach has occurred, then

          14.2. the Company’s obligation to make any payment or provide any benefits to the Executive
under Sections 5, 6, 7, 8 or 9 of this Agreement shall cease immediately and permanently, which
shall not have any impact whatsoever on the Executive’s continuing obligations under Sections 14.3
and 14.4 below, except, however, the benefits outlined in Sections 5.3.8 and 6.3.8 will continue to
be provided;

          14.3. the Executive shall repay to the Company, within ten (10) days after the Executive
receives written demand therefore, an amount equal to ninety percent (90%) of the payments and
benefits previously received by the Executive under this Agreement, plus interest on such amount at
an annual rate equal to the lesser of ten percent (10%) or the maximum non-usurious rate under
applicable law, from the dates on which such payments and benefits were received to the date of
repayment to the Company; and

          14.4. the Executive shall pay to the Company from time to time, within ten (10) days after the
Executive receives written demand therefore, an amount or amounts equal to the reasonable costs and
expenses (including reasonable attorney’s fees and expenses) incurred by or on behalf of the
Company in enforcing this Section 14 from and after the date on which the Company delivers notice
of such breach to the Executive.

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 14

	 	

CONFIDENTIAL

DO NOT COPY

          14.5. It is the desire and intent of the parties that the provisions of this Section 14 be
enforced to the fullest extent permissible under the applicable laws in each jurisdiction in which
enforcement is sought. Accordingly, if any portion of this Section 14 is adjudicated to be invalid
or unenforceable, this Section 14 shall be deemed curtailed, whether as to time or location, to the
minimum extent required for its validity under applicable law and shall be binding and enforceable
with respect to the Executive as so curtailed, such curtailment to apply only with respect to the
operation of this Section 14 in the jurisdiction in which the such adjudication is made. If a
court in any jurisdiction, in adjudicating the validity of this Section 14, imposes any additional
terms or restrictions with respect to this Section 14, this Section 14 shall be deemed amended to
incorporate such additional terms or restrictions.

          14.6. Executive agrees and acknowledges that Executive has received good and adequate
consideration for the covenants set forth in this Section 14 in the form of employment,
compensation and benefits separate and independent of any payments or potential payments in this
Agreement.

     15. Potential Impact of Accounting Restatements on Certain Bonuses and Profits.

          15.1. If the Company is required to prepare an accounting restatement of the Company’s
consolidated balance sheet or statement of operations affecting any reporting period that
transpires during the term of this Agreement due to the material noncompliance of the Company with
any financial requirements under the securities laws, the Company’s Board will be entitled to
determine whether the noncompliance was the result of knowing, intentional, fraudulent or illegal
conduct by the Executive, and if it so determines, to require the Executive to reimburse the
Company for (i) any bonus or other incentive-based or equity-based compensation received by the
Executive from the Company during the term of this Agreement and (ii) any profits realized from the
sale of securities of the issuer by the Executive during the term of this Agreement.

          15.2. In making the determination whether to seek reimbursement from Executive, the Board will
consider whether any bonus, incentive payment, equity award, or other compensation has been awarded
or received by the Executive during the term of this Agreement and whether such compensation was
based on any financial results or operating metrics that were satisfied as a result of the
Executive’s knowing, intentional, fraudulent or illegal conduct. The Board has sole discretion in
determining whether the Executive’s conduct has or has not met the standard of such forfeiture.

          15.3. If the Board determines that a forfeiture is appropriate, such amounts shall be withheld
from any future amounts owed to the Executive as compensation. The Company may commence legal
action to collect such sums as the Board determines is owed to the Company.

     16. Successors.

          16.1. Assignment by the Executive. This Agreement is personal to the Executive and
without the prior written consent of the Company shall not be assignable by the Executive otherwise
than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of
and be enforceable by the Executive’s legal representatives.

          16.2. Successors and Assigns of the Company. This Agreement shall inure to the
benefit of and be binding upon the Company, its successors and assigns. The Company may not assign
this Agreement to any person or entity (except for a successor described in Section 16.3 below)
without the Executive’s written consent.

          16.3. Assumption. The Company shall require any successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the
business and/or assets of the Company to assume expressly and agree to perform this Agreement in
the same manner and to the same extent that the Company would be required to perform it if no such
succession had taken place. As used in this Agreement, “Company” shall mean the Company as
hereinbefore defined and any successor

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 15

	 	

CONFIDENTIAL

DO NOT COPY

to its business and/or assets as aforesaid that assumes and agrees to perform this Agreement
by operation of law or otherwise.

     17. Administration Prior to Change in Control. Prior to a Change in Control, the
Compensation Committee shall have full and complete authority to construe and interpret the
provisions of this Agreement, to determine an individual’s entitlement to benefits under this
Agreement, to make in its sole and absolute discretion all determinations contemplated under this
Agreement, to investigate and make factual determinations necessary or advisable to administer or
implement this Agreement. All determinations made under this Agreement by the Compensation
Committee shall be final and binding on all interested persons. Prior to a Change in Control, the
Compensation Committee may delegate responsibilities for the operation and administration of this
Agreement to one or more officers or employees of the Company. The provisions of this Section 17
shall terminate and be of no further force and effect upon the occurrence of a Change in Control.

     18. Delayed Commencement of Certain Payments.

          18.1. Any payment due hereunder that is not considered non-qualified deferred compensation and
is not subject to Section 409A of the Code shall be paid no later than March 15 of the calendar
year following the year in which the Executive’s Date of Termination occurs provided that all other
payment conditions, including the execution of an unrevoked Release, are met.

          18.2. Not withstanding any provision of this Agreement to the contrary, the parties intend
that this Agreement be construed and applied in a manner that will conform its provisions with the
requirements for exemption from Section 409A of the Code or, if and to the extent payments are
subject to Section 409A of the Code, to conform to Section 409A of the Code in order to avoid the
imposition of additional federal income tax pursuant to Section 409A of the Code. Without limiting
the foregoing, in the event that the Executive is a “specified employee” within the contemplation
of Section 409A(a)(2)(B) of the Code at the time that any payment that is subject to Section 409A
of the Code is made on account of the Executive’s Involuntary Termination the Executive’s
separation from service with the Company and its Affiliates within the contemplation of Section
409A(a)(2)(A)(i) of the Code), then in no event shall such payment or the commencement thereof be
made before the six-month anniversary of the Date of Termination or, if earlier, the date of the
Executive’s post-separation death.

          18.3. Any reimbursement payment made under this Agreement that is considered non-qualified
deferred compensation within the meaning of Section 409A of the Code shall be made within the
timing requirements of Treasury Regulation Section 1.409A-3(i)(iv).

     19. Miscellaneous.

          19.1. Governing Law. This Agreement shall be governed by, construed under and
enforced in accordance with the laws of the State of Tennessee without regard to conflicts-of-laws
principles that would require the application of any other law. The captions of this Agreement are
not part of the provisions hereof and shall have no force or effect.

          19.2. Amendment. This Agreement may not be amended, modified, repealed, waived,
extended or discharged except by an agreement in writing of both parties. No person, other than
pursuant to a resolution of the Board or the Compensation Committee, shall have authority on behalf
of the Company to agree to amend, modify, repeal, waive, extend or discharge any provision of this
Agreement or anything in reference thereto.

          19.3. Insurance. The Company may, at its election and for its benefit, insure the
Executive against accidental loss or death, and the Executive shall submit to such physical
examination and supply such information to the insurance company as may be required in connection
therewith; provided,

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 16

	 	

CONFIDENTIAL

DO NOT COPY

however, that no detailed information concerning the Executive’s physical examination will be
provided to the Company or made available to the Company by the insurance company.

          19.4. Waiver of Breach. A waiver by the Company or the Executive of a breach of any
provision of this Agreement by the other party shall not operate or be construed as a waiver of any
subsequent breach of the other party.

          19.5. Severability. The invalidity or unenforceability of any provision of this
Agreement shall not affect the validity or enforceability of any other provision of this Agreement.

          19.6. Notices. Any notice required or permitted to be given under this Agreement
shall be sufficient in writing and if sent by certified mail or express delivery to the Executive
at his home address or to the Company at Wright Medical Technology, Inc., Attention: General
Counsel, 5677 Airline Road, Arlington, Tennessee 38002, or to such other address as either party
shall notify the other. Notices and communications shall be effective when actually received by
the addressee.

          19.7. Taxes. The Company may withhold from any amounts payable under this Agreement
such federal, state or local taxes as shall be required to be withheld pursuant to any applicable
law or regulation.

          19.8. Entire Agreement. This Agreement contains the entire agreement of the parties
with respect to the subject matter referred to herein and supersedes any and all prior
negotiations, understandings, arrangements, letters of intent, and agreements, whether written or
oral, between the Executive and the Company and its Affiliates, or any of its or their directors,
officers, employees or representatives with respect thereto.

          19.9. No Right of Employment. Nothing in this Agreement shall be construed as giving
the Executive any right to be retained in the employ of the Company or shall interfere in any way
with the right of the Company to terminate the Executive’s employment at any time, with or without
Cause.

          19.10. Unfunded Obligation. The obligations under this Agreement shall be unfunded.
Benefits payable under this Agreement shall be paid from the general assets of the Company. The
Company shall have no obligation to establish any fund or to set aside any assets to provide
benefits under this Agreement.

          19.11. Termination. Notwithstanding anything contained herein, this Agreement shall
automatically terminate and be of no further force and effect and no benefits shall be payable
hereunder in the event that the Company sells or otherwise disposes of any part of the business or
assets of the Company (other than such a sale or disposition which is part of a transaction or
series of transactions which would result in a Change in Control) and as a result of such
transaction, the Executive is offered employment by the buyer of such business or assets (the
“Buyer”) in an executive position with reasonably comparable status, compensation, benefits
and separation agreement and which is consistent with the Executive’s experience and education, but
the Executive declines to accept such offer.

          19.12. Term. The term of this Agreement shall commence from the Effective Date and
shall continue until the third (3rd) anniversary of the Effective Date; provided,
however, that commencing on the second (2nd) anniversary of the Effective Date (and each
anniversary of the Effective Date thereafter), the term of this Agreement shall automatically be
extended for one (1) additional year, unless at least ninety (90) days prior to such date, the
Company or the Executive shall give written notice to the other party that it or he, as the case
may be, does not wish to so extend this Agreement. Notwithstanding the foregoing, if the Company
gives such written notice to the Executive less than one (1) year after a Change in Control, the
term of this Agreement shall be automatically extended until the later of (a) the date that is one
(1) year after the anniversary of the Effective Date that follows such written notice or (b) the
second (2nd) anniversary of the Change in Control Date.

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 17

	 	

CONFIDENTIAL

DO NOT COPY

     IN WITNESS WHEREOF, the parties executed this Agreement as of the Effective Date.

AGREED AND ACCEPTED

	 	 	 	 	 	 	 

	WRIGHT MEDICAL TECHNOLOGY, INC.	 	EDWARD A. STEIGER	 	 
	 
	 	 	 	 	 	 
	By:

	 	/s/ Jason P. Hood
 

Title: Jason P. Hood, Vice President,
          General Counsel and Secretary
	 	/s/ Edward A. Steiger
 

	 	 

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 18

	 	

CONFIDENTIAL

DO NOT COPY

EXHIBIT A

MUTUAL RELEASE AGREEMENT

     THIS MUTUAL RELEASE AGREEMENT (“Release”) dated as of (the “Effective
Date”) is made by and between WRIGHT MEDICAL TECHNOLOGY, INC., a corporation organized and
existing under the laws of the State of Delaware with its principal place of business at 5677
Airline Road, Arlington, Tennessee 38002 (the “Company”), and EDWARD A. STEIGER (the
“Executive”) as provided in the Separation Pay Agreement between the parties.

     The Executive, on behalf of the Executive and the Executive’s heirs, executors,
administrators, successors and assigns, whether herein named or referred to or not, does hereby
release, discharge, and acquit and by these presents does hereby release, acquit, and forever
discharge Company, its successors and assigns, its agents, servants, and employees, its divisions,
subdivisions, and affiliates (collectively, the “Company”), of and from any and all past, present,
and future claims, counterclaims, demands, actions, causes of action, liabilities, damages, costs,
loss of services, expenses, compensation, third-party actions, suits at law or in equity, of every
nature and description, whether known or unknown, suspected or unsuspected, foreseen, or
unforeseen, real or imaginary, actual or potential, and whether arising at law or in equity, under
the common law, state or federal law, or any other law, or otherwise, including, but not limited
to, any claims that have been or might have been asserted as a result of the establishment or
termination of the employer-employee relationship, hereinafter collectively referred to as claims.
It is the intention of the parties hereto to effect a full and final general release of all such
claims. It is expressly understood and agreed that this release and agreement is intended to
cover, and does cover, not only all now known injuries, losses, and damages, but any future
injuries, losses, and damages not now known or anticipated, but which may later develop or be
discovered, including all the effects and consequences thereof.

     Executive does hereby declare that the Executive does understand, covenant, and agree that the
Executive will not make any claims or demands, or file any legal proceedings against Company or
join Company as a party to any claim, demand, or legal proceedings nor shall Executive proceed
against any other party, person, firm, or corporation on the claims described above except as is
necessary in order to enforce the terms and conditions of this Release and the Separation Pay
Agreement.

THE FILING OF ANY CLAIM, DEMAND, OR ANY AND ALL OTHER LEGAL PROCEEDINGS, BY THE EXECUTIVE, AGAINST
COMPANY, SHALL BE DEEMED TO BE A MATERIAL BREACH OF THE TERMS OF THIS AGREEMENT. SUCH BREACH SHALL,
IMMEDIATELY, TERMINATE COMPANY’S DUTY TO PAY ANY FURTHER SUMS TO EXECUTIVE AND SHALL ALSO BIND
EXECUTIVE TO REPAY ANY AND ALL SUMS PAID TO EXECUTIVE PURSUANT TO THE TERMS OF THIS AGREEMENT.
ADDITIONALLY, EXECUTIVE SHALL INDEMNIFY AND HOLD HARMLESS COMPANY FROM ANY AND ALL JUDGMENTS,
COSTS, EXPENSES, OR ATTORNEY FEES WHATSOEVER ARISING ON ACCOUNT OF THE FILING OF ANY SUCH CLAIM,
DEMAND, OR OTHER LEGAL PROCEEDINGS BY THE EXECUTIVE.

     It is further understood and agreed that the acceptance of the consideration more fully
described in the Separation Pay Agreement between the parties is in full accord and satisfaction of
any obligations, claims, and/or disputes that Executive may have with Company.

     And the parties hereby declare, understand, covenant, and agree that the terms of the
Separation Pay Agreement, and the amount stated therein, are the sole consideration for this
release and agreement and that the parties voluntarily accept said consideration for the purpose of
making a full and final compromise, adjustment and settlement of all claims for injuries, losses,
and damages resulting, or to

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 19

	 	

CONFIDENTIAL

DO NOT COPY

result, from said claims.

     Except for any claim under Sections 13, 14 or 15 of the Separation Pay Agreement, the Company,
on behalf of itself, its agents, servants, and employees, its divisions, subdivisions, and
affiliates (collectively, the “Company”), successors and assigns, whether herein named or referred
to or not, does hereby release, discharge, and acquit and by these presents does hereby release,
acquit, and forever discharge Executive, the Executive’s heirs, executors, administrators,
successors and assigns, of and from any and all past, present, and future claims, counterclaims,
demands, actions, causes of action, liabilities, damages, costs, loss of services, expenses,
compensation, third-party actions, suits at law or in equity, of every nature and description,
whether known or unknown, suspected or unsuspected, foreseen, or unforeseen, real or imaginary,
actual or potential, and whether arising at law or in equity, under the common law, state or
federal law, or any other law, or otherwise, including, but not limited to, any claims that have
been or might have been asserted as a result of the establishment or termination of the
employer-employee relationship, hereinafter collectively referred to as claims. It is the
intention of the parties hereto to effect a full and final general release of all such claims. It
is expressly understood and agreed that this release and agreement is intended to cover, and does
cover, not only all now known injuries, losses, and damages, but any future injuries, losses, and
damages not now known or anticipated, but which may later develop or be discovered, including all
the effects and consequences thereof.

     Company does hereby declare that the Company does understand, covenant, and agree that the
Company will not make any claims or demands, or file any legal proceedings against Executive or
join Executive as a party to any claim, demand, or legal proceedings nor shall Company proceed
against any other party, person, firm, or corporation on the claims described above except as is
necessary in order to enforce the terms and conditions of this Release and the Separation Pay
Agreement.

THE FILING OF ANY CLAIM, DEMAND, OR ANY AND ALL OTHER LEGAL PROCEEDINGS, BY THE COMPANY, AGAINST
EXECUTIVE, SHALL BE DEEMED TO BE A MATERIAL BREACH OF THE TERMS OF THIS AGREEMENT. SUCH BREACH
SHALL, IMMEDIATELY, TERMINATE EXECUTIVE’S DUTY TO COMPLY WITH THE NON-SOLICITATION,
NON-INTERFERENCE, AND NON-COMPETITION COVENANTS OF THE SEPARATION PAY AGREEMENT BETWEEN THE
PARTIES. ADDITIONALLY, COMPANY SHALL INDEMNIFY AND HOLD HARMLESS EXECUTIVE FROM ANY AND ALL
JUDGMENTS, COSTS, EXPENSES, OR ATTORNEY FEES WHATSOEVER ARISING ON ACCOUNT OF THE FILING OF ANY
SUCH CLAIM, DEMAND, OR OTHER LEGAL PROCEEDINGS BY THE COMPANY.

     It is further understood and agreed that the acceptance of the consideration more fully
described in the Separation Pay Agreement between the parties is in full accord and satisfaction of
any obligations, claims, and/or disputes that Company may have with Executive.

     It is further understood and agreed that this is the full and complete understanding of the
parties, that it is the integrated memorial of their agreement and that there are no other written
or oral understandings, agreements, covenants, promises, or arrangements, directly or indirectly
connected with this release, that are not incorporated herein. The terms of this release are
contractual and are not mere recitals.

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 20

	 	

CONFIDENTIAL

DO NOT COPY

     Notwithstanding the foregoing, nothing in this Release shall release either party from
obligations resulting from the Separation Pay Agreement nor prohibit either party from seeking the
enforcement of the Separation Pay Agreement.

     IN WITNESS WHEREOF, the parties executed this Release as of the Effective Date.

AGREED AND ACCEPTED

	 	 	 	 	 	 	 	 	 

	WRIGHT MEDICAL TECHNOLOGY, INC.	 	EDWARD A. STEIGER	 	 
	 
	By:
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Title:	 	 	 	 	 	 
	 

	 	 	 	 

	 	 	 	 

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 21

	 	

CONFIDENTIAL

DO NOT COPY

EXHIBIT B

ADEA RELEASE AND AGREEMENT

     As a material inducement to Wright Medical Technology, Inc. (hereinafter referred to as
“Wright” or “Employer”) to enter into this ADEA Release and Agreement (the “Release or “Agreement”)
with Edward A. Steiger (hereinafter referred to as “Executive”) (for Executive, Executive’s heirs,
executors, administrators and assigns), Executive hereby unconditionally releases and forever
discharges Wright and each of the Wright’s stockholders, predecessors, successors, assigns, agents,
directors, officers, employees, representatives, attorneys, divisions, subsidiaries, affiliates and
all persons acting by, through, under, or in concert with any of them from any and all charges,
complaints, claims, liabilities, obligations, promises, agreements, controversies, damages,
actions, causes of action, suits, rights, demands, costs, losses, debts and expenses (including
attorney’s fees and costs actually incurred) of any nature whatsoever, known or unknown, suspected
or unsuspected, including, but not limited to, rights, under the Age Discrimination in Employment
Act of 1967, as amended from time to time, and other federal, state, or local laws prohibiting
discrimination, any claims the employee may have with regard to Executive’s hiring, employment, or
electing the re-employment program and termination of employment claims growing out of any legal
restrictions on Wright’s right to terminate its employees (“Claim” or Claims”), which the
Executive now has, owns or holds, or claims to have owned or held, or which the Executive at any
time hereinafter may have owned or held or claimed to have owned or held against Wright.

     To comply with the Older Workers Benefit Protection Act of 1990, as amended from time to time,
the Release and Agreement has advised Executive of the legal requirements of this Act and fully
incorporates the legal requirements by reference into this Agreement as follows:

	 	a.	 	This Agreement is written in layman’s terms, and the Executive understands and
comprehends its terms;
	 
	 	b.	 	Executive has been advised of Executive’s rights to consult an attorney to
review the Agreement;
	 
	 	c.	 	Executive does not waive any rights or claims that may arise after the date the
Release is executed;
	 
	 	d.	 	Executive is receiving consideration beyond anything of value to which
Executive already is entitled;
	 
	 	e.	 	Executive has been given a reasonable period of time to consider this Agreement
(45 days).

As consideration for this Release, Wright agrees to provide the items listed in the Separation Pay
Agreement dated April 1, 2009. The Executive enters into this Release with full knowledge of its
contents and enters into this Agreement voluntarily.

 

 

	 	 	 

	Wright Medical Technology, Inc.

Separation Pay Agreement

Page 22

	 	

CONFIDENTIAL

DO NOT COPY

AGREED AND ACCEPTED

	 	 	 

	EXECUTIVE:

	 	WRIGHT MEDICAL TECHNOLOGY, INC.
	 
	 	 
	I acknowledge that I fully understand and
agree that this Agreement may be pleaded
by Wright Medical Technology, Inc. as a
complete defense to any claim which
hereafter may be asserted by me or a claim
against Wright Medical Technology, Inc.
for or on account of any matter or thing
whatsoever arising out of the employment
relationship or my termination from active
employment.
	 	 

	 	 	 	 	 	 	 	 	 

	 
	EDWARD A. STEIGER

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	Title: 	 	 	 	 	 
	 

	 	 	 	 

	 	 

	 	 	 

	SWORN TO AND SUBSCRIBED, before me, a
Notary Public, in my presence this
                     day of
                    , 2009

	 	SWORN TO AND SUBSCRIBED, before me, a
Notary Public, in my presence this
                     day of
                    , 2009
	 
	 	 
	 
	 	 
	 

	 	 
	Notary Public

	 	Notary Public
	 
	 	 
	County of                                              

	 	Shelby County
	State of                                                  

	 	Tennessee
	 
	 	 
	My Commission Expires:                     

	 	My Commission Expires:                     

NOTE: EXECUTIVE IS HEREBY ADVISED OF EXECUTIVE’S RIGHT TO RESCIND AND NULLIFY THIS AGREEMENT, WHICH
RIGHT MUST BE EXERCISED, IF AT ALL, WITHIN SEVEN (7) DAYS OF THE DATE OF EXECUTIVE’S SIGNATURE.
EXECUTIVE MUST REVOKE RELEASE BY LETTER TO WRIGHT MEDICAL TECHNOLOGY, INC., ATTENTION: GENERAL
COUNSEL, 5677 AIRLINE ROAD, ARLINGTON, TN 38002, WITHIN SEVEN (7) DAYS. NO CONSIDERATION SHALL BE
CONVEYED UNTIL SUCH TIME PERIOD HAS EXPIRED.exv4w1

Exhibit 4.1

EXECUTION COPY

 

 

TIME WARNER INC.,

HISTORIC TW INC.,

as Guarantor

HOME BOX OFFICE, INC.,

as Guarantor

TURNER BROADCASTING SYSTEM, INC.,

as Guarantor

and

THE BANK OF NEW YORK MELLON,

Trustee

INDENTURE

Dated as of March 11, 2010

 

Providing for Issuance of Senior Securities in Series

 

 

 

 

Table Showing Reflection in Indenture of Certain Provisions

of Trust Indenture Act of 1939,

as amended by the Trust Indenture Reform Act of 1990

Reflected in Indenture

	 	 	 	 	 
	TIA	 	 	 	Section
	§310
	 	(a)(1)	 	6.09
	 
	 	(a)(2)	 	6.09
	 
	 	(a)(3)	 	Not Applicable
	 
	 	(a)(4)	 	Not Applicable
	 
	 	(a)(5)	 	6.09
	 
	 	(b)	 	6.08
	 
	 	 	 	 
	§311
	 	(a)	 	6.13(a)
	 
	 	(b)	 	6.13(b)
	 
	 	(b)(2)	 	7.03(a)
	 
	 	 	 	7.03(b)
	 
	 	 	 	 
	§312
	 	(a)	 	7.01
	 
	 	 	 	7.02(a)
	 
	 	(b)	 	7.03(b)
	 
	 	(c)	 	7.02(c)
	 
	 	 	 	 
	§313
	 	(a)	 	7.03(a)
	 
	 	(b)	 	7.03(b)
	 
	 	(c)	 	7.03(a)
	 
	 	 	 	7.03(b)
	 
	 	(d)	 	7.03(c)
	 
	 	 	 	 
	§314
	 	(a)(1)	 	7.04
	 
	 	(a)(2)	 	7.04
	 
	 	(a)(3)	 	7.04
	 
	 	(a)(4)	 	10.04
	 
	 	(b)	 	Not Applicable
	 
	 	(c)(1)	 	1.02
	 
	 	(c)(2)	 	1.02
	 
	 	(c)(3)	 	Not Applicable
	 
	 	(d)	 	Not Applicable
	 
	 	(e)	 	1.02
	 
	 	 	 	 
	§315
	 	(a)	 	6.01(a)
	 
	 	 	 	6.01(c)
	 
	 	(b)	 	6.02
	 
	 	 	 	7.03(a)
	 
	 	(c)	 	6.01(b)
	 
	 	(d)	 	6.01
	 
	 	(d)(1)	 	6.01(a)
	 
	 	(d)(2)	 	6.01(c)(2)
	 
	 	(d)(3)	 	6.01(c)(3)

 

 

	 	 	 	 	 
	TIA	 	 	 	Section
	 
	 	(e)	 	5.14
	 
	 	 	 	 
	§316
	 	(a)	 	1.01
	 
	 	(a)(1)(A)	 	5.02
	 
	 	 	 	5.12
	 
	 	(a)(1)(B)	 	5.13
	 
	 	(a)(2)	 	Not Applicable
	 
	 	(b)	 	5.08
	 
	 	(c)	 	1.04(d)
	 
	 	 	 	 
	§317
	 	(a)(1)	 	5.03
	 
	 	(a)(2)	 	5.04
	 
	 	(b)	 	10.03
	 
	 	 	 	 
	§318
	 	(a)	 	1.07

 

			
	Note: This table shall not, for any purpose, be deemed to be part of the Indenture.

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page	 
	Article I
	 	 	 	 
	 
	 	 	 	 
	Definitions and Other Provisions of General Application
	 	 	 	 
	 
	 	 	 	 
	SECTION 1.01 Definitions
	 	 	1	 
	SECTION 1.02 Compliance Certificates and Opinions
	 	 	10	 
	SECTION 1.03 Form of Documents Delivered to Trustee
	 	 	10	 
	SECTION 1.04 Acts of Securityholders
	 	 	11	 
	SECTION 1.05 Notices, etc., to Trustee and Company
	 	 	12	 
	SECTION 1.06 Notices to Securityholders; Waiver
	 	 	12	 
	SECTION 1.07 Conflict with Trust Indenture Act
	 	 	13	 
	SECTION 1.08 Effect of Headings and Table of Contents
	 	 	13	 
	SECTION 1.09 Successors and Assigns
	 	 	13	 
	SECTION 1.10 Separability Clause
	 	 	13	 
	SECTION 1.11 Benefits of Indenture
	 	 	13	 
	SECTION 1.12 Governing Law
	 	 	13	 
	SECTION 1.13 Counterparts
	 	 	13	 
	SECTION 1.14 Judgment Currency
	 	 	13	 
	SECTION 1.15 WAIVER OF JURY TRIAL
	 	 	14	 
	SECTION 1.16 Force Majeure
	 	 	14	 
	 
	 	 	 	 
	Article II
	 	 	 	 
	 
	 	 	 	 
	Security Forms
	 	 	 	 
	 
	 	 	 	 
	SECTION 2.01 Forms Generally
	 	 	14	 
	SECTION 2.02 Forms of Securities
	 	 	14	 
	SECTION 2.03 Form of Trustee’s Certificate of Authentication
	 	 	15	 
	SECTION 2.04 Securities Issuable in the Form of a Global Security
	 	 	15	 
	 
	 	 	 	 
	Article III
	 	 	 	 
	 
	 	 	 	 
	The Securities
	 	 	 	 
	 
	 	 	 	 
	SECTION 3.01
General Title; General Limitations; Issuable in Series; Terms of Particular Series
	 	 	17	 
	SECTION 3.02 Denominations
	 	 	19	 
	SECTION 3.03 Execution, Authentication and Delivery and Dating
	 	 	19	 
	SECTION 3.04 Temporary Securities
	 	 	21	 
	SECTION 3.05 Registration, Transfer and Exchange
	 	 	21	 
	SECTION 3.06 Mutilated, Destroyed, Lost and Stolen Securities
	 	 	22	 
	SECTION 3.07 Payment of Interest; Interest Rights Preserved
	 	 	23	 
	SECTION 3.08 Persons Deemed Owners
	 	 	24	 
	SECTION 3.09 Cancelation
	 	 	24	 

i

 

	 	 	 	 	 
	 	 	Page	 
	SECTION 3.10 Computation of Interest
	 	 	24	 
	SECTION 3.11 Delayed Issuance of Securities
	 	 	24	 
	 
	 	 	 	 
	Article IV
	 	 	 	 
	 
	 	 	 	 
	Satisfaction and Discharge
	 	 	 	 
	 
	 	 	 	 
	SECTION 4.01 Satisfaction and Discharge of Indenture
	 	 	25	 
	SECTION 4.02 Application of Trust Money
	 	 	26	 
	SECTION 4.03 Defeasance Upon Deposit of Funds or Government Obligations
	 	 	26	 
	SECTION 4.04 Reinstatement
	 	 	28	 
	 
	 	 	 	 
	Article V
	 	 	 	 
	 
	 	 	 	 
	Remedies
	 	 	 	 
	 
	 	 	 	 
	SECTION 5.01 Events of Default
	 	 	28	 
	SECTION 5.02 Acceleration of Maturity; Rescission and Annulment
	 	 	30	 
	SECTION 5.03 Collection of Indebtedness and Suits for Enforcement by Trustee
	 	 	31	 
	SECTION 5.04 Trustee May File Proofs of Claim
	 	 	32	 
	SECTION 5.05 Trustee May Enforce Claims Without Possession of Securities
	 	 	32	 
	SECTION 5.06 Application of Money Collected
	 	 	33	 
	SECTION 5.07 Limitation on Suits
	 	 	33	 
	SECTION 5.08 Unconditional Right of Securityholders to Receive Principal, Premium
and Interest
	 	 	34	 
	SECTION 5.09 Restoration of Rights and Remedies
	 	 	34	 
	SECTION 5.10 Rights and Remedies Cumulative
	 	 	34	 
	SECTION 5.11 Delay or Omission Not Waiver
	 	 	34	 
	SECTION 5.12 Control by Securityholders
	 	 	34	 
	SECTION 5.13 Waiver of Past Defaults
	 	 	34	 
	SECTION 5.14 Undertaking for Costs
	 	 	35	 
	SECTION 5.15 Waiver of Stay or Extension Laws
	 	 	35	 
	 
	 	 	 	 
	Article VI
	 	 	 	 
	 
	 	 	 	 
	The Trustee
	 	 	 	 
	 
	 	 	 	 
	SECTION 6.01 Certain Duties and Responsibilities
	 	 	35	 
	SECTION 6.02 Notice of Defaults
	 	 	36	 
	SECTION 6.03 Certain Rights of Trustee
	 	 	37	 
	SECTION 6.04 Not Responsible for Recitals or Issuance of Securities
	 	 	38	 
	SECTION 6.05 May Hold Securities
	 	 	38	 
	SECTION 6.06 Money Held in Trust
	 	 	38	 
	SECTION 6.07 Compensation and Reimbursement
	 	 	38	 
	SECTION 6.08 Disqualification; Conflicting Interests
	 	 	39	 
	SECTION 6.09 Corporate Trustee Required; Eligibility
	 	 	39	 
	SECTION 6.10 Resignation and Removal
	 	 	40	 
	SECTION 6.11 Acceptance of Appointment by Successor
	 	 	41	 

ii

 

	 	 	 	 	 
	 	 	Page	 
	SECTION 6.12 Merger, Conversion, Consolidation or Succession to Business
	 	 	42	 
	SECTION 6.13 Preferential Collection of Claims Against Company
	 	 	42	 
	SECTION 6.14 Appointment of Authenticating Agent
	 	 	42	 
	 
	 	 	 	 
	Article VII
	 	 	 	 
	 
	 	 	 	 
	Securityholders’ Lists and Reports by Trustee and Company
	 	 	 	 
	 
	 	 	 	 
	SECTION 7.01 Company to Furnish Trustee Names and Addresses of Securityholders
	 	 	45	 
	SECTION 7.02 Preservation of Information; Communications to Securityholders
	 	 	45	 
	SECTION 7.03 Reports by Trustee
	 	 	46	 
	SECTION 7.04 Reports by Company
	 	 	46	 
	 
	 	 	 	 
	Article VIII
	 	 	 	 
	 
	 	 	 	 
	Consolidation, Merger, Conveyance or Transfer
	 	 	 	 
	 
	 	 	 	 
	SECTION 8.01 Consolidation, Merger, Conveyance or Transfer on Certain Terms
	 	 	47	 
	SECTION 8.02 Successor Person Substituted
	 	 	47	 
	 
	 	 	 	 
	Article IX
	 	 	 	 
	 
	 	 	 	 
	Supplemental Indentures
	 	 	 	 
	 
	 	 	 	 
	SECTION 9.01 Supplemental Indentures Without Consent of Securityholders
	 	 	48	 
	SECTION 9.02 Supplemental Indentures with Consent of Securityholders
	 	 	49	 
	SECTION 9.03 Execution of Supplemental Indentures
	 	 	50	 
	SECTION 9.04 Effect of Supplemental Indentures
	 	 	50	 
	SECTION 9.05 Conformity with Trust Indenture Act
	 	 	51	 
	SECTION 9.06 Reference in Securities to Supplemental Indentures
	 	 	51	 
	 
	 	 	 	 
	Article X
	 	 	 	 
	 
	 	 	 	 
	Covenants
	 	 	 	 
	 
	 	 	 	 
	SECTION 10.01 Payment of Principal, Premium and Interest
	 	 	51	 
	SECTION 10.02 Maintenance of Office or Agency
	 	 	51	 
	SECTION 10.03 Money for Security Payments to Be Held in Trust
	 	 	51	 
	SECTION 10.04 Statement as to Compliance
	 	 	53	 
	SECTION 10.05 Legal Existence
	 	 	53	 
	SECTION 10.06 Limitation on Liens
	 	 	53	 
	SECTION 10.07 Waiver of Certain Covenants
	 	 	55	 

iii

 

	 	 	 	 	 
	 	 	Page	 
	Article XI
	 	 	 	 
	 
	 	 	 	 
	Redemption of Securities
	 	 	 	 
	 
	 	 	 	 
	SECTION 11.01 Applicability of Article
	 	 	55	 
	SECTION 11.02 Election to Redeem; Notice to Trustee
	 	 	56	 
	SECTION 11.03 Selection by Trustee of Securities to Be Redeemed
	 	 	56	 
	SECTION 11.04 Notice of Redemption
	 	 	57	 
	SECTION 11.05 Deposit of Redemption Price
	 	 	58	 
	SECTION 11.06 Securities Payable on Redemption Date
	 	 	58	 
	SECTION 11.07 Securities Redeemed in Part
	 	 	58	 
	SECTION 11.08 Provisions with Respect to Any Sinking Funds
	 	 	58	 
	SECTION 11.09 Rescission of Redemption
	 	 	59	 
	 
	 	 	 	 
	Article XII
	 	 	 	 
	 
	 	 	 	 
	Conversion
	 	 	 	 
	 
	 	 	 	 
	SECTION 12.01 Conversion Privilege
	 	 	60	 
	SECTION 12.02 Conversion Procedure; Rescission of Conversion; Conversion Price; Fractional Shares
	 	 	60	 
	SECTION 12.03 Adjustment of Conversion Price for Common Stock or Marketable
Securities
	 	 	62	 
	SECTION 12.04 Consolidation or Merger of the Company
	 	 	65	 
	SECTION 12.05 Notice of Adjustment
	 	 	66	 
	SECTION 12.06 Notice in Certain Events
	 	 	66	 
	SECTION 12.07 Company to Reserve Stock or other Marketable Securities;
Registration; Listing
	 	 	67	 
	SECTION 12.08 Taxes on Conversion
	 	 	67	 
	SECTION 12.09 Conversion After Record Date
	 	 	67	 
	SECTION 12.10 Corporate Action Regarding Par Value of Common Stock
	 	 	68	 
	SECTION 12.11 Company Determination Final
	 	 	68	 
	SECTION 12.12 Trustee’s Disclaimer
	 	 	68	 
	 
	 	 	 	 
	Article XIII
	 	 	 	 
	 
	 	 	 	 
	Guarantees
	 	 	 	 
	 
	 	 	 	 
	SECTION 13.01 Guarantees
	 	 	68	 

iv

 

     THIS INDENTURE between TIME WARNER INC., a Delaware corporation
(hereinafter called the “Company”) having its principal office at
One Time Warner Center, New York, New York 10019, HISTORIC TW INC., a
Delaware corporation (“Historic TW”), HOME BOX OFFICE, INC., a
Delaware corporation (“HBO”), TURNER BROADCASTING SYSTEM, INC., a
Georgia corporation (“TBS” and, together with Historic TW and HBO,
the “Guarantors”), and THE BANK OF NEW YORK MELLON, a New York
banking corporation, as trustee (hereinafter called the
“Trustee”), is made and entered into as of March 11, 2010.

Recitals of the Company

          The Company has duly authorized the execution and delivery of this Indenture to provide for
the issuance of its debentures, notes, bonds or other evidences of indebtedness, to be issued in
one or more fully registered series.

          All things necessary to make this Indenture a valid and legally binding agreement of the
Company and the Guarantors in accordance with its terms have been done.

Agreements of the Parties

          To set forth or to provide for the establishment of the terms and conditions upon which the
Securities are and are to be authenticated, issued and delivered, and in consideration of the
premises and the purchase of Securities by the Holders thereof, it is mutually covenanted and
agreed as follows, for the equal and proportionate benefit of all Holders of the Securities or of a
series thereof, as the case may be:

ARTICLE I

Definitions and Other Provisions

of General Application

     SECTION 1.01 Definitions. For all purposes of this Indenture and of any indenture
supplemental hereto, except as otherwise expressly provided or unless the context otherwise
requires:

     (1) the terms defined in this Article have the meanings assigned to them in this
Article, and include the plural as well as the singular;

     (2) all other terms used herein which are defined in the Trust Indenture Act or by
Commission rule under the Trust Indenture Act, either directly or by reference therein,
have the meanings assigned to them herein;

     (3) all accounting terms not otherwise defined herein have the meanings assigned to
them in accordance with GAAP and, except as otherwise herein expressly provided, the term
“generally accepted accounting principles” with respect to any computation required or
permitted hereunder shall mean such accounting principles and any accounting rules or
interpretations promulgated by the Commission as are generally accepted in the United
States of America at the date of this Indenture; and

 

 

     (4) all references in this instrument to designated “Articles”, “Sections” and other
subdivisions are to the designated Articles, Sections and other subdivisions of this
instrument as originally executed. The words “herein”, “hereof” and “hereunder” and other
words of similar import refer to this Indenture as a whole and not to any particular
Article, Section or other subdivision.

          Certain terms, used principally in Article VI, are defined in that Article.

          “Act”, when used with respect to any Securityholder, has the meaning specified in
Section 1.04.

          “Affiliate” of any specified Person means any other Person directly or indirectly
controlling or controlled by or under direct or indirect common control with such specified Person.
For the purposes of this definition, “control” when used with respect to any specified Person means
the power to direct the management and policies of such Person, directly or indirectly, whether
through the ownership of voting securities, by contract or otherwise; and the terms “controlling”
and “controlled” have meanings correlative to the foregoing.

          “Authenticating Agent” means any Person authorized by the Company to authenticate
Securities under Section 6.14.

          “Board of Directors” means (i) the board of directors of the Company, (ii) any duly
authorized committee of such board, (iii) any committee of officers of the Company or (iv) any
officer of the Company acting, in the case of (iii) or (iv), pursuant to authority granted by the
board of directors of the Company or any committee of such board.

          “Board Resolution” means a copy of a resolution certified by the Secretary or an
Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in
full force and effect on the date of such certification, and delivered to the Trustee.

          “Business Day” means, with respect to any series of Securities, unless otherwise
specified in a Board Resolution, a supplemental indenture or an Officers’ Certificate with respect
to a particular series of Securities, each day which is not a Saturday, Sunday or other day on
which banking institutions in the pertinent Place or Places of Payment or the city in which the
Corporate Trust Office is located are authorized or required by law or executive order to be
closed.

          “Closing Price” of the Common Stock or other Marketable Security, as the case may be,
shall mean the last reported sale price of such stock or other Marketable Security (regular way) as
shown on the Composite Tape of the NYSE (or, if such stock or other Marketable Security is not
listed or admitted to trading on the NYSE, on the principal national securities exchange on which
such stock or other Marketable Security is listed or admitted to trading), or, in case no such sale
takes place on such day, the average of the closing bid and asked prices on the NYSE (or, if such
stock or other Marketable Security is not listed or admitted to trading on the NYSE, on the
principal national securities exchange on which such stock or other Marketable Security is listed
or admitted to trading), or, if it is not listed or admitted to trading on any national securities
exchange, the average of the closing bid and asked prices as reported by NASDAQ, or if such stock
or other Marketable Security is not so reported, the average of the closing bid and asked prices as
furnished by any member of the Financial Industry Regulatory Authority, Inc., selected from time to
time by the Company for that purpose.

2

 

          “Commission” means the Securities and Exchange Commission, as from time to time
constituted, created under the Securities Exchange Act of 1934, or, if at any time after the
execution of this instrument such Commission is not existing and performing the duties now assigned
to it under the Trust Indenture Act, then the body performing such duties at such time.

          “Common Stock” shall mean the class of Common Stock, par value $.01 per share, of the
Company authorized at the date of this Indenture as originally signed, or any other class of stock
resulting from successive changes or reclassifications of such Common Stock, and in any such case
including any shares thereof authorized after the date of this Indenture.

          “Company” means the Person named as the “Company” in the first paragraph of this
instrument until a successor shall have become such pursuant to the applicable provisions of this
Indenture, and thereafter “Company” shall mean such successor.

          “Company Request”, “Company Order” and “Company Consent” mean a
written request, order or consent, respectively, signed in the name of the Company by its Chairman
of the Board, Chief Executive Officer, Chief Operating Officer, President or a Vice President, and
by its Treasurer, an Assistant Treasurer, Controller, an Assistant Controller, Secretary or an
Assistant Secretary, and delivered to the Trustee.

          “Consolidated Net Worth” means, with respect to any Person, at the date of any
determination, the consolidated stockholders’ or owners’ equity of the holders of capital stock or
partnership interests of such Person and its subsidiaries, determined on a consolidated basis in
accordance with GAAP consistently applied.

          “Conversion Agent” means any Person authorized by the Company to receive Securities to
be converted into Common Stock or other Marketable Securities on behalf of the Company. The Company
initially authorizes the Trustee to act as Conversion Agent for the Securities on its behalf. The
Company may at any time and from time to time authorize one or more Persons to act as Conversion
Agent in addition to or in place of the Trustee with respect to any series of Securities issued
under this Indenture.

          “Conversion Price” means, with respect to any series of Securities which are
convertible into Common Stock or other Marketable Securities, the price per share of Common Stock
or the price per designated unit of other Marketable Security at which the Securities of such
series are so convertible as set forth in the Board Resolution, a supplemental indenture or an
Officers’ Certificate pursuant to authority granted under a Board Resolution with respect to such
series (or in any supplemental indenture entered into pursuant to Section 9.01(9) with respect to
such series), as the same may be adjusted from time to time in accordance with Section 12.03 (or
such supplemental indenture).

          “Converting Holder” shall have the meaning specified in Section 12.02(c) of this
Indenture.

          “Corporate Trust Office” means the office of the Trustee at which at any particular
time its corporate trust business shall be principally administered, which office at the date
hereof is located at 101 Barclay Street, 8W, New York, NY 10286, Attn: Corporate Trust
Administration.

          “Current Market Price” on any date shall mean the average of the daily Closing Prices
per share of Common Stock or of such other Marketable Securities for any thirty (30)

3

 

consecutive Trading Days selected by the Company prior to the day in question, which thirty
(30) consecutive Trading Day period shall not commence more than forty-five (45) Trading Days prior
to the day in question; provided that with respect to Section 12.03(3), the “Current Market Price”
of the Common Stock or of such other Marketable Securities shall mean the average of the daily
Closing Prices per share of Common Stock or of such other Marketable Securities for the five (5)
consecutive Trading Days ending on the date of the distribution referred to in Section 12.03(3) (or
if such date shall not be a Trading Day, on the Trading Day immediately preceding such date).

          “Defaulted Interest” has the meaning specified in Section 3.07.

          “Depository” means, unless otherwise specified by the Company pursuant to either
Section 2.04 or 3.01, with respect to Securities of any series issuable or issued as a Global
Security, The Depository Trust Company, New York, New York, or any successor thereto registered as
a clearing agency under the Securities Exchange Act of 1934, as amended, or other applicable
statute or regulation.

          “Discharged” has the meaning specified in Section 4.03.

          “Event of Default” has the meaning specified in Article V.

          “Federal Bankruptcy Act” has the meaning specified in Section 5.01(5).

          “GAAP” means generally accepted accounting principles as such principles are in effect
in the United States as of the date of this Indenture.

          “Global Security”, when used with respect to any series of Securities issued
hereunder, means a Security which is executed by the Company and authenticated and delivered by the
Trustee to the Depository or pursuant to the Depository’s instruction, all in accordance with this
Indenture and an indenture supplemental hereto, if any, or Board Resolution or an Officers’
Certificate pursuant to authority granted under a Board Resolution and pursuant to a Company
Request, which shall be registered in the name of the Depository or its nominee and which shall
represent, and shall be denominated in an amount equal to the aggregate principal amount of, all of
the Outstanding Securities of such series or any portion thereof, in either case having the same
terms, including, without limitation, the same original issue date, date or dates on which
principal is due, and interest rate or method of determining interest.

          “Guarantee” means the guarantees specified in Section 13.01(a) and (b).

          “Guarantors” means Historic TW, TBS and HBO, in each case unless and until such entity
is released from its Guarantee pursuant to the provisions of Section 13.01(h).

          “HBO” means Home Box Office, Inc., a Delaware corporation and wholly owned subsidiary
of Historic TW, until a successor shall have become such pursuant to the applicable provisions of
this Indenture, and thereafter “HBO” shall mean such successor.

          “Historic TW” means Historic TW Inc., a Delaware corporation and wholly owned
subsidiary of the Company, until a successor shall have become such pursuant to the applicable
provisions of this Indenture, and thereafter “Historic TW” shall mean such successor.

4

 

          “Holder”, when used with respect to any Security, means a Securityholder, which means
a Person in whose name a security is registered in the Security Register.

          “Indebtedness For Borrowed Money” of any Person means, without duplication, (a) all
obligations of such Person for borrowed money, (b) all obligations of such Person evidenced by
bonds, debentures, notes or similar instruments and (c) all guarantee obligations of such Person
with respect to Indebtedness For Borrowed Money of others. The Indebtedness For Borrowed Money of
any Person shall include the Indebtedness For Borrowed Money of any other entity (including any
partnership in which such Person is a general partner) to the extent such Person is liable therefor
as a result of such Person’s ownership interest in or other contractual relationship with such
entity, except to the extent the terms of such Indebtedness For Borrowed Money provide that such
Person is not liable therefor.

          “Indenture” or “this Indenture” means this instrument as originally executed
or as it may from time to time be supplemented or amended by one or more indentures supplemental
hereto entered into pursuant to the applicable provisions hereof and shall include the terms of
particular series of Securities established as contemplated by Section 3.01.

          “Interest”, when used with respect to an Original Issue Discount Security which by its
terms bears interest only after Maturity, means interest payable after Maturity.

          “Interest Payment Date”, when used with respect to any series of Securities, means the
Stated Maturity of any installment of interest on those Securities.

          “Marketable Security” means any common stock, debt security or other security of a
Person which is (or will, upon distribution thereof, be) listed on the NYSE, the American Stock
Exchange, NASDAQ or any other national securities exchange registered under Section 6 of the
Securities Exchange Act of 1934, as amended, or approved for quotation in any system of automated
dissemination of quotations of securities prices in the United States or for which there is a
recognized market maker or trading market.

          “Material Subsidiary” means any Person that is a Subsidiary if at the end of the most
recent fiscal quarter of the Company, the aggregate amount, determined in accordance with GAAP
consistently applied, of securities of, loans and advances to, and other investments in, such
Person held by the Company and its other Subsidiaries exceeded 10% of the Company’s Consolidated
Net Worth.

          “Material U.S. Subsidiary” means any Material Subsidiary that is organized under the
laws of the United States of America or any political subdivision thereof (including any State
thereof or the District of Columbia).

          “Maturity”, when used with respect to any Securities, means the date on which the
principal of any such Security becomes due and payable as therein or herein provided, whether on a
Repayment Date, at the Stated Maturity or by declaration of acceleration, call for redemption or
otherwise.

          “NASDAQ” shall mean the NASDAQ Stock Market.

          “NYSE” shall mean the New York Stock Exchange, Inc.

5

 

          “Officers’ Certificate” means a certificate signed by the Chairman of the Board, the
Chief Executive Officer, the Chief Financial Officer, the Chief Operating Officer or a Vice
President, and by the Treasurer, an Assistant Treasurer, the Controller, an Assistant Controller,
the Secretary or an Assistant Secretary of the Company, and delivered to the Trustee. Wherever this
Indenture requires that an Officers’ Certificate be signed also by a financial expert or an
accountant or other expert, such financial expert, accountant or other expert (except as otherwise
expressly provided in this Indenture) may be in the employ of the Company.

          “Opinion of Counsel” means a written opinion of counsel, who may (except as otherwise
expressly provided in this Indenture) be an employee of or of counsel to the Company, which is
delivered to the Trustee.

          “Original Issue Discount Security” means (i) any Security which provides for an amount
less than the principal amount thereof to be due and payable upon a declaration of acceleration of
the Maturity thereof, and (ii) any other security which is issued with “original issue discount”
within the meaning of Section 1273(a) of the Internal Revenue Code of 1986, as amended, and the
regulations thereunder.

          “Outstanding”, when used with respect to the Securities or Securities of any series,
means, as of the date of determination, all such Securities theretofore authenticated and delivered
under this Indenture, except:

     (i) such Securities theretofore canceled by the Trustee or delivered to the Trustee
for cancelation;

     (ii) such Securities for whose payment or redemption money in the necessary amount has
been theretofore deposited with the Trustee or any Paying Agent in trust for the Holders of
such Securities; provided that, if such Securities are to be redeemed, notice of such
redemption has been duly given pursuant to this Indenture or provision therefor
satisfactory to the Trustee has been made; and

     (iii) such Securities in exchange for or in lieu of which other Securities have been
authenticated and delivered pursuant to this Indenture, or which shall have been paid
pursuant to the terms of Section 3.06 (except with respect to any such Security as to which
proof satisfactory to the Trustee is presented that such Security is held by a Person in
whose hands such Security is a legal, valid and binding obligation of the Company).

In determining whether the Holders of the requisite principal amount of such Securities Outstanding
have given any request, demand, authorization, direction, notice, consent or waiver hereunder, (i)
the principal amount of any Original Issue Discount Security that shall be deemed to be Outstanding
shall be the amount of the principal thereof that would be due and payable as of the date of the
taking of such action upon a declaration of acceleration of the Maturity thereof, and (ii)
Securities owned by the Company or any other obligor upon the Securities or any Affiliate of the
Company or of such other obligor shall be disregarded and deemed not to be Outstanding. In
determining whether the Trustee shall be protected in relying upon any such request, demand,
authorization, direction, notice, consent or waiver, only Securities which a Responsible Officer
assigned to the Corporate Trust Office of the Trustee knows to be owned by the Company or any other
obligor upon the Securities or any Affiliate of the Company or such other obligor shall be so
disregarded. Securities so owned which have been pledged in good faith may be regarded as
Outstanding if the pledgee establishes to the satisfaction of the Trustee the pledgee’s right to
act as owner with respect to such Securities and that the pledgee is not the

6

 

Company or any other obligor upon the Securities or any Affiliate of the Company or such other
obligor.

          “Paying Agent” means any Person authorized by the Company to pay the principal of (and
premium, if any) or interest on any Securities on behalf of the Company. The Company initially
authorizes the Trustee to act as Paying Agent for the Securities on its behalf. The Company may at
any time and from time to time authorize one or more Persons to act as Paying Agent in addition to
or in place of the Trustee with respect to any series of Securities issued under this Indenture.

          “Person” means any individual, corporation, limited liability company, partnership,
joint venture, association, joint-stock company, trust, unincorporated organization or government
or any agency or political subdivision thereof.

          “Place of Payment” means with respect to any series of Securities issued hereunder the
city or political subdivision so designated with respect to the series of Securities in question in
accordance with the provisions of Section 3.01.

          “Predecessor Securities” of any particular Security means every previous Security
evidencing all or a portion of the same debt as that evidenced by such particular Security; and,
for the purposes of this definition, any Security authenticated and delivered under Section 3.06 in
lieu of a lost, destroyed or stolen Security shall be deemed to evidence the same debt as the lost,
destroyed or stolen Security.

          “Redemption Date”, when used with respect to any Security to be redeemed, means the
date fixed for such redemption by or pursuant to this Indenture.

          “Redemption Price”, when used with respect to any Security to be redeemed, means the
price specified in the Security at which it is to be redeemed pursuant to this Indenture.

          “Redemption Rescission Event” shall mean the occurrence of (a) any general suspension
of trading in, or limitation on prices for, securities on the principal national securities
exchange on which shares of Common Stock or Marketable Securities are registered and listed for
trading (or, if shares of Common Stock or Marketable Securities are not registered and listed for
trading on any such exchange, in the over-the-counter market) for more than six-and-one-half
(6-1/2) consecutive trading hours, (b) any decline in either the Dow Jones Industrial Average or
the S&P 500 Index (or any successor index published by Dow Jones & Company, Inc. or S&P) by either
(i) an amount in excess of 10%, measured from the close of business on any Trading Day to the close
of business on the next succeeding Trading Day during the period commencing on the Trading Day
preceding the day notice of any redemption of Securities is given (or, if such notice is given
after the close of business on a Trading Day, commencing on such Trading Day) and ending at the
time and date fixed for redemption in such notice or (ii) an amount in excess of 15% (or if the
time and date fixed for redemption is more than 15 days following the date on which such notice of
redemption is given, 20%), measured from the close of business on the Trading Day preceding the day
notice of such redemption is given (or, if such notice is given after the close of business on a
Trading Day, from such Trading Day) to the close of business on any Trading Day at or prior to the
time and date fixed for redemption, (c) a declaration of a banking moratorium or any suspension of
payments in respect of banks by Federal or state authorities in the United States or (d) the
occurrence of an act of terrorism or commencement of a war or armed hostilities or other national
or international calamity directly or indirectly involving the United

7

 

States which in the reasonable judgment of the Company could have a material adverse effect on
the market for the Common Stock or Marketable Securities.

          “Regular Record Date” for the interest payable on any Security on any Interest Payment
Date means the date specified in such Security as the Regular Record Date.

          “Repayment Date”, when used with respect to any Security to be repaid, means the date
fixed for such repayment pursuant to such Security.

          “Repayment Price”, when used with respect to any Security to be repaid, means the
price at which it is to be repaid pursuant to such Security.

          “Required Currency”, when used with respect to any Security, has the meaning set forth
in Section 1.14.

          “Responsible Officer”, when used with respect to the Trustee, means any officer of the
Trustee with direct responsibility for the administration of this Indenture and also means, with
respect to a particular corporate trust matter, any other officer to whom such matter is referred
because of his knowledge of and familiarity with the particular subject. “Responsible Officer”,
when used with respect to the Company, means any of the Chief Executive Officer, President, Chief
Operating Officer, Chief Financial Officer, General Counsel, Treasurer, Controller or Vice
President, Corporate Finance, of the Company (or any equivalent of the foregoing officers).

          “S&P” means Standard & Poor’s Ratings Service or any successor to the rating agency
business thereof.

          “Security” or “Securities” means any note or notes, bond or bonds, debenture
or debentures, or any other evidences of indebtedness, as the case may be, of any series
authenticated and delivered from time to time under this Indenture.

          “Security Register” shall have the meaning specified in Section 3.05.

          “Security Registrar” means the Person who keeps the Security Register specified in
Section 3.05. The Company initially appoints the Trustee to act as Security Registrar for the
Securities on its behalf. The Company may at any time and from time to time authorize any Person to
act as Security Registrar in place of the Trustee with respect to any series of Securities issued
under this Indenture.

          “Securityholder” means a Person in whose name a security is registered in the Security
Register.

          “Special Record Date” for the payment of any Defaulted Interest means a date fixed by
the Trustee pursuant to Section 3.07.

          “Stated Maturity” when used with respect to any Security or any installment of
principal thereof or interest thereon means the date specified in such Security as the fixed date
on which the principal of such Security or such installment of principal or interest is due and
payable.

8

 

          “Subsidiary” means, with respect to any Person, any corporation more than 50% of the
voting stock of which is owned directly or indirectly by such Person, and any partnership,
association, joint venture or other entity in which such Person owns more than 50% of the equity
interests or has the power to elect a majority of the board of directors or other governing body.

          “TBS” means Turner Broadcasting System, Inc., a Georgia corporation and wholly owned
subsidiary of Historic TW, until a successor shall have become such pursuant to the applicable
provisions of this Indenture, and thereafter “TBS” shall mean such successor.

          “Trading Day” shall mean, with respect to the Common Stock or a Marketable Security,
so long as the common stock or such Marketable Security, as the case may be, is listed or admitted
to trading on the NYSE, a day on which the NYSE is open for the transaction of business, or, if the
Common Stock or such Marketable Security, as the case may be, is not listed or admitted to trading
on the NYSE, a day on which the principal national securities exchange on which the Common Stock or
such Marketable Security, as the case may be, is listed is open for the transaction of business,
or, if the Common Stock or such Marketable Security, as the case may be, is not so listed or
admitted for trading on any national securities exchange, a day on which NASDAQ is open for the
transaction of business.

          “Trust Indenture Act” or “TIA” means the Trust Indenture Act of 1939 as in
force at the date as of which this instrument was executed; provided, however, that, in the event
the Trust Indenture Act of 1939 is amended after such date, “Trust Indenture Act” or “TIA” means,
to the extent required by any such amendment, the Trust Indenture Act of 1939 as so amended.

          “Trustee” means the Person named as the Trustee in the first paragraph of this
instrument until a successor Trustee shall have become such pursuant to the applicable provisions
of this Indenture, and thereafter “Trustee” shall mean and include each Person who is then a
Trustee hereunder. If at any time there is more than one such Person, “Trustee” as used with
respect to the Securities of any series shall mean the Trustee with respect to Securities of that
series.

          “Vice President” when used with respect to the Company or the Trustee means any vice
president, whether or not designated by a number or a word or words added before or after the title
“vice president”, including without limitation, an assistant vice president.

          “Voting Stock”, as applied to the stock of any corporation, means stock of any class
or classes (however designated) having by the terms thereof ordinary voting power to elect a
majority of the members of the board of directors (or other governing body) of such corporation
other than stock having such power only by reason of the happening of a contingency.

          “Works” means motion pictures, video, television, interactive or multi-media
programming, audio-visual works, sound recordings, books and other literary or written material,
any software, copyright or other intellectual property related thereto, acquired directly or
indirectly after the date of this Indenture by purchase, business combination, production, creation
or otherwise, any component of the foregoing or rights with respect thereto, and all improvements
thereon, products and proceeds thereof and revenues derived therefrom.

          “Yield to Maturity” means the yield to maturity on a series of Securities, calculated
by the Company at the time of issuance of such series of Securities, or, if applicable, at

9

 

the most recent redetermination of interest on such series, in accordance with accepted
financial practice.

     SECTION 1.02 Compliance Certificates and Opinions. Upon any application or request
by the Company to the Trustee to take any action under any provision of this Indenture, the Company
shall furnish to the Trustee an Officers’ Certificate stating that all conditions precedent, if any
(including any covenants compliance with which constitutes a condition precedent), provided for in
this Indenture relating to the proposed action have been complied with and an Opinion of Counsel
stating that in the opinion of such Counsel all such conditions precedent, if any (including any
covenants compliance with which constitutes a condition precedent), have been complied with, except
that in the case of any such application or request as to which the furnishing of such documents is
specifically required by any provision of this Indenture relating to such particular application or
request, no additional certificate or opinion need be furnished.

          Every certificate or opinion with respect to compliance with a condition or covenant provided
for in this Indenture (other than annual statements of compliance provided pursuant to Section
10.04) shall include:

     (1) a statement that each individual signing such certificate or opinion has read such
covenant or condition and the definitions herein relating thereto;

     (2) a brief statement as to the nature and scope of the examination or investigation
upon which the statements or opinions contained in such certificate or opinion are based;

     (3) a statement that, in the opinion of each such individual, he has made such
examination or investigation as is necessary to enable him to express an informed opinion
as to whether or not such covenant or condition has been complied with; and

     (4) a statement as to whether, in the opinion of each such individual, such condition
or covenant has been complied with.

     SECTION 1.03 Form of Documents Delivered to Trustee. In any case where several
matters are required to be certified by, or covered by an opinion of, any specified Person, it is
not necessary that all such matters be certified by, or covered by the opinion of, only one such
Person, or that they be so certified or covered by only one document, but one such Person may
certify or give an opinion with respect to some matters and one or more other such Persons may
certify or give an opinion as to the other matters, and any such Person may certify or give an
opinion as to such matters in one or several documents.

          Any certificate or opinion of an officer of the Company may be based, insofar as it relates to
legal matters, upon a certificate or opinion of, or representations by, counsel, unless such
officer knows, or in the exercise of reasonable care should know, that the certificate or opinion
or representations with respect to the matters upon which his certificate or opinion is based are
erroneous. Any such certificate or Opinion of Counsel may be based, insofar as it relates to
factual matters, upon a certificate or opinion of, or representations by, an officer or officers of
the Company stating that the information with respect to such factual matters is in the possession
of the Company, unless such Counsel knows, or in the exercise of reasonable care should know, that
the certificate or opinion or representations with respect to such matters are erroneous.

10

 

          Where any Person is required to make, give or execute two or more applications, requests,
consents, certificates, statements, opinions or other instruments under this Indenture, they may,
but need not, be consolidated and form one instrument.

     SECTION 1.04 Acts of Securityholders. (a) Any request, demand, authorization,
direction, notice, consent, waiver or other action provided by this Indenture to be given or taken
by Securityholders or Securityholders of any series may be embodied in and evidenced by one or more
instruments of substantially similar tenor signed by such Securityholders in person or by an agent
duly appointed in writing or may be embodied in or evidenced by an electronic transmission which
identifies the documents containing the proposal on which such consent is requested and certifies
such Securityholders’ consent thereto and agreement to be bound thereby; and, except as herein
otherwise expressly provided, such action shall become effective when such instrument or
instruments are delivered to the Trustee, and, where it is hereby expressly required, to the
Company. If any Securities are denominated in coin or currency other than that of the United
States, then for the purposes of determining whether the Holders of the requisite principal amount
of Securities have taken any action as herein described, the principal amount of such Securities
shall be deemed to be that amount of United States dollars that could be obtained for such
principal amount on the basis of the spot rate of exchange into United States dollars for the
currency in which such Securities are denominated (as evidenced to the Trustee by an Officers’
Certificate) as of the date the taking of such action by the Holders of such requisite principal
amount is evidenced to the Trustee as provided in the immediately preceding sentence. If any
Securities are Original Issue Discount Securities, then for the purposes of determining whether the
Holders of the requisite principal amount of Securities have taken any action as herein described,
the principal amount of such Original Issue Discount Securities shall be deemed to be the amount of
the principal thereof that would be due and payable upon a declaration of acceleration of the
Maturity thereof as of the date the taking of such action by the Holders of such requisite
principal amount is evidenced to the Trustee as provided in the first sentence of this Section
1.04(a). Such instrument or instruments (and the action embodied therein and evidenced thereby) are
herein sometimes referred to as the “Act” of the Securityholders signing such instrument or
instruments. Proof of execution of any such instrument or of a writing appointing any such agent
shall be sufficient for any purpose of this Indenture and (subject to Section 6.01) conclusive in
favor of the Trustee and the Company, if made in the manner provided in this Section.

          (b) The fact and date of the execution by any Person of any such instrument or writing may be
proved by the affidavit of a witness to such execution or by the certificate of any notary public
or other officer authorized by law to take acknowledgments of deeds, certifying that the individual
signing such instrument or writing acknowledged to him the execution thereof. Where such execution
is by an officer of a corporation or a member of a partnership, on behalf of such corporation or
partnership, such certificate or affidavit shall also constitute sufficient proof of his authority.
The fact and date of the execution of any such instrument or writing, or the authority of the
person executing the same, may also be proved in any other manner which the Trustee deems
sufficient.

          (c) The ownership of Securities shall be proved by the Security Register.

          (d) If the Company shall solicit from the Holders any request, demand, authorization,
direction, notice, consent, waiver or other action, the Company may, at its option, fix in advance
a record date for the determination of Holders entitled to give such request, demand,
authorization, direction, notice, consent, waiver or other action, but the Company shall have no
obligation to do so. Such record date shall be the later of 10 days prior to the first

11

 

solicitation of such action or the date of the most recent list of Holders furnished to the
Trustee pursuant to Section 7.01. If such a record date is fixed, such request, demand,
authorization, direction, notice, consent, waiver or other action may be given before or after the
record date, but only the Holders of record at the close of business on the record date shall be
deemed to be Holders for the purposes of determining whether Holders of the requisite proportion of
Securities outstanding have authorized or agreed or consented to such request, demand,
authorization, direction, notice, consent, waiver or other action, and for that purpose the
Securities outstanding shall be computed as of the record date; provided that no such
authorization, agreement or consent by the Holders on the record date shall be deemed effective
unless it shall become effective pursuant to the provisions of this Indenture not later than six
months after the record date, and that no such authorization, agreement or consent may be amended,
withdrawn or revoked once given by a Holder, unless the Company shall provide for such amendment,
withdrawal or revocation in conjunction with such solicitation of authorizations, agreements or
consents or unless and to the extent required by applicable law.

          (e) Any request, demand, authorization, direction, notice, consent, waiver or other action by
the Holder of any Security shall bind the Holder of every Security issued upon the registration of
transfer thereof or in exchange therefor or in lieu thereof, in respect of anything done or
suffered to be done by the Trustee or the Company in reliance thereon whether or not notation of
such action is made upon such Security.

     SECTION 1.05 Notices, etc., to Trustee and Company. Any request, demand,
authorization, direction, notice, consent, waiver or Act of Securityholders or other document
provided or permitted by this Indenture to be made upon, given or furnished to, or filed with:

     (1) the Trustee by any Securityholder or by the Company shall be sufficient for every
purpose hereunder if made, given, furnished or filed in writing to or with the Trustee at
its Corporate Trust Office, Attention: Securities Servicing; or

     (2) the Company by the Trustee or by any Securityholder shall be sufficient for every
purpose hereunder (except as provided in Section 5.01(4) or, in the case of a request for
repayment, as specified in the Security carrying the right to repayment) if in writing and
mailed, first-class postage prepaid, to the Company addressed to it at the address of its
principal office specified in the first paragraph of this instrument, Attention: Treasurer,
or at any other address previously furnished in writing to the Trustee by the Company.

     SECTION 1.06 Notices to Securityholders; Waiver. Where this Indenture or any
Security provides for notice to Securityholders of any event, such notice shall be sufficiently
given (unless otherwise herein or in such Security expressly provided) if in writing and mailed,
first-class postage prepaid, to each Securityholder affected by such event, at his address as it
appears in the Security Register, not later than the latest date, and not earlier than the earliest
date, prescribed for the giving of such notice. In any case where notice to Securityholders is
given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to
any particular Securityholder shall affect the sufficiency of such notice with respect to other
Securityholders. Where this Indenture or any Security provides for notice in any manner, such
notice may be waived in writing by the Person entitled to receive such notice, either before or
after the event, and such waiver shall be the equivalent of such notice. Waivers of notice by
Securityholders shall be filed with the Trustee, but such filing shall not be a condition precedent
to the validity of any action taken in reliance upon such waiver.

12

 

          In case, by reason of the suspension of regular mail service as a result of a strike, work
stoppage or otherwise, it shall be impractical to mail notice of any event to any Securityholder
when such notice is required to be given pursuant to any provision of this Indenture, then any
method of notification as shall be satisfactory to the Trustee and the Company shall be deemed to
be a sufficient giving of such notice.

     SECTION 1.07 Conflict with Trust Indenture Act. If and to the extent that any
provision hereof limits, qualifies or conflicts with the duties imposed by, or with another
provision (an “incorporated provision”) included in this Indenture by operation of, any of
Sections 310 to 318, inclusive, of the Trust Indenture Act, such imposed duties or incorporated
provision shall control.

     SECTION 1.08 Effect of Headings and Table of Contents. The Article and Section
headings herein and the Table of Contents are for convenience only and shall not affect the
construction hereof.

     SECTION 1.09 Successors and Assigns. All covenants and agreements in this Indenture
by the Company and the Guarantors shall bind their respective successors and assigns, whether so
expressed or not.

     SECTION 1.10 Separability Clause. In case any provision in this Indenture or in the
Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of
the remaining provisions shall not in any way be affected or impaired thereby.

     SECTION 1.11 Benefits of Indenture. Nothing in this Indenture or in any Securities,
express or implied, shall give to any Person, other than the parties hereto and their successors
hereunder, any Authenticating Agent or Paying Agent, the Security Registrar and the Holders of
Securities (or such of them as may be affected thereby), any benefit or any legal or equitable
right, remedy or claim under this Indenture.

     SECTION 1.12 Governing Law. This Indenture shall be construed in accordance with and
governed by the laws of the State of New York.

     SECTION 1.13 Counterparts. This instrument may be executed in any number of
counterparts, each of which so executed shall be deemed to be an original, but all such
counterparts shall together constitute but one and the same instrument.

     SECTION 1.14 Judgment Currency. The Company agrees, to the fullest extent that it
may effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in
any court it is necessary to convert the sum due in respect of the principal of, or premium or
interest, if any, on the Securities of any series (the “Required Currency”) into a currency
in which a judgment will be rendered (the “Judgment Currency”), the rate of exchange used
shall be the rate at which in accordance with normal banking procedures the Trustee could purchase
in the City of New York the Required Currency with the Judgment Currency on the New York Banking
Day preceding that on which a final unappealable judgment is given and (b) its obligations under
this Indenture to make payments in the Required Currency (i) shall not be discharged or satisfied
by any tender, or any recovery pursuant to any judgment (whether or not entered in accordance with
subsection (a)), in any currency other than the Required Currency, except to the extent that such
tender or recovery shall result in the actual receipt, by the payee, of the full amount of the
Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as
an alternative or additional cause of action for the purpose of recovering in the Required

13

 

Currency the amount, if any, by which such actual receipt shall fall short of the full amount
of the Required Currency so expressed to be payable and (iii) shall not be affected by judgment
being obtained for any other sum due under this Indenture. For purposes of the foregoing, “New
York Banking Day” means any day except a Saturday, Sunday or a legal holiday in the City of New
York or a day on which banking institutions in the City of New York are authorized or required by
law or executive order to close.

     SECTION 1.15 WAIVER OF JURY TRIAL. EACH OF THE COMPANY, THE GUARANTORS AND THE
TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL
RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE
NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.

     SECTION 1.16 Force Majeure. In no event shall the Trustee be responsible or liable
for any failure or delay in the performance of its obligations hereunder arising out of or caused
by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work
stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural
catastrophes or acts of God; it being understood that the Trustee shall use reasonable efforts
which are consistent with accepted practices in the banking industry to resume performance as soon
as practicable under the circumstances.

ARTICLE II

Security Forms

     SECTION 2.01 Forms Generally. The Securities shall have such appropriate insertions,
omissions, substitutions and other variations as are required or permitted by this Indenture and
may have such letters, numbers or other marks of identification and such legends or endorsements
placed thereon, as may be required to comply with the rules of any securities exchange, or as may,
consistently herewith, be determined by the officers executing such Securities, as evidenced by
their execution of the Securities. Any portion of the text of any Security may be set forth on the
reverse thereof, with an appropriate reference thereto on the face of the Security.

          The definitive Securities shall be printed, lithographed or engraved or produced by any
combination of these methods on steel engraved borders or may be produced in any other manner, all
as determined by the officers executing such Securities, as evidenced by their execution of such
Securities, subject, with respect to the Securities of any series, to the rules of any securities
exchange on which such Securities are listed.

     SECTION 2.02 Forms of Securities. Each Security shall be in one of the forms
approved from time to time by or pursuant to a Board Resolution, established in one or more
indentures supplemental hereto or pursuant to an Officers’ Certificate pursuant to authority
granted under a Board Resolution. Prior to the delivery of a Security to the Trustee for
authentication in any form approved by or pursuant to a Board Resolution, the Company shall deliver
to the Trustee the Board Resolution by or pursuant to which such form of Security has been
approved, which Board Resolution shall have attached thereto a true and correct copy of the form of
Security which has been approved thereby or, if a Board Resolution authorizes a specific officer or
officers to approve a form of Security, a certificate of such officer or officers approving the
form of Security attached thereto. Any form of Security approved by or pursuant to a Board
Resolution must be acceptable as to form to the Trustee, such acceptance to be evidenced by the

14

 

Trustee’s authentication of Securities in that form or a certificate signed by a Responsible
Officer of the Trustee and delivered to the Company.

     SECTION 2.03 Form of Trustee’s Certificate of Authentication. The form of Trustee’s
Certificate of Authentication for any Security issued pursuant to this Indenture shall be
substantially as follows:

TRUSTEE’S CERTIFICATE OF AUTHENTICATION

          This is one of the Securities of the series designated therein referred to in the
within-mentioned Indenture.

	 	 	 	 	 
	 	THE BANK OF NEW YORK MELLON, as

Trustee,

 	 
	 	by:  	 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	 	 
	 	Dated:  	
 	 
	 	 	 	 
	 	 	 	 
	 

     SECTION 2.04 Securities Issuable in the Form of a Global Security. (a) If the
Company shall establish pursuant to Sections 2.02 and 3.01 that the Securities of a particular
series are to be issued in whole or in part in the form of one or more Global Securities, then the
Company shall execute and the Trustee or its agent shall, in accordance with Section 3.03 and the
Company Order delivered to the Trustee or its agent thereunder, authenticate and deliver, such
Global Security or Securities, which (i) shall represent, and shall be denominated in an amount
equal to the aggregate principal amount of, the Outstanding Securities of such series to be
represented by such Global Security or Securities, or such portion thereof as the Company shall
specify in a Company Order, (ii) shall be registered in the name of the Depository for such Global
Security or Securities or its nominee, (iii) shall be delivered by the Trustee or its agent to the
Depository or pursuant to the Depository’s instruction and (iv) shall bear a legend substantially
to the following effect: “Unless this certificate is presented by an authorized representative of
the Depository to Issuer or its agent for registration of transfer, exchange, or payment, and any
certificate issued is registered in the name of the nominee of the Depository or in such other name
as is requested by an authorized representative of the Depository (and any payment is made to the
nominee of the Depository or to such other entity as is requested by an authorized representative
of the Depository), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY
PERSON IS WRONGFUL inasmuch as the registered owner hereof, the nominee of the Depository, has an
interest herein.”

          (b) Notwithstanding any other provision of this Section 2.04 or of Section 3.05, and subject
to the provisions of paragraph (c) below, unless the terms of a Global Security expressly permit
such Global Security to be exchanged in whole or in part for individual Securities, a Global
Security may be transferred, in whole but not in part and in the manner provided in Section 3.05,
only to a nominee of the Depository for such Global Security, or to the

15

 

Depository, or a successor Depository for such Global Security selected or approved by the
Company, or to a nominee of such successor Depository.

          (c) (i) If at any time the Depository for a Global Security notifies the Company that it is
unwilling or unable to continue as Depository for such Global Security or if at any time the
Depository for the Securities for such series shall no longer be eligible or in good standing under
the Securities Exchange Act of 1934, as amended, or other applicable statute or regulation, the
Company shall appoint a successor Depository with respect to such Global Security. If a successor
Depository for such Global Security is not appointed by the Company within 90 days after the
Company receives such notice or becomes aware of such ineligibility, the Company will execute, and
the Trustee or its agent, upon receipt of a Company Request for the authentication and delivery of
individual Securities of such series in exchange for such Global Security, will authenticate and
deliver, individual Securities of such series of like tenor and terms in an aggregate principal
amount equal to the principal amount of the Global Security in exchange for such Global Security.

     (ii) The Company may at any time and in its sole discretion determine that the Securities of
any series or portion thereof issued or issuable in the form of one or more Global Securities shall
no longer be represented by such Global Security or Securities. In such event the Company will
execute, and the Trustee, upon receipt of a Company Request for the authentication and delivery of
individual Securities of such series in exchange in whole or in part for such Global Security, will
authenticate and deliver individual Securities of such series of like tenor and terms in definitive
form in an aggregate principal amount equal to the principal amount of such Global Security or
Securities representing such series or portion thereof in exchange for such Global Security or
Securities.

     (iii) If specified by the Company pursuant to Sections 2.02 and 3.02 with respect to
Securities issued or issuable in the form of a Global Security, the Depository for such Global
Security may surrender such Global Security in exchange in whole or in part for individual
Securities of such series of like tenor and terms in definitive form on such terms as are
acceptable to the Company and such Depository. Thereupon the Company shall execute, and the Trustee
or its agent shall authenticate and deliver, without service charge, (1) to each Person specified
by such Depository a new Security or Securities of the same series of like tenor and terms and of
any authorized denomination as requested by such Person in aggregate principal amount equal to and
in exchange for such Person’s beneficial interest as specified by such Depository in the Global
Security; and (2) to such Depository a new Global Security of like tenor and terms and in an
authorized denomination equal to the difference, if any, between the principal amount of the
surrendered Global Security and the aggregate principal amount of Securities delivered to Holders
thereof.

     (iv) In any exchange provided for in any of the preceding three paragraphs, the Company will
execute and the Trustee or its agent will authenticate and deliver individual Securities in
definitive registered form in authorized denominations. Upon the exchange of the entire principal
amount of a Global Security for individual Securities, such Global Security shall be canceled by
the Trustee or its agent. Except as provided in the preceding paragraph, Securities issued in
exchange for a Global Security pursuant to this Section shall be registered in such names and in
such authorized denominations as the Depository for such Global Security, pursuant to instructions
from its direct or indirect participants or otherwise, shall instruct the Trustee or the Security
Registrar. The Trustee or the Security Registrar shall deliver at its Corporate Trust Office such
Securities to the Persons in whose names such Securities are so registered.

16

 

ARTICLE III

The Securities

     SECTION 3.01 General Title; General Limitations; Issuable in Series; Terms of Particular
Series. The aggregate principal amount of Securities which may be authenticated and delivered
and Outstanding under this Indenture is not limited.

          The Securities may be issued in one or more series as from time to time may be authorized by
the Board of Directors. There shall be established in or pursuant to a Board Resolution, a
supplemental indenture or an Officers’ Certificate pursuant to authority granted under a Board
Resolution, subject to Section 3.11, prior to the issuance of Securities of any such series:

          (1) the title of the Securities of such series (which shall distinguish the Securities
of such series from Securities of any other series);

          (2) the Person to whom any interest on a Security of such series shall be payable, if
other than the Person in whose name that Security (or one or more Predecessor Securities)
is registered at the close of business on the Regular Record Date for such interest;

          (3) the date or dates on which the principal of the Securities of such series is
payable;

          (4) the rate or rates at which the Securities of such series shall bear interest, if
any, the date or dates from which such interest shall accrue, the Interest Payment Dates on
which any such interest shall be payable and the Regular Record Date for any interest
payable on any Interest Payment Date;

          (5) the place or places where the principal of and any premium and interest on
Securities of such series shall be payable;

          (6) the period or periods within which, the Redemption Price or Prices or the
Repayment Price or Prices, as the case may be, at which and the terms and conditions upon
which Securities of such series may be redeemed or repaid (including the applicability of
Section 11.09), as the case may be, in whole or in part, at the option of the Company or
the Holder;

          (7) the obligation, if any, of the Company to purchase Securities of such series
pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof
and the period or periods within which, the price or prices at which and the terms and
conditions upon which Securities of such series shall be purchased, in whole or in part,
pursuant to such obligation;

          (8) if other than denominations of $1,000 and any integral multiple thereof, the
denominations in which Securities of such series shall be issuable;

          (9) provisions, if any, with regard to the conversion or exchange of the Securities of
such series, at the option of the Holders thereof or the Company, as the case may be, for
or into new Securities of a different series, Common Stock or other securities

17

 

and, if the Securities of such series are convertible into common stock or other
Marketable Securities, the Conversion Price therefor;

          (10) if other than U.S. dollars, the currency or currencies or units based on or
related to currencies in which the Securities of such series shall be denominated and in
which payments of principal of, and any premium and interest on, such Securities shall or
may be payable;

          (11) if the principal of (and premium, if any) or interest, if any, on the Securities
of such series are to be payable, at the election of the Company or a Holder thereof, in a
coin or currency (including a composite currency) other than that in which the Securities
are stated to be payable, the period or periods within which, and the terms and conditions
upon which, such election may be made;

          (12) if the amount of payments of principal of (and premium, if any) or interest, if
any, on the Securities of such series may be determined with reference to an index based on
a coin or currency (including a composite currency) other than that in which the Securities
are stated to be payable, the manner in which such amounts shall be determined;

          (13) any limit upon the aggregate principal amount of the Securities of such series
which may be authenticated and delivered under this Indenture (except for Securities
authenticated and delivered upon registration of transfer of, or in exchange for, or in
lieu of, other Securities of such series pursuant to Sections 3.04, 3.05, 3.06, 9.06, 11.07
and 12.02 and except for any Securities which, pursuant to Section 3.03, are deemed never
to have been authenticated and delivered hereunder);

          (14) provisions, if any, with regard to the exchange of Securities of such series, at
the option of the Holders thereof, for other Securities of the same series of the same
aggregate principal amount or of a different authorized series or different authorized
denomination or denominations, or both;

          (15) provisions, if any, with regard to the appointment by the Company of an
Authenticating Agent in one or more places other than the location of the office of the
Trustee with power to act on behalf of the Trustee and subject to its direction in the
authentication and delivery of the Securities of any one or more series in connection with
such transactions as shall be specified in the provisions of this Indenture or in or
pursuant to such Board Resolution, supplemental indenture or Officers’ Certificate pursuant
to authority granted under a Board Resolution;

          (16) the portion of the principal amount of Securities of the series, if other than
the principal amount thereof, which shall be payable upon declaration of acceleration of
the Maturity thereof pursuant to Section 5.02 or provable in bankruptcy pursuant to Section
5.04;

          (17) any Event of Default with respect to the Securities of such series, if not set
forth herein, and any additions, deletions or other changes to the Events of Default set
forth herein that shall be applicable to the Securities of such series;

          (18) any covenant solely for the benefit of the Securities of such series and any
additions, deletions or other changes to the provisions of Article X or Section 1.01 or

18

 

any definitions relating to such Article that would otherwise be applicable to the
Securities of such series;

          (19) if Section 4.03 of this Indenture shall not be applicable to the Securities of
such series and if Section 4.03 shall be applicable to any covenant or Event of Default
established in or pursuant to a Board Resolution, a supplemental indenture or an Officers’
Certificate pursuant to authority granted under a Board Resolution as described above that
has not already been established herein;

          (20) if the Securities of such series shall be issued in whole or in part in the form
of a Global Security or Securities, the terms and conditions, if any, upon which such
Global Security or Securities may be exchanged in whole or in part for other individual
Securities; and the Depository for such Global Security or Securities; and

          (21) any other terms of such series;

all upon such terms as may be determined in or pursuant to such Board Resolution, supplemental
indenture or Officers’ Certificate pursuant to authority granted under a Board Resolution with
respect to such series.

          The form of the Securities of each series shall be established pursuant to the provisions of
this Indenture in or pursuant to the Board Resolution, the supplemental indenture or the Officers’
Certificate pursuant to authority granted under a Board Resolution creating such series. The
Securities of each series shall be distinguished from the Securities of each other series in such
manner, reasonably satisfactory to the Trustee, as the Board of Directors may determine.

          Unless otherwise provided with respect to Securities of a particular series, the Securities of
any series may only be issuable in registered form, without coupons.

          Any terms or provisions in respect of the Securities of any series issued under this Indenture
may be determined pursuant to this Section by providing for the method by which such terms or
provisions shall be determined.

     SECTION 3.02 Denominations. The Securities of each series shall be issuable in such
denominations and currency as shall be provided in the provisions of this Indenture or in or
pursuant to the Board Resolution, the supplemental indenture or the Officers’ Certificate pursuant
to authority granted under a Board Resolution creating such series. In the absence of any such
provisions with respect to the Securities of any series, the Securities of that series shall be
issuable only in fully registered form in denominations of $1,000 and any integral multiple
thereof.

     SECTION 3.03 Execution, Authentication and Delivery and Dating. The Securities shall
be executed on behalf of the Company by its Chairman of the Board, its Chief Executive Officer, its
Chief Financial Officer, its Chief Operating Officer, one of its Vice Presidents or its Treasurer
or any Assistant Treasurer and attested by its Secretary or one of its Assistant Secretaries. The
signature of any of these officers on the Securities may be manual or facsimile.

          Securities bearing the manual or facsimile signatures of individuals who were at any time the
proper officers of the Company shall bind the Company, notwithstanding that such individuals or any
of them have ceased to hold such offices prior to the authentication and delivery of such
Securities or did not hold such offices at the date of such Securities.

19

 

          At any time and from time to time after the execution and delivery of this Indenture, the
Company may deliver Securities executed by the Company to the Trustee for authentication; and the
Trustee shall, upon Company Order, authenticate and deliver such Securities as in this Indenture
provided and not otherwise.

          Prior to any such authentication and delivery, the Trustee shall be provided with, in addition
to any Officers’ Certificate and Opinion of Counsel required to be furnished to the Trustee
pursuant to Section 1.02, and the Board Resolution and any certificate relating to the issuance of
the series of Securities required to be furnished pursuant to Section 2.02, an Opinion of Counsel
stating that:

          (1) all instruments furnished to the Trustee conform to the requirements of the
Indenture and constitute sufficient authority hereunder for the Trustee to authenticate and
deliver such Securities;

          (2) the form and terms of such Securities have been established in conformity with the
provisions of this Indenture;

          (3) all laws and requirements with respect to the execution and delivery by the
Company of such Securities have been complied with, the Company has the corporate power to
issue such Securities and such Securities have been duly authorized and delivered by the
Company and, assuming due authentication and delivery by the Trustee, constitute legal,
valid and binding obligations of the Company enforceable in accordance with their terms
(subject, as to enforcement of remedies, to applicable bankruptcy, reorganization,
insolvency, moratorium or other laws and legal principles affecting creditors’ rights
generally from time to time in effect and to general equitable principles, whether applied
in an action at law or in equity) and entitled to the benefits of this Indenture, equally
and ratably with all other Securities, if any, of such series Outstanding;

          (4) the Indenture is qualified under the Trust Indenture Act; and

          (5) such other matters as the Trustee may reasonably request;

and, if the authentication and delivery relates to a new series of Securities created by an
indenture supplemental hereto, also stating that all laws and requirements with respect to the form
and execution by the Company of the supplemental indenture with respect to that series of
Securities have been complied with, the Company has corporate power to execute and deliver any such
supplemental indenture and has taken all necessary corporate action for those purposes and any such
supplemental indenture has been duly executed and delivered and constitutes the legal, valid and
binding obligation of the Company enforceable in accordance with its terms (subject, as to
enforcement of remedies, to applicable bankruptcy, reorganization, insolvency, moratorium or other
laws and legal principles affecting creditors’ rights generally from time to time in effect and to
general equitable principles, whether applied in an action at law or in equity).

          The Trustee shall not be required to authenticate such Securities if the issue thereof will
adversely affect the Trustee’s own rights, duties or immunities under the Securities and this
Indenture.

          Unless otherwise provided in the form of Security for any series, all Securities shall be
dated the date of their authentication.

20

 

          No Security shall be entitled to any benefit under this Indenture or be valid or obligatory
for any purpose unless there appears on such Security a certificate of authentication substantially
in the form provided for herein executed by the Trustee by manual or facsimile signature, and such
certificate upon any Security shall be conclusive evidence, and the only evidence, that such
Security has been duly authenticated and delivered hereunder. Notwithstanding the foregoing, if any
Security shall have been authenticated and delivered hereunder but never issued and sold by the
Company, and the Company shall deliver such Security to the Trustee for cancelation as provided in
Section 3.09, for all purposes of this Indenture such Security shall be deemed never to have been
authenticated and delivered hereunder and shall never be entitled to the benefits of this
Indenture.

          SECTION 3.04 Temporary Securities. Pending the preparation of definitive Securities
of any series, the Company may execute, and, upon receipt of the documents required by Section
3.03, together with a Company Order, the Trustee shall authenticate and deliver, temporary
Securities which are printed, lithographed, typewritten or otherwise produced, in any authorized
denomination, substantially of the tenor of the definitive Securities in lieu of which they are
issued and with such appropriate insertions, omissions, substitutions and other variations as the
officers executing such Securities may determine, as evidenced by their execution of such
Securities.

          If temporary Securities of any series are issued, the Company will cause definitive Securities
of such series to be prepared without unreasonable delay. After the preparation of definitive
Securities, the temporary Securities of such series shall be exchangeable for definitive Securities
of such series upon surrender of the temporary Securities of such series at the office or agency of
the Company in a Place of Payment, without charge to the Holder; and upon surrender for cancelation
of any one or more temporary Securities the Company shall execute and the Trustee shall
authenticate and deliver in exchange therefor a like principal amount of definitive Securities of
such series of authorized denominations and of like tenor and terms. Until so exchanged the
temporary Securities of such series shall in all respects be entitled to the same benefits under
this Indenture as definitive Securities of such series.

          SECTION 3.05 Registration, Transfer and Exchange. The Company shall keep or cause to
be kept a register or registers (herein sometimes referred to as the “Security Register”)
in which, subject to such reasonable regulations as it may prescribe, the Company shall provide for
the registration of Securities, or of Securities of a particular series, and of transfers of
Securities or of Securities of such series. Any such register shall be in written form or in any
other form capable of being converted into written form within a reasonable time. At all reasonable
times the information contained in such register or registers shall be available for inspection by
the Trustee at the office or agency to be maintained by the Company as provided in Section 10.02.
There shall be only one Security Register per series of Securities.

          Subject to Section 2.04, upon surrender for registration of transfer of any Security of any
series at the office or agency of the Company maintained for such purpose in a Place of Payment,
the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the
designated transferee or transferees, one or more new Securities of such series of any authorized
denominations, of a like aggregate principal amount and Stated Maturity and of like tenor and
terms.

          Subject to Section 2.04, at the option of the Holder, Securities of any series may be
exchanged for other Securities of such series of any authorized denominations, of a like aggregate
principal amount and Stated Maturity and of like tenor and terms, upon surrender of the

21

 

Securities to be exchanged at such office or agency. Whenever any Securities are so
surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and
deliver, the Securities which the Securityholder making the exchange is entitled to receive.

          All Securities issued upon any registration of transfer or exchange of Securities shall be the
valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under
this Indenture, as the Securities surrendered upon such registration of transfer or exchange.

          Every Security presented or surrendered for registration of transfer or exchange shall (if so
required by the Company or the Trustee) be duly endorsed, or be accompanied by a written instrument
of transfer in form satisfactory to the Company and the Trustee duly executed, by the Holder
thereof or his attorney duly authorized in writing.

          Unless otherwise provided in the Security to be registered for transfer or exchanged, no
service charge shall be made on any Securityholder for any registration of transfer or exchange of
Securities, but the Company may (unless otherwise provided in such Security) require payment of a
sum sufficient to cover any tax or other governmental charge that may be imposed in connection with
any registration of transfer or exchange of Securities, other than exchanges pursuant to Section
3.04, 9.06 or 11.07 not involving any transfer.

          The Company shall not be required (i) to issue, register the transfer of or exchange any
Security of any series during a period beginning at the opening of business 15 days before the day
of the mailing of a notice of redemption of Securities of such series selected for redemption under
Section 11.03 and ending at the close of business on the date of such mailing, or (ii) to register
the transfer of or exchange any Security so selected for redemption in whole or in part.

          None of the Company, the Trustee, any agent of the Trustee, any Paying Agent or the Security
Registrar will have any responsibility or liability for any aspect of the records relating to or
payments made on account of beneficial ownership interests of a Global Security or for maintaining,
supervising or reviewing any records relating to such beneficial ownership interests.

          SECTION 3.06 Mutilated, Destroyed, Lost and Stolen Securities. If (i) any mutilated
Security is surrendered to the Trustee, or the Company and the Trustee receive evidence to their
satisfaction of the destruction, loss or theft of any Security, and (ii) there is delivered to the
Company and the Trustee such security or indemnity as may be required by them to save each of them
harmless, then, in the absence of notice to the Company or the Trustee that such Security has been
acquired by a protected purchaser, the Company shall execute and upon its written request the
Trustee shall authenticate and deliver, in exchange for or in lieu of any such mutilated,
destroyed, lost or stolen Security, a new Security of like tenor, series, Stated Maturity and
principal amount, bearing a number not contemporaneously outstanding.

          In case any such mutilated, destroyed, lost or stolen Security has become or is about to
become due and payable, the Company in its discretion may, instead of issuing a new Security, pay
such Security.

          Upon the issuance of any new Security under this Section, the Company may require the payment
of a sum sufficient to cover any tax or other governmental charge that may

22

 

be imposed in relation thereto and any other expenses (including the fees and expenses of the
Trustee) connected therewith.

          Every new Security issued pursuant to this Section in lieu of any destroyed, lost or stolen
Security shall constitute an original additional contractual obligation of the Company, whether or
not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall be
entitled to all the benefits of this Indenture equally and proportionately with any and all other
Securities of the same series duly issued hereunder.

          The provisions of this Section are exclusive and shall preclude (to the extent lawful) all
other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost
or stolen Securities.

          SECTION 3.07 Payment of Interest; Interest Rights Preserved. Unless otherwise
provided with respect to such Security pursuant to Section 3.01, interest on any Security which is
payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to
the Person in whose name that Security (or one or more Predecessor Securities) is registered at the
close of business on the Regular Record Date for such interest.

          Any interest on any Security which is payable, but is not punctually paid or duly provided
for, on any Interest Payment Date (herein called “Defaulted Interest”) shall forthwith
cease to be payable to the registered Holder on the relevant Regular Record Date by virtue of his
having been such Holder; and, except as hereinafter provided, such Defaulted Interest may be paid
by the Company, at its election in each case, as provided in Clause (1) or Clause (2) below:

          (1) The Company may elect to make payment of any Defaulted Interest to the Persons in
whose names any such Securities (or their respective Predecessor Securities) are registered
at the close of business on a Special Record Date for the payment of such Defaulted
Interest, which shall be fixed in the following manner. The Company shall notify the
Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such
Security and the date of the proposed payment, and at the same time the Company shall
deposit with the Trustee an amount of money equal to the aggregate amount proposed to be
paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the
Trustee for such deposit prior to the date of the proposed payment, such money when
deposited to be held in trust for the benefit of the Persons entitled to such Defaulted
Interest as in this Clause provided. Thereupon the Trustee shall fix a Special Record Date
for the payment of such Defaulted Interest which shall be not more than 15 nor less than 10
days prior to the date of the proposed payment and not less than 10 days after the receipt
by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the
Company of such Special Record Date and, in the name and at the expense of the Company,
shall cause notice of the proposed payment of such Defaulted Interest and the Special
Record Date therefor to be mailed, first class postage prepaid, to the Holder of each such
Security at his address as it appears in the Security Register, not less than 10 days prior
to such Special Record Date. Notice of the proposed payment of such Defaulted Interest and
the Special Record Date therefor having been mailed as aforesaid, such Defaulted Interest
shall be paid to the Persons in whose names such Securities (or their respective
Predecessor Securities) are registered on such Special Record Date and shall no longer be
payable pursuant to the following Clause (2).

          (2) The Company may make payment of any Defaulted Interest in any other lawful manner
not inconsistent with the requirements of any securities exchange on

23

 

which such Securities may be listed, and upon such notice as may be required by such
exchange, if, after notice given by the Company to the Trustee of the proposed payment
pursuant to this Clause, such manner of payment shall be deemed practicable by the Trustee.

          If any installment of interest the Stated Maturity of which is on or prior to the Redemption
Date for any Security called for redemption pursuant to Article XI is not paid or duly provided for
on or prior to the Redemption Date in accordance with the foregoing provisions of this Section,
such interest shall be payable as part of the Redemption Price of such Securities.

          Subject to the foregoing provisions of this Section, each Security delivered under this
Indenture upon registration of transfer of or in exchange for or in lieu of any other Security
shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such
other Security.

          SECTION 3.08 Persons Deemed Owners. The Company, the Trustee and any agent of the
Company or the Trustee may treat the Person in whose name any Security is registered as the owner
of such Security for the purpose of receiving payment of principal of (and premium, if any), and
(subject to Section 3.07) interest on, such Security and for all other purposes whatsoever, whether
or not such Security be overdue, and neither the Company, the Trustee nor any agent of the Company
or the Trustee shall be affected by notice to the contrary.

          None of the Company, the Trustee, any Paying Agent or the Security Registrar will have any
responsibility or liability for any aspect of the records relating to or payments made on account
of beneficial ownership interests in a Global Security or for maintaining, supervising or reviewing
any records relating to such beneficial ownership interests.

          SECTION 3.09 Cancelation. All Securities surrendered for payment, conversion,
redemption, registration of transfer, exchange or credit against a sinking fund shall, if
surrendered to any Person other than the Trustee, be delivered to the Trustee and, if not already
canceled, shall be promptly canceled by it. The Company may at any time deliver to the Trustee for
cancelation any Securities previously authenticated and delivered hereunder which the Company may
have acquired in any manner whatsoever, and all Securities so delivered shall be promptly canceled
by the Trustee. No Security shall be authenticated in lieu of or in exchange for any Securities
canceled as provided in this Section, except as expressly permitted by this Indenture. The Trustee
shall dispose of all canceled Securities in accordance with its standard procedures and deliver a
certificate of such disposition to the Company upon its written request therefor.

          SECTION 3.10 Computation of Interest. Unless otherwise provided as contemplated in
Section 3.01, interest on the Securities shall be calculated on the basis of a 360-day year of
twelve 30-day months.

          SECTION 3.11 Delayed Issuance of Securities. Notwithstanding any contrary provision
herein, if all Securities of a series are not to be originally issued at one time, it shall not be
necessary for the Company to deliver to the Trustee an Officers’ Certificate, Board Resolution,
supplemental indenture, Officers’ Certificate pursuant to authority granted under a Board
Resolution, opinion of counsel or Company Order otherwise required pursuant to Sections 1.02, 2.02,
3.01 and 3.03 at or prior to the time of authentication of each Security of such series if such
documents are delivered to the Trustee or its agent at or prior to the authentication upon original
issuance of the first Security of such series to be issued; provided that any subsequent request by

24

 

the Company to the Trustee to authenticate Securities of such series upon original issuance
shall constitute a representation and warranty by the Company that as of the date of such request,
the statements made in the Officers’ Certificate or other certificates delivered pursuant to
Sections 1.02 and 2.02 shall be true and correct as if made on such date.

          A Company Order, Officers’ Certificate or Board Resolution or supplemental indenture delivered
by the Company to the Trustee in the circumstances set forth in the preceding paragraph may provide
that Securities which are the subject thereof will be authenticated and delivered by the Trustee or
its agent on original issue from time to time in the aggregate principal amount, if any,
established for such series pursuant to such procedures acceptable to the Trustee as may be
specified from time to time by Company Order upon the telephonic, electronic or written order of
Persons designated in such Company Order, Officers’ Certificate, supplemental indenture or Board
Resolution (any such telephonic or electronic instructions to be promptly confirmed in writing by
such Persons) and that such Persons are authorized to determine, consistent with such Company
Order, Officers’ Certificate, supplemental indenture or Board Resolution, such terms and conditions
of said Securities as are specified in such Company Order, Officers’ Certificate, supplemental
indenture or Board Resolution.

ARTICLE IV

Satisfaction and Discharge

          SECTION 4.01 Satisfaction and Discharge of Indenture. This Indenture shall cease to
be of further effect with respect to any series of Securities (except as to any surviving rights of
conversion or registration of transfer or exchange of Securities of such series expressly provided
for herein or in the form of Security for such series), and the Trustee, on receipt of a Company
Request and at the expense of the Company, shall execute proper instruments acknowledging
satisfaction and discharge of this Indenture as to such series, when:

          (1) either

          (A) all Securities of that series theretofore authenticated and delivered (other than
(i) Securities of such series which have been destroyed, lost or stolen and which have been
replaced or paid as provided in Section 3.06, and (ii) Securities of such series for whose
payment money in the Required Currency has theretofore been deposited in trust or
segregated and held in trust by the Company and thereafter repaid to the Company or
discharged from such trust, as provided in Section 10.03) have been delivered to the
Trustee canceled or for cancelation; or

          (B) all such Securities of that series not theretofore delivered to the Trustee
canceled or for cancelation:

     (i) have become due and payable, or

     (ii) will become due and payable at their Stated Maturity within one year, or

     (iii) are to be called for redemption within one year under arrangements
satisfactory to the Trustee for the giving of notice of redemption by the Trustee
in the name, and at the expense, of the Company,

25

 

and the Company, in the case of (i), (ii) or (iii) above, has irrevocably deposited or caused to be
deposited with the Trustee as trust funds in trust for the purpose an amount in the Required
Currency sufficient to pay and discharge the entire indebtedness on such Securities not theretofore
delivered to the Trustee canceled or for cancelation, for principal (and premium, if any) and
interest to the date of such deposit (in the case of Securities which have become due and payable),
or to the Stated Maturity or Redemption Date, as the case may be;

          (2) the Company has paid or caused to be paid all other sums payable hereunder by the
Company with respect to the Securities of such series; and

          (3) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion
of Counsel each stating that all conditions precedent herein provided for relating to the
satisfaction and discharge of this Indenture with respect to the Securities of such series
have been complied with.

Notwithstanding the satisfaction and discharge of this Indenture with respect to any series of
Securities, the obligations of the Company to the Trustee with respect to that series under Section
6.07 shall survive and the obligations of the Company and the Trustee under Sections 3.05, 3.06,
4.02, 10.02 and 10.03 shall survive such satisfaction and discharge.

          SECTION 4.02 Application of Trust Money. Subject to the provisions of the last
paragraph of Section 10.03, all money deposited with the Trustee pursuant to Section 4.01 or
Section 4.03 shall be held in trust and applied by it, in accordance with the provisions of the
series of Securities in respect of which it was deposited and this Indenture, to the payment,
either directly or through any Paying Agent (including the Company acting as its own Paying Agent)
as the Trustee may determine, to the Persons entitled thereto, of the principal (and premium, if
any) and interest for whose payment such money has been deposited with the Trustee; but such money
need not be segregated from other funds except to the extent required by law.

          Anything herein to the contrary notwithstanding, the Trustee shall deliver or pay to the
Company from time to time upon Company Request any money or securities deposited with and held by
it as provided in Section 4.03 and this Section 4.02 which, in the opinion of a nationally
recognized firm of independent public accountants expressed in a written certification thereof
delivered to the Trustee, are in excess of the amount thereof which would then be required to be
deposited to effect an equivalent satisfaction and discharge, Discharge (as defined below) or
covenant defeasance, provided that the Trustee shall not be required to liquidate any securities in
order to comply with the provisions of this paragraph.

          SECTION 4.03 Defeasance Upon Deposit of Funds or Government Obligations. Unless
pursuant to Section 3.01 provision is made that this Section shall not be applicable to the
Securities of any series, at the Company’s option, either (a) the Company and the Guarantors shall
be deemed to have been Discharged (as defined below) from their obligations with respect to any
series of Securities after the applicable conditions set forth below have been satisfied or (b) the
Company shall cease to be under any obligation to comply with any term, provision or condition set
forth in Sections 10.05 and 10.06 and Article VIII (and any other Sections or covenants applicable
to such Securities that are determined pursuant to Section 3.01 to be subject to this provision),
the Guarantors shall be released from the Guarantees and Clause (4) of Section 5.01 of this
Indenture (and any other Events of Default applicable to such Securities that are determined
pursuant to Section 3.01 to be subject to this provision) shall be deemed not to be an Event of
Default with respect to any series of Securities at any time after the applicable conditions set
forth below have been satisfied:

26

 

          (1) the Company shall have deposited or caused to be deposited irrevocably with the
Trustee as trust funds, specifically pledged as security for, and dedicated solely to, the
benefit of the Holders of the Securities of such series, (i) money in an amount, or (ii)
the equivalent in securities of the government which issued the currency in which the
Securities are denominated or government agencies backed by the full faith and credit of
such government which through the payment of interest and principal in respect thereof in
accordance with their terms will provide freely available funds on or prior to the due date
of any payment, money in an amount, or (iii) a combination of (i) and (ii), sufficient, in
the opinion (with respect to (ii) and (iii)) of a nationally recognized firm of independent
public accountants expressed in a written certification thereof delivered to the Trustee,
to pay and discharge each installment of principal (including mandatory sinking fund
payments) and any premium of, interest on and any repurchase or redemption obligations with
respect to the outstanding Securities of such series on the dates such installments of
interest or principal or repurchase or redemption obligations are due (before such a
deposit, if the Securities of such series are then redeemable or may be redeemed in the
future pursuant to the terms thereof, in either case at the option of the Company, the
Company may give to the Trustee, in accordance with Section 11.02, a notice of its election
to redeem all of the Securities of such series at a future date in accordance with Article
XI);

          (2) no Event of Default or event (including such deposit) which with notice or lapse
of time would become an Event of Default with respect to the Securities of such series
shall have occurred and be continuing on the date of such deposit;

          (3) the Company shall have delivered to the Trustee (A) an Opinion of Counsel to the
effect that Holders of the Securities of such series will not recognize income, gain or
loss for Federal income tax purposes as a result of the Company’s exercise of its option
under this Section 4.03 and will be subject to Federal income tax on the same amount and in
the same manner and at the same times as would have been the case if such option had not
been exercised, and, in the case of Securities being Discharged, accompanied by a ruling to
that effect from the Internal Revenue Service, unless, as set forth in such Opinion of
Counsel, there has been a change in the applicable federal income tax law since the date of
this Indenture such that a ruling from the Internal Revenue Service is no longer required
and (B) an Opinion of Counsel, subject to such qualifications, exceptions, assumptions and
limitations as are reasonably deemed necessary by such counsel and are reasonably
satisfactory to counsel for the Trustee, to the effect that the trust resulting from the
deposit referred to in paragraph (1) above does not violate the Investment Company Act of
1940;

          (4) the Company shall have delivered to the Trustee an Officers’ Certificate stating
that the deposit referred to in paragraph (1) above was not made by the Company with the
intent of preferring the Holders over other creditors of the Company or with the intent of
defeating, hindering, delaying or defrauding creditors of the Company or others; and

          (5) the Company shall have delivered to the Trustee an Officers’ Certificate and an
Opinion of Counsel each stating that all conditions precedent herein provided for relating
to the satisfaction and discharge of this Indenture with respect to the Securities of such
series have been complied with.

27

 

          If the Company, at its option, with respect to a series of Securities, satisfies the
applicable conditions pursuant to either clause (a) or (b) of the first sentence of this Section,
then (x), in the event the Company satisfies the conditions to clause (a) and elects clause (a) to
be applicable, each of the Guarantors shall be deemed to have paid and discharged the entire
indebtedness represented by, and obligations under, its respective guarantee of the Securities of
such series and to have satisfied all the obligations under this Indenture relating to the
Securities of such series and (y) in either case, each of the Guarantors shall cease to be under
any obligation to comply with any term, provision or condition set forth in Article VIII (and any
other covenants applicable to such Securities that are determined pursuant to Section 3.01 to be
subject to this provision), and clause (4) of Section 5.01 (and any other Events of Default
applicable to such series of Securities that are determined pursuant to Section 3.01 to be subject
to this provision) shall be deemed not to be an Event of Default with respect to such series of
Securities at any time thereafter.

          “Discharged” means that the Company shall be deemed to have paid and discharged the
entire indebtedness represented by, and obligations under, the Securities of such series and to
have satisfied all the obligations under this Indenture relating to the Securities of such series
(and the Trustee, on receipt of a Company Request and at the expense of the Company, shall execute
proper instruments acknowledging the same), except (A) the rights of Holders of Securities to
receive, from the trust fund described in clause (1) above, payment of the principal and any
premium of and any interest on such Securities when such payments are due; (B) the Company’s
obligations with respect to such Securities under Sections 3.05, 3.06, 4.02, 6.07, 10.02 and 10.03;
(C) the Company’s right of redemption, if any, with respect to any Securities of such series
pursuant to Article XI, in which case the Company may redeem the Securities of such series in
accordance with Article XI by complying with such Article and depositing with the Trustee, in
accordance with Section 11.05, an amount of money sufficient, together with all amounts held in
trust pursuant to Section 4.02 with respect to Securities of such series, to pay the Redemption
Price of all the Securities of such series to be redeemed; and (D) the rights, powers, trusts,
duties and immunities of the Trustee hereunder. A “Discharge” shall mean the meeting by the
Company of the foregoing requirements.

     SECTION 4.04 Reinstatement. If the Trustee or Paying Agent is unable to apply any
money or securities in accordance with Section 4.02 of this Indenture, by reason of any legal
proceeding or by reason of any order or judgment of any court or governmental authority enjoining,
restraining or otherwise prohibiting such application, the Company’s and, if applicable, the
Guarantors’ obligations under this Indenture and the Securities shall be revived and reinstated as
though no deposit had occurred pursuant to Section 4.01 or 4.03 of this Indenture, as the case may
be, until such time as the Trustee or Paying Agent is permitted to apply all such money or
securities in accordance with Section 4.02 of this Indenture; provided that, if the Company has
made any payment of principal of or interest on any Securities because of the reinstatement of its
obligations, the Company shall be subrogated to the rights of the Holders of such Securities to
receive such payment from the money or securities held by the Trustee or Paying Agent.

ARTICLE V

Remedies

     SECTION 5.01 Events of Default. “Event of Default”, wherever used herein,
means with respect to any series of Securities any one of the following events (whatever the reason
for such Event of Default and whether it shall be voluntary or involuntary or be effected by
operation

28

 

of law or pursuant to any judgment, decree or order of any court or any order, rule or
regulation of any administrative or governmental body), unless such event is either inapplicable to
a particular series or it is specifically deleted or modified in or pursuant to the supplemental
indenture, Board Resolution or Officers’ Certificate pursuant to authority granted under a Board
Resolution creating such series of Securities or in the form of Security for such series:

          (1) default in the payment of any interest upon any Security of that series when it
becomes due and payable, and continuance of such default for a period of 30 days; or

          (2) default in the payment of the principal of (or premium, if any, on) any Security
of that series at its Maturity; or

          (3) default in the payment of any sinking or purchase fund or analogous obligation
when the same becomes due by the terms of the Securities of such series; or

          (4) default in the performance, or breach, of any covenant or warranty of the Company,
or any Guarantor in this Indenture in respect of the Securities of such series (other than
a covenant or warranty in respect of the Securities of such series a default in the
performance of which or the breach of which is elsewhere in this Section specifically dealt
with), all of such covenants and warranties in the Indenture which are not expressly stated
to be for the benefit of a particular series of Securities being deemed in respect of the
Securities of all series for this purpose, and continuance of such default or breach for a
period of 90 days after there has been given, by registered or certified mail, to the
Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in
aggregate principal amount of the Outstanding Securities of such series, a written notice
specifying such default or breach and requiring it to be remedied and stating that such
notice is a “Notice of Default” hereunder; or

          (5) the entry of an order for relief against the Company or any Material U.S.
Subsidiary thereof under Title 11, United States Code (the “Federal Bankruptcy
Act”) by a court having jurisdiction in the premises or a decree or order by a court
having jurisdiction in the premises adjudging the Company or any Material U.S. Subsidiary
thereof bankrupt or insolvent under any other applicable Federal or State law, or the entry
of a decree or order approving as properly filed a petition seeking reorganization,
arrangement, adjustment or composition of or in respect of the Company or any Material U.S.
Subsidiary thereof under the Federal Bankruptcy Act or any other applicable Federal or
State law, or appointing a receiver, liquidator, assignee, trustee, sequestrator (or other
similar official) of the Company or any Material U.S. Subsidiary thereof or of any
substantial part of its property, or ordering the winding up or liquidation of its affairs,
and the continuance of any such decree or order unstayed and in effect for a period of 90
consecutive days; or

          (6) the consent by the Company or any Material U.S. Subsidiary thereof to the
institution of bankruptcy or insolvency proceedings against it, or the filing by it of a
petition or answer or consent seeking reorganization or relief under the Federal Bankruptcy
Act or any other applicable Federal or State law, or the consent by it to the filing of any
such petition or to the appointment of a receiver, liquidator, assignee, trustee,
sequestrator (or other similar official) of the Company or any Material U.S. Subsidiary
thereof or of any substantial part of its property, or the making by it of an assignment
for the benefit of creditors, or the admission by it in writing of its inability to

29

 

pay its debts generally as they become due, or the taking of corporate action by the
Company or any Material U.S. Subsidiary thereof in furtherance of any such action; or

          (7) any Guarantee shall for any reason cease to be, or be asserted in writing by any
Guarantor or the Company not to be, in full force and effect, enforceable in accordance
with its terms, except to the extent contemplated by this Indenture and any such Guarantee;
or

          (8) any other Event of Default provided in the supplemental indenture, Board
Resolution or Officers’ Certificate pursuant to authority granted under a Board Resolution
under which such series of Securities is issued or in the form of Security for such series.

          SECTION 5.02 Acceleration of Maturity; Rescission and Annulment. If an Event of
Default described in paragraph (1), (2), (3), (4), (7) or (8) (if the Event of Default under
paragraph (4) or (8) is with respect to less than all series of Securities then Outstanding) of
Section 5.01 occurs and is continuing with respect to any series, then and in each and every such
case, unless the principal of all the Securities of such series shall have already become due and
payable, either the Trustee or the Holders of not less than 25% in aggregate principal amount of
the Securities of such series then Outstanding hereunder (each such series acting as a separate
class), by notice in writing to the Company (and to the Trustee if given by Holders), may declare
the principal amount (or, if the Securities of such series are Original Issue Discount Securities,
such portion of the principal amount as may be specified in the terms of that series) of all the
Securities of such series and all accrued interest thereon to be due and payable immediately, and
upon any such declaration the same shall become and shall be immediately due and payable, anything
in this Indenture or in the Securities of such series contained to the contrary notwithstanding. If
an Event of Default described in paragraph (4) or (8) (if the Event of Default under paragraph (4)
or (8) is with respect to all series of Securities then Outstanding), of Section 5.01 occurs and is
continuing, then and in each and every such case, unless the principal of all the Securities shall
have already become due and payable, either the Trustee or the Holders of not less than 25% in
aggregate principal amount of all the Securities then Outstanding hereunder (treated as one class),
by notice in writing to the Company (and to the Trustee if given by Holders), may declare the
principal amount (or, if any Securities are Original Issue Discount Securities, such portion of the
principal amount as may be specified in the terms thereof) of all the Securities then Outstanding
and all accrued interest thereon to be due and payable immediately, and upon any such declaration
the same shall become and shall be immediately due and payable, anything in this Indenture or in
the Securities contained to the contrary notwithstanding. If an Event of Default of the type set
forth in paragraph (5) or (6) of Section 5.01 occurs and is continuing, the principal of and any
interest on the Securities then outstanding shall become immediately due and payable.

          At any time after such a declaration of acceleration has been made with respect to the
Securities of any or all series, as the case may be, and before a judgment or decree for payment of
the money due has been obtained by the Trustee as hereinafter in this Article provided, the Holders
of a majority in principal amount of the outstanding Securities of such series, by written notice
to the Company and the Trustee, may rescind and annul such declaration and its consequences if:

          (1) the Company has paid or deposited with the Trustee a sum sufficient to pay:

30

 

          (A) all overdue installments of interest on the Securities of such series; and

          (B) the principal of (and premium, if any, on) any Securities of such series which
have become due otherwise than by such declaration of acceleration, and interest thereon at
the rate or rates prescribed therefor by the terms of the Securities of such series, to the
extent that payment of such interest is lawful; and

          (C) interest upon overdue installments of interest at the rate or rates prescribed
therefor by the terms of the Securities of such series to the extent that payment of such
interest is lawful; and

          (D) all sums paid or advanced by the Trustee hereunder and the reasonable
compensation, expenses, disbursements and advances of the Trustee, its agents and counsel
and all other amounts due the Trustee under Section 6.07; and

     (2) all Events of Default with respect to such series of Securities, other than the
nonpayment of the principal of the Securities of such series which have become due solely
by such acceleration, have been cured or waived as provided in Section 5.13.

No such rescission shall affect any subsequent default or impair any right consequent thereon.

          SECTION 5.03 Collection of Indebtedness and Suits for Enforcement by Trustee. The
Company covenants that if:

          (1) default is made in the payment of any installment of interest on any Security of
any series when such interest becomes due and payable; or

          (2) default is made in the payment of the principal of (or premium, if any, on) any
Security at the Maturity thereof; or

          (3) default is made in the payment of any sinking or purchase fund or analogous
obligation when the same becomes due by the terms of the Securities of any series;

and any such default continues for any period of grace provided with respect to the Securities of
such series, the Company will, upon demand of the Trustee, pay to it, for the benefit of the Holder
of any such Security (or the Holders of any such series in the case of Clause (3) above), the whole
amount then due and payable on any such Security (or on the Securities of any such series in the
case of Clause (3) above) for principal (and premium, if any) and interest, with interest, to the
extent that payment of such interest shall be legally enforceable, upon the overdue principal (and
premium, if any) and upon overdue installments of interest, at such rate or rates as may be
prescribed therefor by the terms of any such Security (or of Securities of any such series in the
case of Clause (3) above); and, in addition thereto, such further amount as shall be sufficient to
cover the costs and expenses of collection, including the reasonable compensation, expenses,
disbursements and advances of the Trustee, its agents and counsel and all other amounts due the
Trustee under Section 6.07.

          If the Company fails to pay such amounts forthwith upon such demand, the Trustee, in its own
name and as trustee of an express trust, may institute a judicial proceeding for the collection of
the sums so due and unpaid, and may prosecute such proceeding to judgment or

31

 

final decree, and may enforce the same against the Company or any other obligor upon the
Securities of such series and collect the money adjudged or decreed to be payable in the manner
provided by law out of the property of the Company or any other obligor upon such Securities,
wherever situated.

          If an Event of Default with respect to any series of Securities occurs and is continuing, the
Trustee may in its discretion proceed to protect and enforce its rights and the rights of the
Holders of Securities of such series by such appropriate judicial proceedings as the Trustee shall
deem most effectual to protect and enforce any such rights, whether for the specific enforcement of
any covenant or agreement in this Indenture or in aid of the exercise of any power granted herein,
or to enforce any other proper remedy.

          SECTION 5.04 Trustee May File Proofs of Claim. In case of the pendency of any
receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment,
composition or other judicial proceeding relative to the Company or any other obligor upon the
Securities or the property of the Company or of such other obligor or their creditors, the Trustee
(irrespective of whether the principal of the Securities shall then be due and payable as therein
expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made
any demand on the Company for the payment of overdue principal or interest) shall be entitled and
empowered, by intervention in such proceedings or otherwise:

     (i) to file and prove a claim for the whole amount of principal (or portion
thereof determined pursuant to Section 3.01(16) to be provable in bankruptcy) (and
premium, if any) and interest owing and unpaid in respect of the Securities and to
file such other papers or documents as may be necessary and advisable in order to
have the claims of the Trustee (including any claim for the reasonable
compensation, expenses, disbursements and advances of the Trustee, its agents and
counsel and all other amounts due the Trustee under Section 6.07) and of the
Securityholders allowed in such judicial proceeding; and

     (ii) to collect and receive any moneys or other property payable or
deliverable on any such claims and to distribute the same;

and any receiver, assignee, trustee, liquidator, sequestrator (or other similar official) in any
such judicial proceeding is hereby authorized by each Securityholder to make such payment to the
Trustee and in the event that the Trustee shall consent to the making of such payments directly to
the Securityholders, to pay to the Trustee any amount due to it for the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts
due the Trustee under Section 6.07.

          Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to
or accept or adopt on behalf of any Securityholder any plan of reorganization, arrangement,
adjustment or composition affecting the Securities or the rights of any Holder thereof, or to
authorize the Trustee to vote in respect of the claim of any Securityholder in any such proceeding.

          SECTION 5.05 Trustee May Enforce Claims Without Possession of Securities. All rights
of action and claims under this Indenture or the Securities of any series may be prosecuted and
enforced by the Trustee without the possession of any of the Securities of such series or the
production thereof in any proceeding relating thereto, and any such proceeding instituted by the
Trustee shall be brought in its own name as trustee of an express trust, and any

32

 

recovery of judgment shall, after provision for the payment of the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agent and counsel and any other amounts
due the Trustee under Section 6.07, be for the ratable benefit of the Holders of the Securities of
the series in respect of which such judgment has been recovered.

          SECTION 5.06 Application of Money Collected. Any money collected by the Trustee with
respect to a series of Securities pursuant to this Article shall be applied in the following order,
at the date or dates fixed by the Trustee and, in case of the distribution of such money on account
of principal (or premium, if any) or interest, upon presentation of the Securities of such series
and the notation thereon of the payment if only partially paid and upon surrender thereof if fully
paid:

          FIRST: To the payment of all amounts due the Trustee under Section 6.07.

          SECOND: To the payment of the amounts then due and unpaid upon the Securities of that series
for principal (and premium, if any) and interest, in respect of which or for the benefit of which
such money has been collected, ratably, without preference or priority of any kind, according to
the amounts due and payable on such Securities for principal (and premium, if any) and interest,
respectively.

          THIRD: To the Company.

          SECTION 5.07 Limitation on Suits. No Holder of any Security of any series shall have
any right to institute any proceeding, judicial or otherwise, with respect to this Indenture, or
for the appointment of a receiver or trustee, or for any other remedy hereunder, unless:

          (1) such Holder has previously given written notice to the Trustee of a continuing
Event of Default with respect to Securities of such series;

          (2) the Holders of not less than 25% in principal amount of the outstanding Securities
of such series shall have made written request to the Trustee to institute proceedings in
respect of such Event of Default in its own name as Trustee hereunder;

          (3) such Holder or Holders have offered to the Trustee indemnity reasonably
satisfactory to it against the costs, expenses and liabilities to be incurred in compliance
with such request;

          (4) the Trustee for 60 days after its receipt of such notice, request and offer of
indemnity has failed to institute any such proceeding; and

          (5) no direction inconsistent with such written request has been given to the Trustee
during such 60-day period by the Holders of a majority in principal amount of the
Outstanding Securities of such series;

it being understood and intended that no one or more Holders of Securities of such series shall
have any right in any manner whatever by virtue of, or by availing of, any provision of this
Indenture to affect, disturb or prejudice the rights of any other Holders of Securities of such
series, or to obtain or to seek to obtain priority or preference over any other such Holders or to
enforce any right under this Indenture, except in the manner herein provided and for the equal and
proportionate benefit of all the Holders of all Securities of such series.

33

 

          SECTION 5.08 Unconditional Right of Securityholders to Receive Principal, Premium and
Interest. Notwithstanding any other provisions in this Indenture, the Holder of any Security
shall have the right, which is absolute and unconditional, to receive payment of the principal of
(and premium, if any) and (subject to Section 3.07) interest on such Security on the respective
Stated Maturities expressed in such Security (or, in the case of redemption or repayment, on the
Redemption Date or Repayment Date, as the case may be) and to institute suit for the enforcement of
any such payment, and such right shall not be impaired without the consent of such Holder.

          SECTION 5.09 Restoration of Rights and Remedies. If the Trustee or any
Securityholder has instituted any proceeding to enforce any right or remedy under this Indenture
and such proceeding has been discontinued or abandoned for any reason, then and in every such case
the Company, the Trustee and the Securityholders shall, subject to any determination in such
proceeding, be restored severally and respectively to their former positions hereunder, and
thereafter all rights and remedies of the Trustee and the Securityholders shall continue as though
no such proceeding had been instituted.

          SECTION 5.10 Rights and Remedies Cumulative. No right or remedy herein conferred
upon or reserved to the Trustee or to the Securityholders is intended to be exclusive of any other
right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative
and in addition to every other right and remedy given hereunder or now or hereafter existing at law
or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or
otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right
or remedy.

          SECTION 5.11 Delay or Omission Not Waiver. No delay or omission of the Trustee or of
any Holder of any Security to exercise any right or remedy accruing upon any Event of Default shall
impair any such right or remedy or constitute a waiver of any such Event of Default or an
acquiescence therein. Every right and remedy given by this Article or by law to the Trustee or to
the Securityholders may be exercised from time to time, and as often as may be deemed expedient, by
the Trustee or by the Securityholders, as the case may be.

          SECTION 5.12 Control by Securityholders. The Holders of a majority in principal
amount of the Outstanding Securities of any series shall have the right to direct the time, method
and place of conducting any proceeding for any remedy available to the Trustee or exercising any
trust or power conferred on the Trustee with respect to the Securities of such series, provided
that:

          (1) the Trustee shall have the right to decline to follow any such direction if the
Trustee, being advised by counsel, determines that the action so directed may not lawfully
be taken or would conflict with this Indenture or if the Trustee in good faith shall, by a
Responsible Officer, determine that the proceedings so directed would involve it in
personal liability or be unjustly prejudicial to the Holders not taking part in such
direction, and

          (2) the Trustee may take any other action deemed proper by the Trustee which is not
inconsistent with such direction.

          SECTION 5.13 Waiver of Past Defaults. The Holders of not less than a majority in
principal amount of the Outstanding Securities of any series may on behalf of the Holders of

34

 

all the Securities of such series waive any past default hereunder with respect to such series
and its consequences, except a default not theretofore cured:

          (1) in the payment of the principal of (or premium, if any) or interest on any
Security of such series, or in the payment of any sinking or purchase fund or analogous
obligation with respect to the Securities of such series, or

          (2) in respect of a covenant or provision hereof which under Article IX cannot be
modified or amended without the consent of the Holder of each Outstanding Security of such
series.

          Upon any such waiver, such default shall cease to exist, and any Event of Default arising
therefrom shall be deemed to have been cured, for every purpose of this Indenture; but no such
waiver shall extend to any subsequent or other default or impair any right consequent thereon.

          SECTION 5.14 Undertaking for Costs. All parties to this Indenture agree, and each
Holder of any Security by his acceptance thereof shall be deemed to have agreed, that any court may
in its discretion require, in any suit for the enforcement of any right or remedy under this
Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the
filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that
such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees and
expenses, against any party litigant in such suit, having due regard to the merits and good faith
of the claims or defenses made by such party litigant; but the provisions of this Section shall not
apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder, or group
of Securityholders, holding in the aggregate more than 10% in principal amount of the Outstanding
Securities of any series to which the suit relates, or to any suit instituted by any Securityholder
for the enforcement of the payment of the principal of (or premium, if any) or interest on an
Security on or after the respective Stated Maturities expressed in such Security (or, in the case
of redemption or repayment, on or after the Redemption Date or Repayment Date, as the case may be).

          SECTION 5.15 Waiver of Stay or Extension Laws. The Company covenants (to the extent
that it may lawfully do so) that it will not at any time insist upon, or plead, or in any manner
whatsoever claim or take the benefit or advantage of, any stay or extension law wherever enacted,
now or at any time hereafter in force, which may affect the covenants or the performance of this
Indenture; and the Company (to the extent that it may lawfully do so) hereby expressly waives all
benefit or advantage of any such law, and covenants that it will not hinder, delay or impede the
execution of any power herein granted to the Trustee, but will suffer and permit the execution of
every such power as though no such law had been enacted.

ARTICLE VI

The Trustee

          SECTION 6.01 Certain Duties and Responsibilities. (a) Except during the continuance
of an Event of Default with respect to any series of Securities:

35

 

          (1) the Trustee undertakes to perform such duties and only such duties as are
specifically set forth in this Indenture with respect to the Securities of such series, and
no implied covenants or obligations shall be read into this Indenture against the Trustee;
and

          (2) in the absence of bad faith on its part, the Trustee may, with respect to
Securities of such series, conclusively rely, as to the truth of the statements and the
correctness of the opinions expressed therein, upon certificates or opinions furnished to
the Trustee and conforming to the requirements of this Indenture; but in the case of any
such certificates or opinions which by any provision hereof are specifically required to be
furnished to the Trustee, the Trustee shall be under a duty to examine the same to
determine whether or not they conform to the requirements of this Indenture (but need not
confirm or investigate the accuracy of mathematical calculations or other facts stated
therein).

          (b) In case an Event of Default with respect to any series of Securities has occurred and is
continuing, the Trustee shall exercise with respect to the Securities of such series such of the
rights and powers vested in it by this Indenture, and use the same degree of care and skill in
their exercise, as a prudent man would exercise or use under the circumstances in the conduct of
his own affairs.

          (c) No provision of this Indenture shall be construed to relieve the Trustee from liability
for its own negligent action, its own negligent failure to act, or its own willful misconduct,
except that:

          (1) this Subsection shall not be construed to limit the effect of Subsection (a) of
this Section;

          (2) the Trustee shall not be liable for any error of judgment made in good faith by a
Responsible Officer, unless it shall be proved that the Trustee was negligent in
ascertaining the pertinent facts;

          (3) the Trustee shall not be liable with respect to any action taken or omitted to be
taken by it in good faith in accordance with the direction of the Holders of a majority in
principal amount of the Outstanding Securities of any series relating to the time, method
and place of conducting any proceeding for any remedy available to the Trustee, or
exercising any trust or power conferred upon the Trustee, under this Indenture with respect
to the Securities of such series; and

          (4) no provision of this Indenture shall require the Trustee to expend or risk its own
funds or otherwise incur any financial liability in the performance of any of its duties
hereunder, or in the exercise of any of its rights or powers, if it shall have reasonable
grounds for believing that repayment of such funds or adequate indemnity against such risk
or liability is not reasonably assured to it.

          (d) Whether or not therein expressly so provided, every provision of this Indenture relating
to the conduct or affecting the liability of or affording protection to the Trustee shall be
subject to the provisions of this Section.

          SECTION 6.02 Notice of Defaults. Within 90 days after the occurrence of any default
hereunder with respect to Securities of any series, the Trustee shall transmit by mail to all
Securityholders of such series, as their names and addresses appear in the Security Register,

36

 

notice of such default hereunder known to the Trustee, unless such default shall have been
cured or waived; provided, however, that, except in the case of a default in the payment of the
principal of (or premium, if any) or interest on any Security of such series or in the payment of
any sinking or purchase fund installment or analogous obligation with respect to Securities of such
series, the Trustee shall be protected in withholding such notice if and so long as the board of
directors, the executive committee or a trust committee of directors and/or Responsible Officers of
the Trustee in good faith determine that the withholding of such notice is in the interests of the
Securityholders of such series; and provided, further, that in the case of any default of the
character specified in Section 5.01(4) with respect to Securities of such series no such notice to
Securityholders of such series shall be given until at least 90 days after the occurrence thereof.
For the purpose of this Section, the term “default”, with respect to Securities of any series,
means any event which is, or after notice or lapse of time or both would become, an Event of
Default with respect to Securities of such series.

          SECTION 6.03 Certain Rights of Trustee. Except as otherwise provided in Section
6.01:

     (a) the Trustee may conclusively rely and shall be fully protected in acting or
refraining from acting upon any resolution, certificate, statement, instrument, opinion,
report, notice, request, direction, consent, order, bond, debenture or other paper or
document believed by it to be genuine and to have been signed or presented by the proper
party or parties;

     (b) any request or direction of the Company mentioned herein shall be sufficiently
evidenced by a Company Request or Company Order and any resolution of the Board of
Directors may be sufficiently evidenced by a Board Resolution;

     (c) whenever in the administration of this Indenture the Trustee shall deem it
desirable that a matter be proved or established prior to taking, suffering or omitting any
action hereunder, the Trustee (unless other evidence be herein specifically prescribed)
may, in the absence of bad faith on its part, rely upon an Officers’ Certificate;

     (d) the Trustee may consult with counsel and the advice of such counsel or an Opinion
of Counsel shall be full and complete authorization and protection in respect of any action
taken, suffered or omitted by it hereunder in good faith and in reliance thereon;

     (e) the Trustee shall be under no obligation to exercise any of the rights or powers
vested in it by this Indenture at the request or direction of any of the Securityholders
pursuant to this Indenture, unless such Securityholders shall have offered to the Trustee
security or indemnity reasonably satisfactory to it against the costs, expenses and
liabilities which might be incurred by it in compliance with such request or direction;

     (f) the Trustee shall not be bound to make any investigation into the facts or matters
stated in any resolution, certificate, statement, instrument, opinion, report, notice,
request, direction, consent, order, bond, debenture or other paper or document, but the
Trustee, in its discretion, may make such further inquiry or investigation into such facts
or matters as it may see fit, and, if the Trustee shall determine to make such further
inquiry or investigation, it shall be entitled to examine the books, records and premises
of the Company, personally or by agent or attorney;

37

 

     (g) the Trustee may execute any of the trusts or powers hereunder or perform any
duties hereunder either directly or by or through agents or attorneys and the Trustee shall
not be responsible for any misconduct or negligence on the part of any agent or attorney
appointed with due care by it hereunder;

     (h) the Trustee shall not be charged with knowledge of any default (as defined in
Section 6.02) or Event of Default with respect to the Securities of any series for which it
is acting as Trustee unless either (1) a Responsible Officer of the Trustee assigned to the
Corporate Trust Office of the Trustee (or any successor division or department of the
Trustee) shall have actual knowledge of such default or Event of Default or (2) written
notice of such default or Event of Default shall have been given to the Trustee by the
Company or any other obligor on such Securities or by any Holder of such Securities;

     (i) the Trustee shall not be liable for any action taken, suffered or omitted by it in
good faith and believed by it to be authorized or within the discretion or rights or powers
conferred upon it by this Indenture;

     (j) the rights, privileges, protections, immunities and benefits given to the Trustee,
including, without limitation, its right to be indemnified, are extended to, and shall be
enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian
and other Person employed to act hereunder; and

     (k) in no event shall the Trustee be responsible or liable for special, indirect or
consequential loss or damage of any kind whatsoever (including, but not limited to, loss of
profit) irrespective of whether the Trustee has been advised of the likelihood of such loss
or damage and regardless of the form of action, except to the extent such loss or damage
shall be determined to have been caused by its own negligence or bad faith.

          SECTION 6.04 Not Responsible for Recitals or Issuance of Securities. The recitals
contained herein and in the Securities, except the certificates of authentication, shall be taken
as the statements of the Company, and the Trustee assumes no responsibility for their correctness.
The Trustee makes no representations as to the validity or sufficiency of this Indenture or of the
Securities. The Trustee shall not be accountable for the use or application by the Company of
Securities or the proceeds thereof.

          SECTION 6.05 May Hold Securities. The Trustee, any Authenticating Agent, any Paying
Agent, the Security Registrar, any Conversion Agent or any other agent of the Company, in its
individual or any other capacity, may become the owner or pledgee of Securities and, subject to
Sections 6.08 and 6.13, may otherwise deal with the Company or any Guarantor with the same rights
it would have if it were not Trustee, Authenticating Agent, Paying Agent, Security Registrar,
Conversion Agent or such other agent.

          SECTION 6.06 Money Held in Trust. Subject to the provisions of Section 10.03 hereof,
all moneys in any currency or currency received by the Trustee shall, until used or applied as
herein provided, be held in trust for the purposes for which they were received, but need not be
segregated from other funds except to the extent required by law. The Trustee shall be under no
liability for interest on any money received by it hereunder except as otherwise agreed in writing
with the Company.

          SECTION 6.07 Compensation and Reimbursement. The Company agrees:

38

 

          (1) to pay to the Trustee from time to time reasonable compensation for all services
rendered by it hereunder (which compensation shall not be limited by any provision of law
in regard to the compensation of a trustee of an express trust);

          (2) except as otherwise expressly provided herein, to reimburse the Trustee upon its
request for all reasonable expenses, disbursements and advances incurred or made by the
Trustee in accordance with any provision of this Indenture (including the reasonable
compensation and the expenses and disbursements of its agents and counsel), except any such
expense, disbursement or advance as shall be determined to have been caused by its own
negligence or bad faith; and

          (3) to indemnify the Trustee for, and to hold it harmless against, any loss, liability
or expense incurred without negligence or bad faith on its part, arising out of or in
connection with the acceptance or administration of this trust, including the costs and
expenses of defending itself against any claim or liability in connection with the exercise
or performance of any of its powers or duties hereunder.

          As security for the performance of the obligations of the Company under this Section the
Trustee shall have a lien prior to the Securities upon all property and funds held or collected by
the Trustee as such, except funds held in trust for the payment of principal of (and premium, if
any) or interest on particular Securities.

          When the Trustee incurs expenses or renders services in connection with an Event of Default
specified in Section 5.01(5) or (6), the expenses and the compensation for the services are
intended to constitute expenses of administration under any bankruptcy law.

          The Company’s obligations under this Section 6.07 and any lien arising hereunder shall survive
the resignation or removal of any Trustee, the discharge of the Company’s obligations pursuant to
Article IV of this Indenture and/or the termination of this Indenture.

          SECTION 6.08 Disqualification; Conflicting Interests. The Trustee for the Securities
of any series issued hereunder shall be subject to the provisions of Section 310(b) of the Trust
Indenture Act during the period of time provided for therein. In determining whether the Trustee
has a conflicting interest as defined in Section 310(b) of the Trust Indenture Act with respect to
the Securities of any series, there shall be excluded this Indenture with respect to Securities of
any particular series of Securities other than that series. Nothing herein shall prevent the
Trustee from filing with the Commission the application referred to in the second to last paragraph
of Section 310(b) of the Trust Indenture Act.

          SECTION 6.09 Corporate Trustee Required; Eligibility. There shall at all times be a
Trustee hereunder with respect to each series of Securities, which shall be either:

     (i) a corporation organized and doing business under the laws of the United
States of America or of any State, authorized under such laws to exercise corporate
trust powers and subject to supervision or examination by Federal or State
authority, or

     (ii) a corporation or other Person organized and doing business under the laws
of a foreign government that is permitted to act as Trustee pursuant to a rule,
regulation or order of the Commission, authorized under such laws to

39

 

exercise corporate trust powers, and subject to supervision or
examination by authority of such foreign government or a political subdivision
thereof substantially equivalent to supervision or examination applicable to United
States institutional trustees;

in either case having a combined capital and surplus of at least $50,000,000. If such corporation
publishes reports of condition at least annually, pursuant to law or to the requirements of the
aforesaid supervising or examining authority, then for the purposes of this Section, the combined
capital and surplus of such corporation shall be deemed to be its combined capital and surplus as
set forth in its most recent report of condition so published. Neither the Company nor any Person
directly or indirectly controlling, controlled by, or under common control with the Company shall
serve as trustee for the Securities of any series issued hereunder. If at any time the Trustee with
respect to any series of Securities shall cease to be eligible in accordance with the provisions of
this Section, it shall resign immediately in the manner and with the effect specified in Section
6.10.

          SECTION 6.10 Resignation and Removal. (a) No resignation or removal of the Trustee
and no appointment of a successor Trustee pursuant to this Article shall become effective until the
acceptance of appointment by the successor Trustee under Section 6.11.

          (b) The Trustee may resign with respect to any series of Securities at any time by giving
written notice thereof to the Company. If an instrument of acceptance by a successor Trustee shall
not have been delivered to the Trustee within 30 days after the giving of such notice of
resignation, the resigning Trustee may petition any court of competent jurisdiction for the
appointment of a successor Trustee.

          (c) The Trustee may be removed with respect to any series of Securities at any time by Act of
the Holders of a majority in principal amount of the outstanding Securities of that series,
delivered to the Trustee and to the Company. If an instrument of acceptance by a successor Trustee
shall not have been delivered to the Trustee within 30 days after the giving of such notice of
removal, the removed Trustee may petition any court of competent jurisdiction for the appointment
of a successor Trustee.

          (d) If at any time:

          (1) the Trustee shall fail to comply with Section 310(b) of the Trust Indenture Act
pursuant to Section 6.08 with respect to any series of Securities after written request
therefor by the Company or by any Securityholder who has been a bona fide Holder of a
Security of that series for at least six months, unless the Trustee’s duty to resign is
stayed in accordance with the provisions of Section 310(b) of the Trust Indenture Act, or

          (2) the Trustee shall cease to be eligible under Section 6.09 with respect to any
series of Securities and shall fail to resign after written request therefor by the Company
or by any such Securityholder, or

          (3) the Trustee shall become incapable of acting with respect to any series of
Securities, or

          (4) the Trustee shall be adjudged a bankrupt or insolvent or a receiver of the Trustee
or of its property shall be appointed or any public officer shall take charge or

40

 

control of the Trustee or of its property or affairs for the purpose of
rehabilitation, conservation or liquidation, then, in any such case, (i) the Company by a
Board Resolution may remove the Trustee, with respect to the series, or in the case of
Clause (4), with respect to all series, or (ii) subject to Section 5.14, any Securityholder
who has been a bona fide Holder of a Security of such series for at least six months may,
on behalf of himself and all others similarly situated, petition any court of competent
jurisdiction for the removal of the Trustee and the appointment of a successor Trustee with
respect to the series, or, in the case of Clause (4), with respect to all series.

          (e) If the Trustee shall resign, be removed or become incapable of acting with respect to any
series of Securities, or if a vacancy shall occur in the office of the Trustee with respect to any
series of Securities for any cause, the Company, by Board Resolution, shall promptly appoint a
successor Trustee for that series of Securities.

If, within one year after such resignation, removal or incapacity, or the occurrence of such
vacancy, a successor Trustee with respect to such series of Securities shall be appointed by Act of
the Holders of a majority in principal amount of the Outstanding Securities of such series
delivered to the Company and the retiring Trustee, the successor Trustee so appointed shall,
forthwith upon its acceptance of such appointment, become the successor Trustee with respect to
such series and supersede the successor Trustee appointed by the Company with respect to such
series. If no successor Trustee with respect to such series shall have been so appointed by the
Company or the Securityholders of such series and accepted appointment in the manner hereinafter
provided, subject to Section 5.14, any Securityholder who has been a bona fide Holder of a Security
of that series for at least six months may, on behalf of himself and all others similarly situated,
petition any court of competent jurisdiction for the appointment of a successor Trustee with
respect to such series.

          (f) The Company shall give notice of each resignation and each removal of the Trustee with
respect to any series and each appointment of a successor Trustee with respect to any series by
mailing written notice of such event by first-class mail, postage prepaid, to the Holders of
Securities of that series as their names and addresses appear in the Security Register. Each notice
shall include the name of the successor Trustee and the address of its principal Corporate Trust
Office.

          SECTION 6.11 Acceptance of Appointment by Successor. Every successor Trustee
appointed hereunder shall execute, acknowledge and deliver to the Company and to the predecessor
Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the
predecessor Trustee shall become effective with respect to any series as to which it is resigning
or being removed as Trustee, and such successor Trustee, without any further act, deed or
conveyance, shall become vested with all the rights, powers, trusts and duties of the predecessor
Trustee with respect to any such series; but, on request of the Company or the successor Trustee,
such predecessor Trustee shall, upon payment of its reasonable charges hereunder, if any, execute
and deliver an instrument transferring to such successor Trustee all the rights, powers and trusts
of the predecessor Trustee, and shall duly assign, transfer and deliver to such successor Trustee
all property and money held by such predecessor trustee hereunder with respect to all or any such
series, subject nevertheless to its lien, if any, provided for in Section 6.07. Upon request of any
such successor Trustee, the Company shall execute any and all instruments for more fully and
certainly vesting in and confirming to such successor Trustee all such rights, powers and trusts.

41

 

          In case of the appointment hereunder of a successor Trustee with respect to the Securities of
one or more (but not all) series, the Company, the predecessor Trustee and each successor Trustee
with respect to the Securities of any applicable series shall execute and deliver an indenture
supplemental hereto which shall contain such provisions as shall be deemed necessary or desirable
to confirm that all the rights, powers, trusts and duties of the predecessor Trustee with respect
to the Securities of any series as to which the predecessor Trustee is not being succeeded shall
continue to be vested in the predecessor Trustee, and shall add to or change any of the provisions
of this Indenture as shall be necessary to provide for or facilitate the administration of the
trusts hereunder by more than one Trustee, it being understood that nothing herein or in such
supplemental indenture shall constitute such Trustees co-trustees of the same trust and that each
such Trustee shall be Trustee of a trust or trusts hereunder separate and apart from any trust or
trusts hereunder administered by any other such Trustee.

          No successor Trustee with respect to any series of Securities shall accept its appointment
unless at the time of such acceptance such successor Trustee shall be qualified and eligible with
respect to that series under this Article.

          SECTION 6.12 Merger, Conversion, Consolidation or Succession to Business. Any
corporation into which the Trustee may be merged or converted or with which it may be consolidated,
or any corporation resulting from any merger, conversion or consolidation to which the Trustee
shall be a party, or any corporation succeeding to all or substantially all of the corporate trust
business of the Trustee, shall be the successor of the Trustee hereunder, provided such corporation
shall be otherwise qualified and eligible under this Article, without the execution or filing of
any paper or any further act on the part of any of the parties hereto. In case any Securities shall
have been authenticated, but not delivered, by the Trustee then in office, any successor by merger,
conversion or consolidation to such authenticating Trustee may adopt such authentication and
deliver the Securities so authenticated with the same effect as if such successor Trustee had
itself authenticated such Securities.

          SECTION 6.13 Preferential Collection of Claims Against Company. The Trustee shall
comply with TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b). A
Trustee who has resigned or been removed shall be subject to TIA Section 311(a) to the extent
indicated.

          SECTION 6.14 Appointment of Authenticating Agent. At any time when any of the
Securities remain Outstanding the Trustee, with the approval of the Company, may appoint an
Authenticating Agent or Agents with respect to one or more series of Securities which shall be
authorized to act on behalf of the Trustee to authenticate Securities of such series issued upon
original issuance, exchange, registration of transfer or partial redemption thereof or pursuant to
Section 3.06, and Securities so authenticated shall be entitled to the benefits of this Indenture
and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder.
Wherever reference is made in this Indenture to the authentication and delivery of Securities by
the Trustee or the Trustee’s certificate of authentication, such reference shall be deemed to
include authentication and delivery on behalf of the Trustee by an Authenticating Agent and a
certificate of authentication executed on behalf of the Trustee by an Authenticating Agent. Each
Authenticating Agent shall be acceptable to the Company and shall at all times be a corporation
organized and doing business under the laws of the United States of America, any State thereof or
the District of Columbia, authorized under such laws to act as an Authenticating Agent, having a
combined capital and surplus of not less than $50,000,000 and, if other than the Company itself,
subject to supervision or examination by Federal or State authority. If such Authenticating Agent
publishes reports of condition at least annually, pursuant to law or to the requirements of said

42

 

supervising or examining authority, then for the purposes of this Section, the combined
capital and surplus of such Authenticating Agent shall be deemed to be its combined capital and
surplus as set forth in its most recent report of condition so published. If at any time an
Authenticating Agent shall cease to be eligible in accordance with the provisions of this Section,
such Authenticating Agent shall resign immediately in the manner and with the effect specified in
this Section.

          Any corporation into which an Authenticating Agent may be merged or converted or with which it
may be consolidated, or any corporation resulting from any merger, conversion or consolidation to
which such Authenticating Agent shall be a party, or any corporation succeeding to the corporate
agency or corporate trust business of an Authenticating Agent, shall continue to be an
Authenticating Agent, provided such corporation shall be otherwise eligible under this Section,
without the execution or filing of any paper or any further act on the part of the Trustee or the
Authenticating Agent.

          An Authenticating Agent may resign at any time by giving written notice thereof to the Trustee
and, if other than the Company, to the Company. The Trustee may at any time terminate the agency of
an Authenticating Agent by giving written notice thereof to such Authenticating Agent and, if other
than the Company, to the Company. Upon receiving such a notice of resignation or upon such a
termination, or in case at any time such Authenticating Agent shall cease to be eligible in
accordance with the provisions of this Section, the Trustee, with the approval of the Company, may
appoint a successor Authenticating Agent which shall be acceptable to the Company and shall mail
written notice of such appointment by first-class mail, postage prepaid, to all Holders of
Securities of the series with respect to which such Authenticating Agent will serve, as their names
and addresses appear in the Security Register. Any successor Authenticating Agent upon acceptance
of its appointment hereunder shall become vested with all the rights, powers and duties of its
predecessor hereunder, with like effect as if originally named as an Authenticating Agent. No
successor Authenticating Agent shall be appointed unless eligible under the provisions of this
Section.

          The Company agrees to pay to each Authenticating Agent from time to time reasonable
compensation for its services under this Section.

          If an appointment with respect to one or more series is made pursuant to this Section, the
Securities of such series may have endorsed thereon, in addition to the Trustee’s certificate of
authentication, an alternate certificate of authentication in the following form:

          This is one of the Securities of the series designated therein referred to in the
within-mentioned Indenture.

	 	 	 	 	 
	 	THE BANK OF NEW YORK MELLON, as Trustee,

 	 
	 	by:  	 	 
	 	 	As Authenticating Agent 	 
	 	 	 	 
	 

43

 

	 	 	 	 	 
	 	 	 
	 	by:  	
 	 
	 	 	As Authorized Agent 	 
	 	 	 	 
	 
	 	  	 	 
	 	 	 
	 	Dated:  	 	 
	 	 	 	 
	 	 	 	 
	 

44

 

ARTICLE VII

Securityholders’ Lists and Reports by

Trustee and Company

          SECTION 7.01 Company to Furnish Trustee Names and Addresses of Securityholders.

          The Company will furnish or cause to be furnished to the Trustee:

          (1) semi-annually, not more than 15 days after December 15 and June 15 in each year in
such form as the Trustee may reasonably require, a list of the names and addresses of the
Holders of Securities of each series as of such December 15 and June 15, as applicable, and

          (2) at such other times as the Trustee may request in writing, within 30 days after
the receipt by the Company of any such request, a list of similar form and content as of a
date not more than 15 days prior to the time such list is furnished; provided, however,
that if and so long as the Trustee shall be the Security Registrar for Securities of a
series, no such list need be furnished with respect to such series of Securities.

          SECTION 7.02 Preservation of Information; Communications to Securityholders. (a)
The Trustee shall preserve, in as current a form as is reasonably practicable, the names and
addresses of Holders of Securities contained in the most recent list furnished to the Trustee as
provided in Section 7.01 and the names and addresses of Holders of Securities received by the
Trustee in its capacity as Security Registrar, if so acting. The Trustee may destroy any list
furnished to it as provided in Section 7.01 upon receipt of a new list so furnished.

          (b) If three or more Holders of Securities of any series (hereinafter referred to as
“applicants”) apply in writing to the Trustee, and furnish to the Trustee reasonable proof
that each such applicant has owned a Security of such series for a period of at least six months
preceding the date of such application, and such application states that the applicants desire to
communicate with other Holders of Securities of such series or with the Holders of all Securities
with respect to their rights under this Indenture or under such Securities and is accompanied by a
copy of the form of proxy or other communication which such applicants propose to transmit, then
the Trustee shall, within five Business Days after the receipt of such application, at its
election, either:

          (1) afford such applicants access to the information preserved at the time by the
Trustee in accordance with Section 7.02(a), or

          (2) inform such applicants as to the approximate number of Holders of Securities of
such series or all Securities, as the case may be, whose names and addresses appear in the
information preserved at the time by the Trustee in accordance with Section 7.02(a), and as
to the approximate cost of mailing to such Securityholders the form of proxy or other
communication, if any, specified in such application.

          If the Trustee shall elect not to afford such applicants access to such information, the
Trustee shall, upon the written request of such applicants, mail to each Holder of a Security of

45

 

such series or to all Securityholders, as the case may be, whose names and addresses appear in the
information preserved at the time by the Trustee in accordance with Section 7.02(a), a copy of the
form of proxy or other communication which is specified in such request, with reasonable promptness
after a tender to the Trustee of the material to be mailed and of payment, or provision for the
payment, of the reasonable expenses of mailing, unless, within five days after such tender, the
Trustee shall mail to such applicants and file with the Commission, together with a copy of the
material to be mailed, a written statement to the effect that, in the opinion of the Trustee, such
mailing would be contrary to the best interests of the Holders of Securities of such series or all
Securityholders, as the case may be, or would be in violation of applicable law. Such written
statement shall specify the basis of such opinion. If the Commission, after opportunity for a
hearing upon the objections specified in the written statement so filed, shall enter an order
refusing to sustain any of such objections or if, after the entry of an order sustaining one or
more of such objections, the Commission shall find, after notice and opportunity for hearing, that
all the objections so sustained have been met and shall enter an order so declaring, the Trustee
shall mail copies of such material to all Securityholders of such series or all Securityholders, as
the case may be, with reasonable promptness after the entry of such order and the renewal of such
tender; otherwise the Trustee shall be relieved of any obligation or duty to such applicants
respecting their application.

          (c) Every Holder of Securities, by receiving and holding the same, agrees with the Company and
the Trustee that neither the Company nor the Trustee shall be held accountable by reason of the
disclosure of any such information as to the names and addresses of the Holders of Securities in
accordance with Section 7.02(b), regardless of the source from which such information was derived,
and that the Trustee shall not be held accountable by reason of mailing any material pursuant to a
request made under Section 7.02(b).

          SECTION 7.03 Reports by Trustee. (a) Within 60 days after May 15 of each year
commencing with the first May 15 after the issuance of Securities, the Trustee shall transmit by
mail, at the Company’s expense, to all Holders as their names and addresses appear in the Security
Register, as provided in Trust Indenture Act 313(c), a brief report dated as of May 15 in
accordance with and with respect to the matters required by Trust Indenture Act Section 313(a).

          (b) The Trustee shall transmit, at the Company’s expense, to all Holders as their names and
addresses appear in the Security Register, as provided in Trust Indenture Act 313(c), a brief
report in accordance with and with respect to the matters required by Trust Indenture Act Section
313(b).

          (c) A copy of each such report shall, at the time of such transmission to Holders, be
furnished to the Company and, in accordance with Trust Indenture Act Section 313(d), be filed by
the Trustee with each stock exchange upon which the Securities are listed, and also with the
Commission.

          SECTION 7.04 Reports by Company. The Company shall file with the Trustee, and
transmit to Holders, such information, documents and other reports, and such summaries thereof, as
may be required pursuant to the Trust Indenture Act at the times and in the manner provided
pursuant to such Act; provided that any such information, documents or reports required to be filed
with the Commission pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 shall be
filed with the Trustee within 15 days after the same is so required to be filed with the
Commission. The Company also shall comply with the other provisions of Trust Indenture Act Section
314(a). Delivery of such reports, information and documents to the Trustee is for informational
purposes only and the Trustee’s receipt of such shall not constitute constructive

46

 

notice of any information contained therein or determinable from information contained
therein, including the Company’s compliance with any of its covenants hereunder (as to which the
Trustee is entitled to rely exclusively on Officers’ Certificates).

ARTICLE VIII

Consolidation, Merger, Conveyance or Transfer

          SECTION 8.01 Consolidation, Merger, Conveyance or Transfer on Certain Terms. None of
the Company or any Guarantor shall consolidate with or merge into any other Person or convey or
transfer its properties and assets substantially as an entirety to any Person, unless:

          (1) (a) in the case of the Company, the Person formed by such consolidation or into
which the Company is merged or the Person which acquires by conveyance or transfer the
properties and assets of the Company substantially as an entirety shall be organized and
existing under the laws of the United States of America or any State thereof or the
District of Columbia, and shall expressly assume, by an indenture supplemental hereto,
executed and delivered to the Trustee, in form satisfactory to the Trustee, the due and
punctual payment of the principal of (and premium, if any) and interest on all the
Securities and the performance of every covenant of this Indenture (as supplemented from
time to time) on the part of the Company to be performed or observed; (b) in the case of
any Guarantor, the Person formed by such consolidation or into which such Guarantor is
merged or the Person which acquires by conveyance or transfer the properties and assets of
such Guarantor substantially as an entirety shall be either (i) the Company or another
Guarantor or (ii) a Person organized and existing under the laws of the United States of
America or any State thereof or the District of Columbia, and in the case of clause (ii),
shall expressly assume, by an indenture supplemental hereto, executed and delivered to the
Trustee, in form satisfactory to the Trustee, the performance of every covenant of this
Indenture (as supplemented from time to time) on the part of such Guarantor to be performed
or observed;

          (2) immediately after giving effect to such transaction, no Event of Default, and no
event which, after notice or lapse of time, or both, would become an Event of Default,
shall have happened and be continuing; and

          (3) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion
of Counsel each stating that such consolidation, merger, conveyance or transfer and such
supplemental indenture comply with this Article and that all conditions precedent herein
provided for relating to such transaction have been complied with.

          Notwithstanding the foregoing, the provisions of this Section 8.01 shall not apply to any
Guarantor if at such time such Guarantor has been released from its obligations under its Guarantee
in accordance with Section 13.01(h).

          SECTION 8.02 Successor Person Substituted. Upon any consolidation or merger, or any
conveyance or transfer of the properties and assets of the Company or any Guarantor substantially
as an entirety in accordance with Section 8.01, the successor Person formed by such consolidation
or into which the Company or such Guarantor is merged or to which such conveyance or transfer is
made shall succeed to, and be substituted for, and may

47

 

exercise every right and power of, the Company or such Guarantor, as the case may be, under
this Indenture with the same effect as if such successor had been named as the Company or such
Guarantor herein. In the event of any such conveyance or transfer, the Company or such Guarantor,
as the case may be, as the predecessor shall be discharged from all obligations and covenants under
this Indenture and the Securities and may be dissolved, wound up or liquidated at any time
thereafter.

ARTICLE IX

Supplemental Indentures

          SECTION 9.01 Supplemental Indentures Without Consent of Securityholders. Without the
consent of the Holders of any Securities, the Company, when authorized by a Board Resolution, and
the Trustee, at any time and from time to time, may enter into one or more indentures supplemental
hereto, in form satisfactory to the Trustee, for any of the following purposes:

          (1) to evidence the succession of another corporation or Person to the Company or any
Guarantor, and the assumption by any such successor of the respective covenants of the
Company or any Guarantor herein and in the Securities; or

          (2) to add to the covenants of the Company or any Guarantor, or to surrender any right
or power herein conferred upon the Company or any Guarantor, for the benefit of the Holders
of the Securities of any or all series (and if such covenants or the surrender of such
right or power are to be for the benefit of less than all series of Securities, stating
that such covenants are expressly being included or such surrenders are expressly being
made solely for the benefit of one or more specified series); or

          (3) to cure any ambiguity, to correct or supplement any provision herein which may be
inconsistent with any other provision herein, or to make any other provisions with respect
to matters or questions arising under this Indenture; or

          (4) to add to this Indenture such provisions as may be expressly permitted by the TIA,
excluding, however, the provisions referred to in Section 316(a)(2) of the TIA as in effect
at the date as of which this instrument was executed or any corresponding provision in any
similar federal statute hereafter enacted; or

          (5) to establish any form of Security, as provided in Article II, to provide for the
issuance of any series of Securities as provided in Article III and to set forth the terms
thereof, and/or to add to the rights of the Holders of the Securities of any series; or

          (6) to evidence and provide for the acceptance of appointment by another corporation
as a successor Trustee hereunder with respect to one or more series of Securities and to
add to or change any of the provisions of this Indenture as shall be necessary to provide
for or facilitate the administration of the trusts hereunder by more than one Trustee,
pursuant to Section 6.11; or

          (7) to add any additional Events of Default in respect of the Securities of any or all
series (and if such additional Events of Default are to be in respect of less than all

48

 

series of Securities, stating that such Events of Default are expressly being included
solely for the benefit of one or more specified series); or

          (8) to provide for uncertificated Securities in addition to or in place of
certificated Securities and to provide for bearer Securities; provided that uncertificated
Securities are issued in registered form for purposes of Section 163(f) of the Internal
Revenue Code of 1986, as amended, or in a manner such that the uncertificated Securities
are as described in Section 163(f)(2)(B) of such Internal Revenue Code; or

          (9) to provide for the terms and conditions of conversion into Common Stock or other
Marketable Securities of the Securities of any series which are convertible into Common
Stock or other Marketable Securities, if different from those set forth in Article XII; or

          (10) to secure the Securities of any series pursuant to Section 10.06 or otherwise; or

          (11) to add additional guarantors in respect of the Securities; or

          (12) to make any change necessary to comply with any requirement of the Commission in
connection with the qualification of this Indenture or any supplemental indenture under the
Trust Indenture Act.

          No supplemental indenture for the purposes identified in Clauses (2), (3), (5) or (7) above
may be entered into if to do so would adversely affect the rights of the Holders of Outstanding
Securities of any series in any material respect.

          SECTION 9.02 Supplemental Indentures with Consent of Securityholders. With the
consent of the Holders of not less than a majority in principal amount of the Outstanding
Securities of all series affected by such supplemental indenture or indentures (acting as one
class), by Act of said Holders delivered to the Company and the Trustee (in accordance with Section
1.04 hereof), the Company, when authorized by a Board Resolution, and the Trustee may enter into an
indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing
in any manner or eliminating any of the provisions of this Indenture or of modifying in any manner
the rights of the Holders of the Securities of each such series under this Indenture; provided,
however, that no such supplemental indenture shall, without the consent of the Holder of each
Outstanding Security affected thereby:

          (1) change the Maturity of the principal of, or the Stated Maturity of any premium on,
or any installment of interest on, any Security, or reduce the principal amount thereof or
the interest or any premium thereon, or change the method of computing the amount of
principal thereof or interest thereon on any date or change any Place of Payment where, or
the coin or currency in which, any Security or any premium or interest thereon is payable,
or impair the right to institute suit for the enforcement of any such payment on or after
the Maturity or the Stated Maturity, as the case may be (or, in the case of redemption or
repayment, on or after the Redemption Date or the Repayment Date, as the case may be), or
alter the provisions of this Indenture so as to affect adversely the terms, if any, of
conversion of any Securities into Common Stock or other securities; or

49

 

          (2) reduce the percentage in principal amount of the Outstanding Securities of any
series, the consent of whose Holders is required for any such supplemental indenture, or
the consent of whose Holders is required for any waiver of compliance with certain
provisions of this Indenture or certain defaults hereunder and their consequences, provided
for in this Indenture; or

          (3) modify any of the provisions of this Section 9.02, Section 5.13 or Section 10.07,
except to increase any such percentage or to provide that certain other provisions of this
Indenture cannot be modified or waived without the consent of the Holder of each
Outstanding Security affected thereby; or

          (4) impair or adversely affect the right of any Holder to institute suit for the
enforcement of any payment on, or with respect to, the Securities of any series on or after
the Stated Maturity of such Securities (or in the case of redemption, on or after the
Redemption Date); or

          (5) amend or modify Section 13.01 of this Indenture in any manner adverse to the
rights of the Holders of the Outstanding Securities of any series.

          For purposes of this Section 9.02, if the Securities of any series are issuable upon the
exercise of warrants, each holder of an unexercised and unexpired warrant with respect to such
series shall be deemed to be a Holder of Outstanding Securities of such series in the amount
issuable upon the exercise of such warrant. For such purposes, the ownership of any such warrant
shall be determined by the Company in a manner consistent with customary commercial practices. The
Trustee for such series shall be entitled to rely on an Officers’ Certificate as to the principal
amount of Securities of such series in respect of which consents shall have been executed by
holders of such warrants.

          A supplemental indenture which changes or eliminates any covenant or other provision of this
Indenture which has expressly been included solely for the benefit of one or more particular series
of Securities, or which modifies the rights of the Holders of Securities of such series with
respect to such covenant or other provision, shall be deemed not to affect the rights under this
Indenture of Holders of Securities of any other series.

          It shall not be necessary for any Act of Securityholders under this Section to approve the
particular form of any proposed supplemental indenture, but it shall be sufficient if such Act
shall approve the substance thereof.

          SECTION 9.03 Execution of Supplemental Indentures. In executing, or accepting the
additional trusts created by, any supplemental indenture permitted by this Article or the
modifications thereby of the trusts created by this Indenture, the Trustee shall be provided with,
and (subject to Section 6.01) shall be fully protected in relying upon, an Opinion of Counsel
stating that the execution of such supplemental indenture is authorized or permitted by this
Indenture. The Trustee may, but shall not be obligated to, enter into any such supplemental
indenture which affects the Trustee’s own rights, duties or immunities under this Indenture or
otherwise.

          SECTION 9.04 Effect of Supplemental Indentures. Upon the execution of any
supplemental indenture under this Article, this Indenture shall be modified in accordance
therewith, and such supplemental indenture shall form a part of this Indenture for all purposes;

50

 

and every Holder of Securities theretofore or thereafter authenticated and delivered hereunder
shall be bound thereby to the extent provided therein.

          SECTION 9.05 Conformity with Trust Indenture Act. Every supplemental indenture
executed pursuant to this Article shall conform to the requirements of TIA as then in effect.

          SECTION 9.06 Reference in Securities to Supplemental Indentures. Securities
authenticated and delivered after the execution of any supplemental indenture pursuant to this
Article may, and shall if required by the Trustee, bear a notation in form approved by the Trustee
as to any matter provided for in such supplemental indenture. If the Company shall so determine,
new Securities so modified as to conform, in the opinion of the Trustee and the Board of Directors,
to any such supplemental indenture may be prepared and executed by the Company and authenticated
and delivered by the Trustee in exchange for Outstanding Securities.

ARTICLE X

Covenants

          SECTION 10.01 Payment of Principal, Premium and Interest. With respect to each
series of Securities, the Company will duly and punctually pay the principal of (and premium, if
any) and interest on such Securities in accordance with their terms and this Indenture, and will
duly comply with all the other terms, agreements and conditions contained in, or made in the
Indenture for the benefit of, the Securities of such series.

          SECTION 10.02 Maintenance of Office or Agency. The Company will maintain an office
or agency in each Place of Payment where Securities may be presented or surrendered for payment,
where Securities may be surrendered for registration of transfer or exchange, where notices and
demands to or upon the Company in respect of the Securities and this Indenture may be served and
where any Securities with conversion privileges may be presented and surrendered for conversion.
The Company will give prompt written notice to the Trustee of the location, and of any change in
the location, of such office or agency. If at any time the Company shall fail to maintain such
office or agency or shall fail to furnish the Trustee with the address thereof, such presentations,
surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee,
and the Company hereby appoints the Trustee as its agent to receive all such presentations,
surrenders, notices and demands.

          Unless otherwise set forth in, or pursuant to, a Board Resolution, supplemental indenture or
Officers’ Certificate pursuant to authority granted under a Board Resolution with respect to a
series of Securities, the Company hereby initially designates as the Place of Payment for each
series of Securities, the Borough of Manhattan, the City and State of New York, and initially
appoints the Trustee at its Corporate Trust Office as the Company’s office or agency for each such
purpose in such city.

          SECTION 10.03 Money for Security Payments to Be Held in Trust. If the Company shall
at any time act as its own Paying Agent for any series of Securities, it will, on or before each
due date of the principal of (and premium, if any) or interest on, any of the Securities of such
series, segregate and hold in trust for the benefit of the Persons entitled thereto a sum
sufficient to pay the principal (and premium, if any) or interest so becoming due until such sums

51

 

shall be paid to such Persons or otherwise disposed of as herein provided, and will promptly
notify the Trustee of its action or failure to act.

          Whenever the Company shall have one or more Paying Agents for any series of Securities, it
will, on or prior to each due date of the principal of (and premium, if any) or interest on, any
Securities of such series, deposit with a Paying Agent a sum sufficient to pay the principal (and
premium, if any) or interest so becoming due, such sum to be held in trust for the benefit of the
Persons entitled to such principal (and premium, if any) or interest, and (unless such Paying Agent
is the Trustee) the Company will promptly notify the Trustee of its action or failure so to act.

          The Company will cause each Paying Agent other than the Trustee for any series of Securities
to execute and deliver to the Trustee an instrument in which such Paying Agent shall agree with the
Trustee, subject to the provisions of this Section, that such Paying Agent will:

          (1) hold all sums held by it for the payment of principal of (and premium, if any) or
interest on Securities of such series in trust for the benefit of the Persons entitled
thereto until such sums shall be paid to such Persons or otherwise disposed of as herein
provided;

          (2) give the Trustee notice of any default by the Company (or any other obligor upon
the Securities of such series) in the making of any such payment of principal (and premium,
if any) or interest on the Securities of such series; and

          (3) at any time during the continuance of any such default, upon the written request
of the Trustee, forthwith pay to the Trustee all sums so held in trust by such Paying
Agent.

                    The Company may at any time, for the purpose of obtaining the satisfaction and discharge of
this Indenture with respect to any series of Securities or for any other purpose, pay, or by
Company Order direct any Paying Agent to pay, to the Trustee all sums held in trust by the Company
or such Paying Agent in respect of each and every series of Securities as to which it seeks to
discharge this Indenture or, if for any other purpose, all sums so held in trust by the Company in
respect of all Securities, such sums to be held by the Trustee upon the same trusts as those upon
which such sums were held by the Company or such Paying Agent; and, upon such payment by any Paying
Agent to the Trustee, such Paying Agent shall be released from all further liability with respect
to such money.

          Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in
trust for the payment of the principal of (and premium, if any) or interest on any Security of any
series and remaining unclaimed for two years after such principal (and premium, if any) or interest
has become due and payable shall be paid to the Company on Company Request, or (if then held by the
Company) shall be discharged from such trust; and the Holder of such Security shall thereafter as
an unsecured general creditor, look only to the Company for payment thereof, and all liability of
the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company
as trustee thereof, shall thereupon cease. The Trustee or such Paying Agent, before being required
to make any such repayment, may at the expense of the Company mail to the Holders of the Securities
as to which the money to be repaid was held in trust, as their names and addresses appear in the
Security Register, a notice that such moneys remain unclaimed and that, after a date specified in
the notice, which shall not be less than 30 days from the date on which the notice was first mailed
to the Holders of the Securities as to

52

 

which the money to be repaid was held in trust, any unclaimed balance of such moneys then
remaining will be paid to the Company free of the trust formerly impressed upon it.

          SECTION 10.04 Statement as to Compliance. The Company and each Guarantor will
deliver to the Trustee, within 120 days after the end of each fiscal year, a written statement
signed by the principal executive officer, principal financial officer or principal accounting
officer of the Company or such Guarantor, as applicable, stating that:

          (1) a review of the activities of the Company or such Guarantor, as applicable, during
such year and of performance under this Indenture and under the terms of the Securities has
been made under his supervision; and

          (2) to the best of his knowledge, based on such review, the Company or such Guarantor,
as applicable, has fulfilled all its obligations under this Indenture and has complied with
all conditions and covenants on its part contained in this Indenture through such year, or,
if there has been a default in the fulfillment of any such obligation, covenant or
condition, specifying each such default known to him and the nature and status thereof.

          For the purpose of this Section 10.04, default and compliance shall be determined without
regard to any grace period or requirement of notice provided pursuant to the terms of this
Indenture.

          SECTION 10.05 Legal Existence. Subject to Article VIII the Company will do or cause
to be done all things necessary to preserve and keep in full force and effect its legal existence.

          SECTION 10.06 Limitation on Liens. Neither the Company nor any Material Subsidiary
of the Company shall incur, create, issue, assume, guarantee or otherwise become liable for any
Indebtedness For Borrowed Money that is secured by a lien on any asset now owned or hereafter
acquired by it unless the Company makes or causes to be made effective provisions whereby the
Securities issued under this Indenture will be secured by such lien equally and ratably with (or
prior to) all other indebtedness thereby secured so long as any such indebtedness shall be secured.
The foregoing restriction does not apply to the following:

     (i) liens existing as of the date of this Indenture;

     (ii) liens created by Subsidiaries of the Company to secure indebtedness of
such Subsidiaries to the Company or to one or more other Subsidiaries of the
Company;

     (iii) liens affecting property of a Person existing at the time it becomes a
Subsidiary of the Company or at the time it merges into or consolidates with the
Company or a Subsidiary of the Company or at the time of a sale, lease or other
disposition of all or substantially all of the properties of such Person to the
Company or its Subsidiaries;

     (iv) liens on property existing at the time of the acquisition thereof or
incurred to secure payment of all or a part of the purchase price thereof or to
secure indebtedness incurred prior to, at the time of, or within 18 months after
the

53

 

acquisition thereof for the purpose of financing all or part of the purchase
price thereof, in a principal amount not exceeding 110% of the purchase price;

     (v) liens on any property to secure all or part of the cost of improvements or
construction thereon or indebtedness incurred to provide funds for such purpose in
a principal amount not exceeding 110% of the cost of such improvements or
construction;

     (vi) liens consisting of or relating to the sale, transfer, distribution, or
financing of motion pictures, video and television programs, sound recordings,
books or rights with respect thereto to or with groups who may receive tax benefits
or other third-party investors in connection with the financing and/or distribution
of such motion pictures, video and television programming, sound recordings or
books in the ordinary course of business and the granting to the Company or any of
its Subsidiaries of rights to distribute such motion pictures, video and television
programming, sound recordings or books; provided, however, that no such lien shall
attach to any asset or right of the Company or its Subsidiaries (other than (1) the
motion pictures, video and television programming, sound recordings, books or
rights which were sold, transferred to or financed by groups who may receive tax
benefits or third-party investors in question or the proceeds arising therefrom and
(2) the stock or other equity interests of a Subsidiary substantially all of the
assets of which consist of such motion pictures, video and television programming,
sound recordings, books or rights and related proceeds);

     (vii) liens on shares of stock, indebtedness or other securities of a Person
that is not a Subsidiary of the Company;

     (viii) liens on Works which either (1) existed in such Works before the time
of their acquisition and were not created in anticipation thereof, or (2) were
created solely for the purpose of securing obligations to financiers, producers,
distributors, exhibitors, completion guarantors, inventors, copyright holders,
financial institutions or other participants incurred in the ordinary course of
business in connection with the acquisition, financing, production, completion,
distribution or exhibition of Works;

     (ix) any lien on the office building and hotel complex located in Atlanta,
Georgia known as the CNN Center Complex, including the parking decks for such
complex (to the extent such parking decks are owned or leased by the Company or its
Subsidiaries), or any portion thereof and all property rights therein and the
products, revenues and proceeds therefrom created as part of any mortgage financing
or sale-leaseback of the CNN Center Complex;

     (x) liens on satellite transponders and all property rights therein and the
products, revenues and proceeds therefrom which secure obligations incurred in
connection with the acquisition, utilization or operation of such satellite
transponders or the refinancing of any such obligations;

     (xi) liens on capital leases entered into after the date of this Indenture
provided that such liens extend only to the property or assets that are the subject
of such capital leases;

54

 

     (xii) liens resulting from progress payments or partial payments under United
States government contracts or subcontracts;

     (xiii) any extension, renewal or replacement of any lien referred to in the
foregoing clauses (i) through (xii) inclusive, or of any indebtedness secured
thereby; provided, however, that the principal amount of indebtedness secured
thereby shall not exceed the principal amount of indebtedness so secured at the
time of such extension, renewal or replacement, or at the time the lien was issued,
created or assumed or otherwise permitted, and that such extension, renewal or
replacement lien shall be limited to all or part of substantially the same property
which secured the lien extended, renewed or replaced (plus improvements on such
property); and

     (xiv) other liens arising in connection with indebtedness of the Company and
its Subsidiaries in an aggregate principal amount for the Company and its
Subsidiaries not exceeding at the time such lien is issued, created or assumed the
greater of (A) 15% of the Consolidated Net Worth of the Company and (B) $500
million.

          SECTION 10.07 Waiver of Certain Covenants. The Company may omit in respect of any
series of Securities, in any particular instance, to comply with any covenant or condition set
forth in Sections 10.05 or 10.06 or set forth in a Board Resolution, supplemental indenture or
Officers’ Certificate pursuant to authority granted under a Board Resolution with respect to the
Securities of such series, unless otherwise specified in such Board Resolution, supplemental
indenture or Officers’ Certificate, if before or after the time for such compliance the Holders of
not less than a majority in principal amount of the Outstanding Securities of all series affected
by such waiver (voting as one class) shall, by Act of such Securityholders delivered to the Company
and the Trustee (in accordance with Section 1.04 hereof), either waive such compliance in such
instance or generally waive compliance with such covenant or condition, but no such waiver shall
extend to or affect such covenant or condition except to the extent so expressly waived, and, until
such waiver shall become effective, the obligations of the Company and the duties of the Trustee in
respect of any such covenant or condition shall remain in full force and effect. Nothing in this
Section 10.07 shall permit the waiver of compliance with any covenant or condition set forth in
such Board Resolution, supplemental indenture or Officers’ Certificate which, if in the form of an
indenture supplemental hereto, would not be permitted by Section 9.02 without the consent of the
Holder of each Outstanding Security affected thereby.

ARTICLE XI

Redemption of Securities

          SECTION 11.01 Applicability of Article. The Company may reserve the right to redeem
and pay before Stated Maturity all or any part of the Securities of any series, either by optional
redemption, sinking or purchase fund or analogous obligation or otherwise, by provision therefor in
the form of Security for such series established and approved pursuant to Section 2.02 and on such
terms as are specified in such form or in the indenture supplemental hereto with respect to
Securities of such series as provided in Section 3.01. Redemption of Securities of any series shall
be made in accordance with the terms of such Securities and, to the extent that this Article does
not conflict with such terms, the succeeding Sections of this Article. Notwithstanding anything to
the contrary in this Indenture, except in the case of redemption

55

 

pursuant to a sinking fund, the Trustee shall not make any payment in connection with the
redemption of Securities until the close of business on the Redemption Date.

          SECTION 11.02 Election to Redeem; Notice to Trustee. The election of the Company to
redeem any Securities redeemable at the election of the Company shall be evidenced by, or pursuant
to authority granted by, a Board Resolution or an Officers’ Certificate pursuant to authority
granted under a Board Resolution. In case of any redemption at the election of the Company of less
than all of the Securities of any series, the Company shall, at least 45 days prior to the
Redemption Date fixed by the Company (unless a shorter notice shall be satisfactory to the
Trustee), notify the Trustee of such Redemption Date and of the principal amount of Securities of
such series and the Tranche (as defined in Section 11.03) to be redeemed.

          In the case of any redemption of Securities (i) prior to the expiration of any restriction on
such redemption provided in the terms of such Securities or elsewhere in this Indenture, or (ii)
pursuant to an election of the Company which is subject to a condition specified in the terms of
such Securities, the Company shall furnish the Trustee with an Officers’ Certificate evidencing
compliance with such restriction or condition.

          SECTION 11.03 Selection by Trustee of Securities to Be Redeemed. If less than all
the Securities of like tenor and terms of any series (a “Tranche”) are to be redeemed, the
particular Securities to be redeemed shall be selected not more than 45 days prior to the
Redemption Date by the Trustee, from the Outstanding Securities of such Tranche not previously
called for redemption, by such method as the Trustee shall deem fair and appropriate and which may
include provision for the selection for redemption of portions of the principal of Securities of
such Tranche of a denomination larger than the minimum authorized denomination for Securities of
that series. Unless otherwise provided in the terms of a particular series of Securities, the
portions of the principal of Securities so selected for partial redemption shall be equal to the
minimum authorized denomination of the Securities of such series, or an integral multiple thereof,
and the principal amount which remains outstanding shall not be less than the minimum authorized
denomination for Securities of such series. If less than all the Securities of unlike tenor and
terms of a series are to be redeemed, the particular Tranche of Securities to be redeemed shall be
selected by the Company.

          If any convertible Security selected for partial redemption is converted in part before the
termination of the conversion right with respect to the portion of the Security so selected, the
converted portion of such Security shall be deemed (so far as may be) to be the portion selected
for redemption.

          Upon any redemption of fewer than all the Securities of a series or Tranche, the Company and
the Trustee may treat as Outstanding any Securities surrendered for conversion during the period of
15 days next preceding the mailing of a notice of redemption, and need not treat as Outstanding any
Security authenticated and delivered during such period in exchange for the unconverted portion of
any Security converted in part during such period.

          The Trustee shall promptly notify the Company in writing of the Securities selected for
redemption and, in the case of any Security selected for partial redemption, the principal amount
thereof to be redeemed.

          Securities shall be excluded from eligibility for selection for redemption if they are
identified by registration and certificate number in a written statement signed by an authorized
officer of the Company and delivered to the Trustee at least 45 days prior to the Redemption Date

56

 

as being owned of record and beneficially by, and not pledged or hypothecated by either, (a)
the Company or (b) an entity specifically identified in such written statement as being an
Affiliate of the Company.

          For all purposes of this Indenture, unless the context otherwise requires, all provisions
relating to the redemption of Securities shall relate, in the case of any Security redeemed or to
be redeemed only in part, to the portion of the principal of such Security which has been or is to
be redeemed.

          SECTION 11.04 Notice of Redemption. Notice of redemption shall be given by
first-class mail, postage prepaid, mailed not less than 15 (unless otherwise provided in the Board
Resolution, supplemental indenture or Officers’ Certificate pursuant to authority granted under a
Board Resolution establishing the relevant series) nor more than 45 days prior to the Redemption
Date, to each holder of Securities to be redeemed, at his address appearing in the Security
Register.

          All notices of redemption shall state:

          (1) the Redemption Date;

          (2) the Redemption Price;

          (3) if less than all Outstanding Securities of any series are to be redeemed, the
identification (and, in the case of partial redemption, the respective principal amounts)
of the Securities to be redeemed;

          (4) that on the Redemption Date the Redemption Price will become due and payable upon
each such Security, and that interest, if any, thereon shall cease to accrue from and after
said date;

          (5) the place where such Securities are to be surrendered for payment of the
Redemption Price, which shall be the office or agency of the Company in the Place of
Payment;

          (6) that the redemption is on account of a sinking or purchase fund, or other
analogous obligation, if that be the case;

          (7) if such Securities are convertible into Common Stock or other securities, the
Conversion Price and the date on which the right to convert such Securities into Common
Stock or other securities will terminate; and

          (8) if applicable, that the redemption may be rescinded by the Company, at its sole
option, pursuant to Section 11.09 of this Indenture upon the occurrence of a Redemption
Rescission Event.

          Notice of redemption of Securities to be redeemed at the election of the Company shall be
given by the Company or, at the Company’s request, by the Trustee in the name and at the expense of
the Company; provided that if the Trustee is asked to give such notice it shall be given at least
five (5) Business Days prior notice.

57

 

          SECTION 11.05 Deposit of Redemption Price. On or prior to any Redemption Date and
subject to Section 11.09, the Company shall deposit with the Trustee or with a Paying Agent (or, if
the Company is acting as its own Paying Agent, segregate and hold in trust as provided in Section
10.03) an amount of money sufficient to pay the Redemption Price of all the Securities which are to
be redeemed on that date. If any Security to be redeemed is converted into Common Stock or other
securities, any money so deposited with the Trustee or a Paying Agent shall be paid to the Company
upon Company Request or, if then so segregated and held in trust by the Company, shall be
discharged from such trust.

          SECTION 11.06 Securities Payable on Redemption Date. Notice of redemption having
been given as aforesaid, the Securities so to be redeemed shall, subject to Section 11.09, on the
Redemption Date, become due and payable at the Redemption Price therein specified and from and
after such date (unless the Company shall default in the payment of the Redemption Price) such
Securities shall cease to bear interest and any rights to convert such Securities shall terminate.
Upon surrender of such Securities for redemption in accordance with the notice and subject to
Section 11.09, such Securities shall be paid by the Company at the Redemption Price. Unless
otherwise provided with respect to such Securities pursuant to Section 3.01, installments of
interest the Stated Maturity of which is on or prior to the Redemption Date shall be payable to the
Holders of such Securities registered as such on the relevant Regular Record Dates according to
their terms and the provisions of Section 3.07.

          If any Security called for redemption shall not be so paid upon surrender thereof for
redemption, the principal shall, until paid, bear interest from the Redemption Date at the rate
borne by the Security, or as otherwise provided in such Security.

          SECTION 11.07 Securities Redeemed in Part. Any Security which is to be redeemed only
in part shall be surrendered at the office or agency of the Company in the Place of Payment with
respect to that series (with, if the Company or the Trustee so requires, due endorsement by, or a
written instrument of transfer in form satisfactory to the Company and the Trustee duly executed
by, the Holder thereof or his attorney duly authorized in writing) and the Company shall execute
and the Trustee shall authenticate and deliver to the Holder of such Security without service
charge, a new Security or Securities of the same series and Stated Maturity and of like tenor and
terms, of any authorized denomination as requested by such Holder in aggregate principal amount
equal to and in exchange for the unredeemed portion of the principal of the Security so
surrendered.

          SECTION 11.08 Provisions with Respect to Any Sinking Funds. Unless the form or terms
of any series of Securities shall provide otherwise, in lieu of making all or any part of any
mandatory sinking fund payment with respect to such series of Securities in cash, the Company may
at its option (1) deliver to the Trustee for cancelation any Securities of such series theretofore
acquired by the Company or converted by the Holder thereof into Common Stock or other securities,
or (2) receive credit for any Securities of such series (not previously so credited) acquired by
the Company (including by way of optional redemption (pursuant to the sinking fund or otherwise but
not by way of mandatory sinking fund redemption) or converted by the Holder thereof into Common
Stock or other securities and theretofore delivered to the Trustee for cancelation, and if it does
so then (i) Securities so delivered or credited shall be credited at the applicable sinking fund
Redemption Price with respect to Securities of such series, and (ii) on or before the 60th day next
preceding each sinking fund Redemption Date with respect to such series of Securities, the Company
will deliver to the Trustee (A) an Officers’ Certificate specifying the portions of such sinking
fund payment to be satisfied by payment of cash and by delivery or credit of Securities of such
series acquired by the Company or converted by the

58

 

Holder thereof, and (B) such Securities, to the extent not previously surrendered. Such
Officers’ Certificate shall also state the basis for such credit and that the Securities for which
the Company elects to receive credit have not been previously so credited and were not acquired by
the Company through operation of the mandatory sinking fund, if any, provided with respect to such
Securities and shall also state that no Event of Default with respect to Securities of such series
has occurred and is continuing. All Securities so delivered to the Trustee shall be canceled by the
Trustee and no Securities shall be authenticated in lieu thereof.

          If the sinking fund payment or payments (mandatory or optional) with respect to any series of
Securities made in cash plus any unused balance of any preceding sinking fund payments with respect
to Securities of such series made in cash shall exceed $50,000 (or a lesser sum if the Company
shall so request), unless otherwise provided by the terms of such series of Securities, that cash
shall be applied by the Trustee on the sinking fund Redemption Date with respect to Securities of
such series next following the date of such payment to the redemption of Securities of such series
at the applicable sinking fund Redemption Price with respect to Securities of such series, together
with accrued interest, if any, to the date fixed for redemption, with the effect provided in
Section 11.06. The Trustee shall select, in the manner provided in Section 11.03, for redemption on
such sinking fund Redemption Date a sufficient principal amount of Securities of such series to
utilize that cash and shall thereupon cause notice of redemption of the Securities of such series
for the sinking fund to be given in the manner provided in Section 11.04 (and with the effect
provided in Section 11.06) for the redemption of Securities in part at the option of the Company.
Any sinking fund moneys not so applied or allocated by the Trustee to the redemption of Securities
of such series shall be added to the next cash sinking fund payment with respect to Securities of
such series received by the Trustee and, together with such payment, shall be applied in accordance
with the provisions of this Section 11.08. Any and all sinking fund moneys with respect to
Securities of any series held by the Trustee at the Maturity of Securities of such series, and not
held for the payment or redemption of particular Securities of such series, shall be applied by the
Trustee, together with other moneys, if necessary, to be deposited sufficient for the purpose, to
the payment of the principal of the Securities of such series at Maturity.

          On or before each sinking fund Redemption Date provided with respect to Securities of any
series, the Company shall pay to the Trustee in cash a sum equal to all accrued interest, if any,
to the date fixed for redemption on Securities to be redeemed on such sinking fund Redemption Date
pursuant to this Section 11.08.

          SECTION 11.09 Rescission of Redemption. In the event that this Section 11.09 is
specified to be applicable to a series of Securities pursuant to Section 3.01 and a Redemption
Rescission Event shall occur following any day on which a notice of redemption shall have been
given pursuant to Section 11.04 hereof but at or prior to the time and date fixed for redemption as
set forth in such notice of redemption, the Company may, at its sole option, at any time prior to
the earlier of (i) the close of business on that day which is two Trading Days following such
Redemption Rescission Event and (ii) the time and date fixed for redemption as set forth in such
notice, rescind the redemption to which such notice of redemption shall have related by making a
public announcement of such rescission (the date on which such public announcement shall have been
made being hereinafter referred to as the “Rescission Date”). The Company shall be deemed
to have made such announcement if it shall issue a release to the Dow Jones New Service, Reuters
Information Services or any successor news wire service. From and after the making of such
announcement, the Company shall have no obligation to redeem Securities called for redemption
pursuant to such notice of redemption or to pay the Redemption Price therefor and all rights of
Holders of Securities shall be restored as if such notice of redemption had not been

59

 

given. As promptly as practicable following the making of such announcement, the Company shall
telephonically notify the Trustee and the Paying Agent of such rescission. The Company shall give
notice of any such rescission by first-class mail, postage prepaid, mailed as promptly as
practicable but in no event later than the close of business on the day which is five Trading Days
following the Rescission Date to each Holder of Securities at the close of business on the
Rescission Date, to any other Person that was a Holder of Securities and that shall have
surrendered Securities for conversion following the giving of notice of the subsequently rescinded
redemption and to the Trustee and the Paying Agent. Each notice of rescission shall (w) state that
the redemption described in the notice of redemption has been rescinded, (x) state that any
Converting Holder shall be entitled to rescind the conversion of Securities surrendered for
conversion following the day on which notice of redemption was given but on or prior to the date of
the mailing of the Company’s notice of rescission, (y) be accompanied by a form prescribed by the
Company to be used by any Converting Holder rescinding the conversion of Securities so surrendered
for conversion (and instructions for the completion and delivery of such form, including
instructions with respect to any payment that may be required to accompany such delivery) and (z)
state that such form must be properly completed and received by the Company no later than the close
of business on a date that shall be 15 Trading Days following the date of the mailing of such
notice of rescission.

ARTICLE XII

Conversion

          SECTION 12.01 Conversion Privilege. In the event that this Article XII is specified
to be applicable to a series of Securities pursuant to Section 3.01, the Holder of a Security of
such series shall have the right, at such Holder’s option, to convert, in accordance with the terms
of such series of Securities and this Article XII, all or any part (in a denomination of, unless
otherwise specified in a Board Resolution, supplemental indenture or Officers’ Certificate pursuant
to authority granted under a Board Resolution with respect to Securities of such series, $1,000 in
principal amount or any integral multiple thereof) of such Security into shares of Common Stock or
other Marketable Securities specified in such Board Resolution, supplemental indenture or Officers’
Certificate pursuant to authority granted under a Board Resolution at any time or, as to any
Securities called for redemption, at any time prior to the time and date fixed for such redemption
(unless the Company shall default in the payment of the Redemption Price, in which case such right
shall not terminate at such time and date).

          SECTION 12.02 Conversion Procedure; Rescission of Conversion; Conversion Price; Fractional
Shares. (a) Each Security to which this Article is applicable shall be convertible at the
office of the Conversion Agent, and at such other place or places, if any, specified in a Board
Resolution, supplemental indenture or Officers’ Certificate pursuant to authority granted under a
Board Resolution with respect to the Securities of such series, into fully paid and nonassessable
shares (calculated to the nearest 1/100th of a share) of Common Stock or other Marketable
Securities. The Securities will be converted into shares of Common Stock or such other Marketable
Securities at the Conversion Price therefor. No payment or adjustment shall be made in respect of
dividends on the Common Stock or such other Marketable Securities, or accrued interest on a
converted Security except as described in Section 12.09. The Company may, but shall not be
required, in connection with any conversion of Securities, to issue a fraction of a share of Common
Stock or of such other Marketable Security, and, if the Company shall determine not to issue any
such fraction, the Company shall, subject to Section 12.03(4), make a

60

 

cash payment (calculated to the nearest cent) equal to such fraction multiplied by the Closing
Price of the Common Stock or such other Marketable Security on the last Trading Day prior to the
date of conversion.

          (b) Before any Holder of a Security shall be entitled to convert the same into Common Stock or
other Marketable Securities, such Holder shall surrender such Security duly endorsed to the Company
or in blank, at the office of the Conversion Agent or at such other place or places, if any,
specified in a Board Resolution, supplemental indenture or Officers’ Certificate pursuant to
authority granted under a Board Resolution with respect to the Securities of such series, and shall
give written notice to the Company at said office or place that he elects to convert the same and
shall state in writing therein the principal amount of Securities to be converted and the name or
names (with addresses) in which he wishes the certificate or certificates for Common Stock or for
such other Marketable Securities to be issued; provided, however, that no Security or portion
thereof shall be accepted for conversion unless the principal amount of such Security or such
portion, when added to the principal amount of all other Securities or portions thereof then being
surrendered by the Holder thereof for conversion, exceeds the then effective Conversion Price with
respect thereto. If more than one Security shall be surrendered for conversion at one time by the
same Holder, the number of full shares of Common Stock or such other Marketable Securities which
shall be deliverable upon conversion shall be computed on the basis of the aggregate principal
amount of the Securities (or specified portions thereof to the extent permitted thereby) so
surrendered. Subject to the next succeeding sentence, the Company will, as soon as practicable
thereafter, issue and deliver at said office or place to such Holder of a Security, or to his
nominee or nominees, certificates for the number of full shares of Common Stock or other Marketable
Security to which he shall be entitled as aforesaid, together, subject to the last sentence of
paragraph (a) above, with cash in lieu of any fraction of a share to which he would otherwise be
entitled. The Company shall not be required to deliver certificates for shares of Common Stock or
other Marketable Securities while the stock transfer books for such stock or the transfer books for
such Marketable Securities, as the case may be, or the Security Register are duly closed for any
purpose, but certificates for shares of Common Stock or other Marketable Securities shall be issued
and delivered as soon as practicable after the opening of such books or Security Register. A
Security shall be deemed to have been converted as of the close of business on the date of the
surrender of such Security for conversion as provided above, and the person or persons entitled to
receive the Common Stock or other Marketable Securities issuable upon such conversion shall be
treated for all purposes as the record Holder or Holders of such Common Stock or other Marketable
Securities as of the close of business on such date. In case any Security shall be surrendered for
partial conversion, the Company shall execute and the Trustee shall authenticate and deliver to or
upon the written order of the Holder of the Securities so surrendered, without charge to such
Holder (subject to the provisions of Section 12.08), a new Security or Securities in authorized
denominations in an aggregate principal amount equal to the unconverted portion of the surrendered
Security.

          (c) Notwithstanding anything to the contrary contained herein, in the event the Company shall
have rescinded a redemption of Securities pursuant to Section 11.09 hereof, any Holder of
Securities that shall have surrendered Securities for conversion following the day on which notice
of the subsequently rescinded redemption shall have been given but prior to the later of (a) the
close of business on the Trading Day next succeeding the date on which public announcement of the
rescission of such redemption shall have been made and (b) the date of the mailing of the notice of
rescission required by Section 11.09 hereof (a “Converting Holder”) may rescind the
conversion of such Securities surrendered for conversion by (i) properly completing a form
prescribed by the Company and mailed to Holders of Securities (including Converting Holders) with
the Company’s notice of rescission, which form shall provide for the certification

61

 

by any Converting Holder rescinding a conversion on behalf of any beneficial owner (within the
meaning of Rule 13d-3 under the Securities Exchange Act of 1934) of Securities that the beneficial
ownership (within the meaning of such Rule) of such Securities shall not have changed from the date
on which such Securities were surrendered for conversion to the date of such certification and (ii)
delivering such form to the Company no later than the close of business on that date which is
15 Trading Days following the date of the mailing of the Company’s notice of rescission. The
delivery of such form by a Converting Holder shall be accompanied by (x) any certificates
representing shares of Common Stock or other securities issued to such Converting Holder upon a
conversion of Securities that shall be rescinded by the proper delivery of such form (the
“Surrendered Securities”), (y) any securities, evidences of indebtedness or assets (other
than cash) distributed by the Company to such Converting Holder by reason of such Converting Holder
being a record holder of Surrendered Securities and (z) payment in New York Clearing House funds or
other funds acceptable to the Company of an amount equal to the sum of (I) any cash such Converting
Holder may have received in lieu of the issuance of fractional Surrendered Securities and (II) any
cash paid or payable by the Company to such Converting Holder by reason of such Converting Holder
being a record holder of Surrendered Securities. Upon receipt by the Company of any such form
properly completed by a Converting Holder and any certificates, securities, evidences of
indebtedness, assets or cash payments required to be returned by such Converting Holder to the
Company as set forth above, the Company shall instruct the transfer agent or agents for shares of
Common Stock or other securities to cancel any certificates representing Surrendered Securities
(which Surrendered Securities shall be deposited in the treasury of the Company) and shall instruct
the Registrar to reissue certificates representing Securities to such Converting Holder (which
Securities shall be deemed to have been outstanding at all times during the period following their
surrender for conversion). The Company shall, as promptly as practicable, and in no event more than
five Trading Days following the receipt of any such properly completed form and any such
certificates, securities, evidences of indebtedness, assets or cash payments required to be so
returned, pay to the Holder of Securities surrendered to the Company pursuant to a rescinded
conversion or as otherwise directed by such Holder any interest paid or other payment made to
Holders of Securities during the period from the time such Securities shall have been surrendered
for conversion to the rescission of such conversion. All questions as to the validity, form,
eligibility (including time of receipt) and acceptance of any form submitted to the Company to
rescind the conversion of Securities, including questions as to the proper completion or execution
of any such form or any certification contained therein, shall be resolved by the Company, whose
determination shall be final and binding.

     SECTION 12.03 Adjustment of Conversion Price for Common Stock or Marketable
Securities. The Conversion Price with respect to any Security which is convertible into Common
Stock or other Marketable Securities shall be adjusted from time to time as follows:

          (1) In case the Company shall, at any time or from time to time while any of such
Securities are outstanding, (i) pay a dividend in shares of its Common Stock or other
Marketable Securities, (ii) combine its outstanding shares of Common Stock or other
Marketable Securities into a smaller number of shares or securities, (iii) subdivide its
outstanding shares of Common Stock or other Marketable Securities or (iv) issue by
reclassification of its shares of Common Stock or other Marketable Securities any shares of
stock or other Marketable Securities of the Company, then the Conversion Price in effect
immediately before such action shall be adjusted so that the Holders of such Securities,
upon conversion thereof into Common Stock or other Marketable Securities immediately
following such event, shall be entitled to receive the kind and amount of shares of capital
stock of the Company or other Marketable Securities which they would have owned or been
entitled to receive upon or by reason of such event if such Securities

62

 

had been converted immediately before the record date (or, if no record date, the
effective date) for such event. An adjustment made pursuant to this Section 12.03(1) shall
become effective retroactively immediately after the record date in the case of a dividend
or distribution and shall become effective retroactively immediately after the effective
date in the case of a subdivision, combination or reclassification. For the purposes of
this Section 12.03(1), each Holder of Securities shall be deemed to have failed to exercise
any right to elect the kind or amount of securities receivable upon the payment of any such
dividend, subdivision, combination or reclassification (provided that if the kind or amount
of securities receivable upon such dividend, subdivision, combination or reclassification
is not the same for each nonelecting share, then the kind and amount of securities or other
property receivable upon such dividend, subdivision, combination or reclassification for
each nonelecting share shall be deemed to be the kind and amount so receivable per share by
a plurality of the nonelecting shares).

          (2) In case the Company shall, at any time or from time to time while any of such
Securities are outstanding, issue rights or warrants to all holders of shares of its Common
Stock or other Marketable Securities entitling them (for a period expiring within 45 days
after the record date for such issuance) to subscribe for or purchase shares of Common
Stock or other Marketable Securities (or securities convertible into shares of Common Stock
or other Marketable Securities) at a price per share less than the Current Market Price of
the Common Stock or other Marketable Securities at such record date (treating the price per
share of the securities convertible into Common Stock or other Marketable Securities as
equal to (x) the sum of (i) the price for a unit of the security convertible into Common
Stock or other Marketable Securities plus (ii) any additional consideration initially
payable upon the conversion of such security into Common Stock or other Marketable
Securities divided by (y) the number of shares of Common Stock or other Marketable
Securities initially underlying such convertible security), the Conversion Price with
respect to such Securities shall be adjusted so that it shall equal the price determined by
dividing the Conversion Price in effect immediately prior to the date of issuance of such
rights or warrants by a fraction, the numerator of which shall be the number of shares of
Common Stock or other Marketable Securities outstanding on the date of issuance of such
rights or warrants plus the number of additional shares of Common Stock or other Marketable
Securities offered for subscription or purchase (or into which the convertible securities
so offered are initially convertible), and the denominator of which shall be the number of
shares of Common Stock or other Marketable Securities outstanding on the date of issuance
of such rights or warrants plus the number of shares or securities which the aggregate
offering price of the total number of shares or securities so offered for subscription or
purchase (or the aggregate purchase price of the convertible securities so offered plus the
aggregate amount of any additional consideration initially payable upon conversion of such
Securities into Common Stock or other Marketable Securities) would purchase at such Current
Market Price of the Common Stock or other Marketable Securities. Such adjustment shall
become effective retroactively immediately after the record date for the determination of
stockholders entitled to receive such rights or warrants.

          (3) In case the Company shall, at any time or from time to time while any of such
Securities are outstanding, distribute to all holders of shares of its Common Stock or
other Marketable Securities (including any such distribution made in connection with a
consolidation or merger in which the Company is the continuing corporation and the Common
Stock or other Marketable Securities are not changed or exchanged) cash, evidences of its
indebtedness, securities or assets (excluding (i) regular periodic cash

63

 

dividends in amounts, if any, determined from time to time by the Board of Directors,
(ii) in dividends payable in shares of Common Stock or other Marketable Securities for
which adjustment is made under Section 12.03(1) or (iii) rights or warrants to subscribe
for or purchase securities of the Company (excluding those referred to in Section
12.03(2)), then in each such case the Conversion Price with respect to such Securities
shall be adjusted so that it shall equal the price determined by dividing the Conversion
Price in effect immediately prior to the date of such distribution by a fraction, the
numerator of which shall be the Current Market Price of the Common Stock or other
Marketable Securities on the record date referred to below, and the denominator of which
shall be such Current Market Price of the Common Stock or other Marketable Securities less
the then fair market value (as determined by the Board of Directors of the Company, whose
determination shall be conclusive) of the portion of the cash or assets or evidences of
indebtedness or securities so distributed or of such subscription rights or warrants
applicable to one share of Common Stock or one other Marketable Security (provided that
such denominator shall never be less than 1.0); provided, however, that no adjustment shall
be made with respect to any distribution of rights to purchase securities of the Company if
a Holder of Securities would otherwise be entitled to receive such rights upon conversion
at any time of such Securities into Common Stock or other Marketable Securities unless such
rights are subsequently redeemed by the Company, in which case such redemption shall be
treated for purposes of this Section as a dividend on the Common Stock or other Marketable
Securities. Such adjustment shall become effective retroactively immediately after the
record date for the determination of stockholders or holders of Marketable Securities
entitled to receive such distribution; and in the event that such distribution is not so
made, the Conversion Price shall again be adjusted to the Conversion Price which would then
be in effect if such record date had not been fixed.

          (4) The Company shall be entitled to make such additional adjustments in the
Conversion Price, in addition to those required by subsections 12.03(1), 12.03(2) and
12.03(3), as shall be necessary in order that any dividend or distribution of Common Stock
or other Marketable Securities, any subdivision, reclassification or combination of shares
of Common Stock or other Marketable Securities or any issuance of rights or warrants
referred to above shall not be taxable to the holders of Common Stock or other Marketable
Securities for United States Federal income tax purposes.

          (5) In any case in which this Section 12.03 shall require that any adjustment be made
effective as of or retroactively immediately following a record date, the Company may elect
to defer (but only for five Trading Days following the filing of the statement referred to
in Section 12.05) issuing to the Holder of any Securities converted after such record date
the shares of Common Stock and other capital stock of the Company or other Marketable
Securities issuable upon such conversion over and above the shares of Common Stock and
other capital stock of the Company or other Marketable Securities issuable upon such
conversion on the basis of the Conversion Price prior to adjustment; provided, however,
that the Company shall deliver to such Holder a due bill or other appropriate instrument
evidencing such Holder’s right to receive such additional shares upon the occurrence of the
event requiring such adjustment.

          (6) All calculations under this Section 12.03 shall be made to the nearest cent or
one-hundredth of a share or security, with one-half cent and .005 of a share, respectively,
being rounded upward. Notwithstanding any other provision of this Section 12.03, the
Company shall not be required to make any adjustment of the Conversion

64

 

Price unless such adjustment would require an increase or decrease of at least 1% of
such price. Any lesser adjustment shall be carried forward and shall be made at the time of
and together with the next subsequent adjustment which, together with any adjustment or
adjustments so carried forward, shall amount to an increase or decrease of at least 1% in
such price. Any adjustments under this Section 12.03 shall be made successively whenever an
event requiring such an adjustment occurs.

          (7) In the event that at any time, as a result of an adjustment made pursuant to this
Section 12.03, the Holder of any Security thereafter surrendered for conversion shall
become entitled to receive any shares of stock of or other Marketable Securities of the
Company other than shares of Common Stock or Marketable Securities into which the
Securities originally were convertible, the Conversion Price of such other shares or
Marketable Securities so receivable upon conversion of any such Security shall be subject
to adjustment from time to time in a manner and on terms as nearly equivalent as
practicable to the provisions with respect to Common Stock and Marketable Securities
contained in subparagraphs (1) through (6) of this Section 12.03, and the provisions of
Sections 12.01, 12.02 and 12.04 through 12.09 with respect to the Common Stock or other
Marketable Securities shall apply on like or similar terms to any such other shares or
Marketable Securities and the determination of the Board of Directors as to any such
adjustment shall be conclusive.

          (8) No adjustment shall be made pursuant to this Section (i) if the effect thereof
would be to reduce the Conversion Price below the par value (if any) of the Common Stock or
other Marketable Security, if any, or (ii) subject to Section 12.03(5) hereof, with respect
to any Security that is converted prior to the time such adjustment otherwise would be
made.

          SECTION 12.04 Consolidation or Merger of the Company. In case of either (a) any
consolidation or merger to which the Company is a party, other than a merger or consolidation in
which the Company is the surviving or continuing corporation and which does not result in a
reclassification of, or change (other than a change in par value or from par value to no par value
or from no par value to par value, as a result of a subdivision or combination) in, outstanding
shares of Common Stock or other Marketable Securities or (b) any sale or conveyance of all or
substantially all of the property and assets of the Company to another Person, then each Security
then Outstanding shall be convertible from and after such merger, consolidation, sale or conveyance
of property and assets into the kind and amount of shares of stock or other securities and property
(including cash) receivable upon such consolidation, merger, sale or conveyance by a holder of the
number of shares of Common Stock or other Marketable Securities into which such Securities would
have been converted immediately prior to such consolidation, merger, sale or conveyance, subject to
adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided
for in this Article XII (and assuming such holder of Common Stock or other Marketable Securities
failed to exercise his rights of election, if any, as to the kind or amount of securities, cash or
other property (including cash) receivable upon such consolidation, merger, sale or conveyance
(provided that, if the kind or amount of securities, cash or other property (including cash)
receivable upon such consolidation, merger, sale or conveyance is not the same for each nonelecting
share, then the kind and amount of securities, cash or other property (including cash) receivable
upon such consolidation, merger, sale or conveyance for each nonelecting share, shall be deemed to
be the kind and amount so receivable per share by a plurality of the nonelecting shares or
securities)). The Company shall not enter into any of the transactions referred to in clause (a) or
(b) of the preceding sentence unless effective provision shall be made so as to give effect to the
provisions set forth in this

65

 

Section 12.04. The provisions of this Section 12.04 shall apply similarly to successive
consolidations, mergers, sales or conveyances.

          SECTION 12.05 Notice of Adjustment. Whenever an adjustment in the Conversion Price
with respect to a series of Securities is required:

          (1) the Company shall forthwith place on file with the Trustee and any Conversion
Agent for such Securities a certificate of the Treasurer of the Company, stating the
adjusted Conversion Price determined as provided herein and setting forth in reasonable
detail such facts as shall be necessary to show the reason for and the manner of computing
such adjustment, such certificate to be conclusive evidence that the adjustment is correct;
and

          (2) a notice stating that the Conversion Price has been adjusted and setting forth the
adjusted Conversion Price shall forthwith be mailed, first class postage prepaid, by the
Company to the Holders of record of such Outstanding Securities.

          SECTION 12.06 Notice in Certain Events. In case:

          (1) of a consolidation or merger to which the Company is a party and for which
approval of any stockholders of the Company is required, or of the sale or conveyance to
another person or entity or group of persons or entities acting in concert as a
partnership, limited partnership, syndicate or other group (within the meaning of Rule
13d-3 under the Securities Exchange Act of 1934) of all or substantially all of the
property and assets of the Company; or

          (2) of the voluntary or involuntary dissolution, liquidation or winding up of the
Company; or

          (3) of any action triggering an adjustment of the Conversion Price pursuant to this
Article XII;

then, in each case, the Company shall cause to be filed with the Trustee and the Agent for the
applicable Securities, and shall cause to be mailed, first class postage prepaid, to the Holders of
record of applicable Securities, at least 15 days prior to the applicable date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of any
distribution or grant of rights or warrants triggering an adjustment to the Conversion Price
pursuant to this Article XII, or, if a record is not to be taken, the date as of which the holders
of record of Common Stock or other Marketable Securities entitled to such distribution, rights or
warrants are to be determined, or (y) the date on which any reclassification, consolidation,
merger, sale, conveyance, dissolution, liquidation or winding up triggering an adjustment to the
Conversion Price pursuant to this Article XII is expected to become effective, and the date as of
which it is expected that holders of Common Stock or other Marketable Securities of record shall be
entitled to exchange their Common Stock or other Marketable Securities for securities or other
property deliverable upon such reclassification, consolidation, merger, sale, conveyance,
dissolution, liquidation or winding up.

          Failure to give such notice or any defect therein shall not affect the legality or validity of
the proceedings described in clause (1), (2) or (3) of this Section.

66

 

          SECTION 12.07 Company to Reserve Stock or other Marketable Securities; Registration;
Listing. (a) The Company shall at all times reserve and keep available, free from preemptive
rights, out of its authorized but unissued shares of Common Stock or other Marketable Securities,
for the purpose of effecting the conversion of the Securities, such number of its duly authorized
shares of Common Stock or number or principal amount of other Marketable Securities as shall from
time to time be sufficient to effect the conversion of all applicable outstanding Securities into
such Common Stock or other Marketable Securities at any time (assuming that, at the time of the
computation of such number of shares or securities, all such Securities would be held by a single
Holder); provided, however, that nothing contained herein shall preclude the Company from
satisfying its obligations in respect of the conversion of the Securities by delivery of purchased
shares of Common Stock or other Marketable Securities which are held in the treasury of the
Company. The Company shall from time to time, in accordance with the laws of the State of Delaware,
use its best efforts to cause the authorized amount of the Common Stock or other Marketable
Securities to be increased if the aggregate of the authorized amount of the Common Stock or other
Marketable Securities remaining unissued and the issued shares of such Common Stock or other
Marketable Securities in its treasury (other than any such shares reserved for issuance in any
other connection) shall not be sufficient to permit the conversion of all Securities.

          (b) If any shares of Common Stock or other Marketable Securities which would be issuable upon
conversion of Securities hereunder require registration with or approval of any governmental
authority before such shares or securities may be issued upon such conversion, the Company will in
good faith and as expeditiously as possible endeavor to cause such shares or securities to be duly
registered or approved, as the case may be. The Company will endeavor to list the shares of Common
Stock or other Marketable Securities required to be delivered upon conversion of the Securities
prior to such delivery upon the principal national securities exchange upon which the outstanding
Common Stock or other Marketable Securities is listed at the time of such delivery.

          SECTION 12.08 Taxes on Conversion. The Company shall pay any and all documentary,
stamp or similar issue or transfer taxes that may be payable in respect of the issue or delivery of
shares of Common Stock or other Marketable Securities on conversion of Securities pursuant hereto.
The Company shall not, however, be required to pay any such tax which may be payable in respect of
any transfer involved in the issue or delivery of shares of Common Stock or other Marketable
Securities or the portion, if any, of the Securities which are not so converted in a name other
than that in which the Securities so converted were registered, and no such issue or delivery shall
be made unless and until the person requesting such issue has paid to the Company the amount of
such tax or has established to the satisfaction of the Company that such tax has been paid.

          SECTION 12.09 Conversion After Record Date. If any Securities are surrendered for
conversion subsequent to the record date preceding an Interest Payment Date but on or prior to such
Interest Payment Date (except Securities called for redemption on a Redemption Date between such
record date and Interest Payment Date), the Holder of such Securities at the close of business on
such record date shall be entitled to receive the interest payable on such securities on such
Interest Payment Date notwithstanding the conversion thereof. Securities surrendered for conversion
during the period from the close of business on any record date next preceding any Interest Payment
Date to the opening of business on such Interest Payment Date shall (except in the case of
Securities which have been called for redemption on a Redemption Date within such period) be
accompanied by payment in New York Clearing House funds or other funds acceptable to the Company of
an amount equal to the interest payable on

67

 

such Interest Payment Date on the Securities being surrendered for conversion. Except as
provided in this Section 12.09, no adjustments in respect of payments of interest on Securities
surrendered for conversion or any dividends or distributions or interest on the Common Stock or
other Marketable Securities issued upon conversion shall be made upon the conversion of any
Securities.

          SECTION 12.10 Corporate Action Regarding Par Value of Common Stock.Before taking any
action which would cause an adjustment reducing the applicable Conversion Price below the then par
value (if any) of the shares of Common Stock or other Marketable Securities deliverable upon
conversion of the Securities, the Company will take any corporate action which may, in the opinion
of its counsel, be necessary in order that the Company may validly and legally issue fully paid and
nonassessable shares of Common Stock or other Marketable Securities at such adjusted Conversion
Price.

          SECTION 12.11 Company Determination Final. Any determination that the Company or the
Board of Directors must make pursuant to this Article is conclusive.

          SECTION 12.12 Trustee’s Disclaimer. The Trustee has no duty to determine when an
adjustment under this Article should be made, how it should be made or what it should be. The
Trustee has no duty to determine whether any supplemental indenture need be entered into or whether
any provisions of any supplemental indenture are correct. The Trustee makes no representation as
to the validity or value of any securities or assets issued upon conversion of Securities. The
Trustee shall not be responsible for the Company’s failure to comply with this Article. Each
Conversion Agent other than the Company shall have the same protection under this Section as the
Trustee.

ARTICLE XIII

Guarantees

          SECTION 13.01 Guarantees. (a) Historic TW, as primary obligor and not merely as
surety, will fully, irrevocably and unconditionally guarantee, to each Holder of Securities
(including each Holder of Securities issued under the Indenture after the date of this Indenture)
and to the Trustee and its successors and assigns (i) the full and punctual payment of principal of
and interest on the Securities when due, whether at maturity, by acceleration, by redemption or
otherwise, and all other monetary obligations of the Company under this Indenture (including
obligations to the Trustee) and the Securities and (ii) the full and punctual performance within
applicable grace periods of all other obligations of the Company under this Indenture and the
Securities.

          (b) Each of TBS and HBO, as primary obligor and not merely as surety, will fully, irrevocably
and unconditionally guarantee, to each Holder of Securities (including each Holder of Securities
issued under the Indenture after the date of this Indenture) and to the Trustee and its successors
and assigns (i) the full and punctual payment of all monies due under the Guarantee of Historic TW,
and all other monetary obligations of Historic TW under this Indenture (including obligations to
the Trustee) and (ii) the full and punctual performance within applicable grace periods of all
other obligations of Historic TW under this Indenture and its Guarantee.

68

 

          (c) Each of the Guarantors further agrees that its obligations hereunder shall be
unconditional irrespective of the absence or existence of any action to enforce the same, the
recovery of any judgment against the Company or any other Guarantor (except to the extent such
judgment is paid) or any waiver or amendment of the provisions of this Indenture or the Securities
to the extent that any such action or any similar action would otherwise constitute a legal or
equitable discharge or defense of a guarantor (except that each such waiver or amendment shall be
effective in accordance with its terms).

          (d) Each of the Guarantors further agrees that each Guarantee constitutes a guarantee of
payment, performance and compliance and not merely of collection.

          (e) Each of the Guarantors further agrees to waive presentment to, demand of payment from and
protest to the Company or any other Person, and also waives diligence, notice of acceptance of its
Guarantee, presentment, demand for payment, notice of protest for nonpayment, the filing of claims
with a court in the event of merger or bankruptcy of the Company or any other Person and any right
to require a proceeding first against the Company or any other Person. The obligations of the
Guarantors shall not be affected by any failure or policy on the part of the Trustee to exercise
any right or remedy under this Indenture or the Securities of any series.

          (f) The obligation of each Guarantor to make any payment hereunder may be satisfied by causing
the Company or any other Person to make such payment. If any Holder of any Security or the Trustee
is required by any court or otherwise to return to the Company or any Guarantor, or any custodian,
trustee, liquidator or other similar official acting in relation to any of the Company or any
Guarantor, any amount paid by any of them to the Trustee or such Holder, the Guarantee of such
Guarantor, to the extent theretofore discharged, shall be reinstated in full force and effect.

          (g) Each Guarantor also agrees to pay any and all reasonable costs and expenses (including
reasonable attorneys’ fees) incurred by the Trustee or any Holder of Securities in enforcing any of
their respective rights under its Guarantees.

          (h) Any term or provision of this Indenture to the contrary notwithstanding, each Guarantor
will be automatically released from its obligations under its Guarantee upon receipt by the Trustee
of a certificate of a Responsible Officer of the Company certifying that such Guarantor has no
outstanding Indebtedness For Borrowed Money as of the date of such certificate, other than any
other guarantee of Indebtedness For Borrowed Money that will be released concurrently with the
release of such Guarantee.

          (i) Any term or provision of this Indenture to the contrary notwithstanding, the maximum
aggregate amount of each of the Guarantees shall not exceed the maximum amount that can be
guaranteed by the relevant Guarantor without rendering the relevant Guarantee under this Indenture
voidable under applicable law relating to fraudulent conveyance or fraudulent transfer or similar
laws affecting the rights of creditors generally.

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK.]

69

 

          IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of
the day and year first above written.

	 	 	 	 	 
	 	TIME WARNER INC.,

 	 
	 	by:  	/s/ Edward B. Ruggiero
 	 
	 	 	Name:  	Edward B. Ruggiero 	 
	 	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	HISTORIC TW INC.,

 	 
	 	by:  	/s/ Edward B. Ruggiero
 	 
	 	 	Name:  	Edward B. Ruggiero 	 
	 	 	Title:  	Senior Vice President and
Treasurer 	 
	 
	 	HOME BOX OFFICE, INC.,

 	 
	 	by:  	/s/ Edward B. Ruggiero
 	 
	 	 	Name:  	Edward B. Ruggiero 	 
	 	 	Title:  	Senior Vice President and Assistant
Treasurer 	 
	 
	 	TURNER BROADCASTING SYSTEM, INC.,

 	 
	 	by:  	/s/ Edward B. Ruggiero
 	 
	 	 	Name:  	Edward B. Ruggiero 	 
	 	 	Title:  	Senior Vice President and Assistant
Treasurer 	 
	 

70

 

	 	 	 	 	 
	 	THE BANK OF NEW YORK MELLON, as Trustee.

 	 
	 	by:  	/s/ Timothy W. Casey
 	 
	 	 	Name:  	Timothy W. Casey 	 
	 	 	Title:  	Senior Associate 	 
	 

71

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}]]